Author: "Yi Y." / Publisher: springer - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Yi Y."' showing total 2,992 results

Start Over Author "Yi Y." Publisher springer

2,992 results on '"Yi Y."'

1. Instance as Identity: A Generic Online Paradigm for Video Instance Segmentation

Author: Zhu, F, Zongxin, Y, Xin, Y, Yi, Y, Yunchao, W, Zhu, F, Zongxin, Y, Xin, Y, Yi, Y, and Yunchao, W
Published: 2023

2. Measurement and QCD analysis of double-differential inclusive jet cross sections in proton-proton collisions at root s=13 TeV

Author: Tumasyan, A., Adam, W., Rejkovic, J. W., Bergauer, T., Chatterjee, S., Damanakis, K., Dragicevic, M., Escalante Del Valle, Fruhwirth, A., Jeitler, R., Krammer, M., Lechner, N., Liko, L., Mikulec, D., Paulitsch, I., Pitters, P., Schieck, F. M., Schofbeck, J., Schwarz, R., Templ, D., Waltenberger, S., Wulz, W., C. -E., Chekhovsky, V., Litomin, A., Makarenko, V., Darwish, M. R., Wolf, De, Janssen, E. A., Kello, T., Lelek, T., Rejeb, Sfar, Van, Mechelen, Van, Putte, Van, Remortel, Blekman, N., Bols, F., D'Hondt, E. S., Delcourt, J., Faham, El, Lowette, H., Moortgat, S., Morton, S., Muller, A., Sahasransu, D., Tavernier, A. R., Van, Doninck, Beghin, W., Bilin, D., Clerbaux, B., Lentdecker, De, Favart, G., Grebenyuk, L., Kalsi, A., Lee, A. K., Mahdavikhorrami, K., Makarenko, M., Moureaux, I., Petre, L., Popov, L., Postiau, A., Starling, N., Thomas, E., L. V., Bemden, En, M. V., Velde, Er, Vanlaer, C., Cornelis, P., Dobur, T., Knolle, D., Lambrecht, J., Mestdach, L., Niedziela, G., Roskas, M., Samalan, C., Skovpen, A., Tytgat, K., Vermassen, M., Wezenbeek, B., Benecke, L., Bethani, A., Bruno, A., Bury, G., Caputo, F., David, C., Delaere, P., Donertas, C., Giammanco, I. S., Jaffel, A., Jain, K., Lemaitre, Sa., Mondal, V., Prisci, K., Aro, J., Taliercio, A., Teklishyn, M., Tran, T. T., Vischia, P., Wertz, S., Alves, G. A., Hensel, C., Moraes, A., Alda, Junior, W. L., Alves Gallo Pereira, Barroso Ferreira Filho, Br, M., Malbouisson, Ao, Carvalho, H., Chinellato, W., Costa, Da, E. M., Silveira, Da, G. G., De Jesus Damiao, Fonseca De Souza, Mora, Herrera, Mota, Amarilo, Mundim, K., Nogima, L., Rebello, Teles, Santoro, P., Silva Do Amaral, Sznajder, S. M., Thiel, A., Torres Da Silva De Araujo, Vilela, Pereira, Bernardes, A., Calligaris, C. A., Fern, L., ez Perez Tomei, Gregores, T. R., Lemos, E. M., Mercadante, D. S., Novaes, P. G., Padula, S. F., S, Ra, S., Aleks, Rov, Antchev, A., Hadjiiska, G., Iaydjiev, R., Misheva, P., Rodozov, M., Shopova, M., Sultanov, M., Dimitrov, G., Ivanov, A., Litov, T., Pavlov, L., Petkov, B., Petrov, P., Cheng, A., Javaid, T., Mittal, T., Yuan, M., Ahmad, L., Bauer, M., Dozen, G., Hu, C., Martins, Z., Wang, J., Yi, Y., Chapon, K., Chen, E., Chen, G. M., Chen, H. S., Iemmi, M., Kapoor, F., Leggat, A., Liao, D., Liu, H., Z. -A., Milosevic, V., Monti, F., Sharma, R., Tao, J., Thomas-Wilsker, J., Zhang, H., Zhao, J., Agapitos, A., An, Y., Ban, Y., Chen, C., Levin, A., Li, Q., Lyu, X., Mao, Y., Qian, S. J., Wang, D., Wang, Q., Xiao, J., Lu, M., You, Z., Gao, X., Okawa, H., Zhang, Y., Lin, Z., Xiao, M., Avila, C., Cabrera, A., Florez, C., Fraga, J., Mejia, Guisao, Ramirez, J., Ruiz, Alvarez, J. D., Salazar, Gonzalez, Giljanovic, C. A., Godinovic, D., Lelas, N., Puljak, D., Antunovic, I., Kovac, Z., Sculac, M., Brigljevic, T., Ferencek, V., Majumder, D., Roguljic, D., Starodumov, M., Susa, A., Attikis, T., Christoforou, A., Erodotou, K., Ioannou, E., Kole, A., Kolosova, G., Konstantinou, M., Mousa, S., Nicolaou, J., Ptochos, C., Razis, F., Rykaczewski, P. A., Saka, H., Finger, H., Finger, M., r. M., J, Kveton, A., Ayala, E., Carrera, Jarrin, Assran, E., Ellithi, Kamel, Mahmoud, A., Mohammed, M. A., Bhowmik, Y., Dewanjee, S., Ehataht, R. K., Kadastik, K., M. N., An, S., Nielsen, C., Pata, J., Raidal, M., Tani, L., Veelken, C., Eerola, P., Forthomme, L., Kirschenmann, H., Osterberg, K., Voutilainen, M., Bharthuar, S., Brucken, E., Garcia, F., Havukainen, J., Kim, M. S., Kinnunen, R., Lampen, T., Lassila-Perini, K., Lehti, S., Linden, T., Lotti, M., Martikainen, L., Myllymaki, M., Ott, J., Siikonen, H., Tuominen, E., Tuominiemi, J., Luukka, P., Petrow, H., Tuuva, T., Amendola, C., Besancon, M., Couderc, F., Dejardin, M., Denegri, D., Faure, J. L., Ferri, F., Ganjour, S., Gras, P., Hamel de Monchenault, Jarry, G., Lenzi, P., Locci, B., Malcles, E., J. R., Er, J., Rosowsky, A., Sahin, M. O., Savoy-Navarro, A., Titov, M., G. B., Yu, Ahuja, S., Beaudette, F., Bonanomi, M., Buchot, Perraguin, Busson, A., Cappati, P., Charlot, A., Davignon, C., Diab, O., Falmagne, B., Ghosh, G., Granier de Cassagnac, Hakimi, R., Kucher, A., Motta, I., Nguyen, J., Och, M., O, C., Paganini, P., Rembser, J., Salerno, R., Sarkar, U., Sauvan, J. B., Sirois, Y., Tarabini, A., Zabi, A., Zghiche, A., Agram, J. -L., Rea, J., Apparu, D., Bloch, D., Bourgatte, G., Brom, J. -M., Chabert, E. C., Collard, C., Darej, D., Fontaine, J. -C., Goerlach, U., Grimault, C., Bihan, Le, A. -C., Nibigira, E., Van, Hove, Asilar, P., Beauceron, E., Bernet, S., Boudoul, C., Camen, G., Carle, C., Chanon, A., Contardo, N., Depasse, D., Mamouni, El, Fay, H., Gascon, J., Gouzevitch, S., Ille, M., Laktineh, B., Lattaud, I. B., Lesauvage, H., Lethuillier, A., Mirabito, M., Perries, L., Shchablo, S., Sordini, K., Torterotot, V., Touquet, L., G. V., Donckt, Er, Viret, M., Lomidze, S., Toriashvili, I., Tsamalaidze, T., Botta, Z., Feld, V., Klein, L., Lipinski, K., Meuser, M., Pauls, D., Rowert, A., Schulz, N., Teroerde, J., Dodonova, M., Eliseev, A., Erdmann, D., Fackeldey, M., Fischer, P., Ghosh, B., Hebbeker, S., Hoepfner, T., Ivone, K., Mastrolorenzo, F., Merschmeyer, L., Meyer, M., Mocellin, A., Mondal, G., Mukherjee, S., Noll, S., Novak, D., Pook, A., Pozdnyakov, T., Rath, A., Reithler, Y., Roemer, H., Schmidt, J., Schuler, A., Sharma, S. C., Vigilante, A., Wiedenbeck, L., Zaleski, S., Dziwok, S., Flugge, C., Haj, Ahmad, Hlushchenko, W., Kress, O., Nowack, T., Pistone, A., Pooth, C., Roy, O., Sert, D., Stahl, H., Ziemons, A., Zotz, T., Aarup, Petersen, Aldaya, Martin, Asmuss, M., Baxter, P., Bayatmakou, S., Behnke, M., Bermudez, Martinez, Bhattacharya, A., Bin, Anuar, Borras, A. A., Brunner, K., Campbell, D., Cardini, A., Colombina, C., Consuegra, Rodriguez, Correia, Silva, Danilov, G., Silva, De, Didukh, M., Eckerlin, L., Eckstein, G., Eren, D., Estevez, Banos, Filatov, L. I., Gallo, O., Gao, E., Geiser, J., Giraldi, A., Grohsjean, A., Guthoff, A., Jafari, M., Jomhari, A., Jung, N. Z., Kasem, H., Kasemann, A., Kaveh, M., Kleinwort, H., Kruecker, C., Lange, D., Lidrych, W., Lipka, J., Lohmann, K., Maekelae, W., Mankel, T., Melzer-Pellmann, R., I. -A., Mendizabal, Morentin, Metwally, M., Meyer, J., Meyer, A. B., Mnich, M., Mussgiller, J., Otarid, A., Perez, Adan, Pitzl, D., Raspereza, D., Ribeiro, Lopes, Ruebenach, B., Saggio, J., Saibel, A., Savitskyi, A., Scham, M., Scheurer, M., Schnake, V., Schuetze, S., Schwanenberger, P., Shchedrolosiev, C., Sosa, Ricardo, Stafford, R. E., Tonon, D., Van De Klundert, Walsh, M., Walter, R., Wen, D., Wichmann, Y., Wiens, K., Wissing, L., Wuchterl, C., Zlebcik, S., Aggleton, R., Albrecht, R., Bein, S., Benato, S., Connor, L., Leo, De, Eich, K., Feindt, M., Froehlich, F., Garbers, A., Garutti, C., Gunnellini, E., Hajheidari, P., Haller, M., Hinzmann, J., Kasieczka, A., Klanner, G., Kogler, R., Kramer, R., Kutzner, T., Lange, V., Lange, J., Lobanov, T., Malara, A., Nigamova, A., Pena, Rodriguez, Rieger, K. J., Schleper, O., Schroeder, P., Schw, M., T, J., Sonneveld, J., Stadie, H., Steinbrueck, G., Tews, A., Zoi, I., Bechtel, J., Brommer, S., Burkart, M., Butz, E., Caspart, R., Chwalek, T., Boer, De, Dierlamm, W., Droll, A., Morabit, El, Faltermann, K., Giffels, N., Gosewisch, M., Gottmann, J. o., Hartmann, A., Heidecker, F., Husemann, C., Keicher, U., Koppenhoefer, P., Maier, R., Metzler, S., Mitra, M., Mueller, S., Neukum, Th., Nuernberg, M., Quast, A., Rabbertz, G., Rauser, K., Savoiu, J., Schnepf, D., Seith, M., Shvetsov, D., Simonis, I., Ulrich, H. J., Van Der Linden, Von, Cube, Wassmer, R. F., Weber, M., Wiel, M., Wolf, S., Wozniewski, R., Wunsch, S., Anagnostou, S., Daskalakis, G., Geralis, G., Kyriakis, T., Loukas, A., Stakia, D., Diamantopoulou, A., Karasavvas, M., Karathanasis, D., Kontaxakis, G., Koraka, P., Manousakis-Katsikakis, C. K., Panagiotou, A., Papavergou, A., Saoulidou, I., Theofilatos, N., Tziaferi, K., Vellidis, E., Vourliotis, K., Bakas, E., Kousouris, G., Papakrivopoulos, K., Tsipolitis, I., Zacharopoulou, G., Adamidis, A., Bestintzanos, K., Evangelou, I., Foudas, I., Gianneios, C., Katsoulis, P., Kokkas, P., Manthos, P., Papadopoulos, N., Strologas, I., Csanad, J., Farkas, M., Gadallah, K., Lokos, M. M. A., Major, S., P. M., Al, K., Mehta, A., Pasztor, G., Radl, A. J., Suranyi, O., Veres, G. I., Bartok, M., Bencze, G., Hajdu, C., Horvath, D., Sikler, F., Veszpremi, V., Czellar, S., Karancsi, J., Molnar, J., Szillasi, Z., Teyssier, D., Raics, P., Trocsanyi, Z. L., Ujvari, B., Csorgo, T., Nemes, F., Novak, T., Choudhury, S., Komaragiri, J. R., Kumar, D., Panwar, L., Tiwari, P. C., Bahinipati, S., Kar, C., Mal, P., Mishra, T., Muraleedharan Nair Bindhu, Nayak, V. K., Saha, A., Sur, P., Swain, N., Vats, S. K., Bansal, D., Beri, S., Bhatnagar, S. B., Chaudhary, V., Chauhan, G., Dhingra, S., Gupta, N., Kaur, R., Kaur, A., Kaur, M., Kumari, S., Meena, P., M. S., Eep, K., Singh, J. B., Virdi, A. K., Ahmed, A., Bhardwaj, A., Choudhary, B. C., Gola, M., Keshri, S., Kumar, A., Naimuddin, M., Priyanka, P., Ranjan, K., Shah, A., Bharti, M., Bhattacharya, R., Bhattacharya, S., Bhowmik, D., Dutta, S., Gomber, B., Maity, M., Palit, P., Rout, P. K., Saha, G., Sahu, B., Sarkar, S., Sharan, M., Singh, B., Thakur, S., Behera, P. K., Behera, S. C., Kalbhor, P., Muhammad, A., Pradhan, R., Pujahari, P. R., Sharma, A., Sikdar, A. K., Dutta, D., Jha, V., Kumar, V., Mishra, D. K., Naskar, K., Netrakanti, P. K., Pant, L. M., Shukla, P., Aziz, T., Dugad, S., Kumar, M., Banerjee, S., Chudasama, R., Guchait, M., Karmakar, S., Kumar, S., Majumder, G., Mazumdar, K., Alpana, K., Dube, S., Kansal, B., Laha, A., P, Ey, Rane, S., Rastogi, A., Bakhshiansohi, S., Khazaie, H., Zeinali, E., Chenarani, M., Etesami, S., Khakzad, S. M., Mohammadi, Najafabadi, Grunewald, M., Abbrescia, M., Aly, M., Aruta, R., Colaleo, C., Creanza, A., Filippis, De, Palma, De, Florio, Di, Pilato, Di, Elmetenawee, A., Fiore, W., Gelmi, L., Gul, A., Iaselli, M., Ince, G., Lezki, M., Maggi, S., Maggi, G., Margjeka, M., Mastrapasqua, I., My, V., Nuzzo, S., Pellecchia, S., Pompili, A., Pugliese, A., Ramos, G., Ranieri, D., Selvaggi, A., Silvestris, G., Simone, L., Venditti, F. M., Verwilligen, R., Abbiendi, P., Battilana, G., Bonacorsi, C., Borgonovi, D., Brigliadori, L., Campanini, L., Capiluppi, R., Castro, P., Cavallo, A., Cuffiani, F. R., Dallavalle, M., Diotalevi, G. M., Fabbri, T., Fanfani, F., Giacomelli, A., Giommi, P., Gr, L., I, C., Guiducci, L., Meo, Lo, Lunerti, S., Marcellini, L., Masetti, S., Navarria, G., Perrotta, F. L., Primavera, A., Rossi, F., Rovelli, A. M., Siroli, T., Albergo, G. P., Costa, S., Mattia, Di, Potenza, A., Tricomi, R., Tuve, A., Barbagli, C., Cassese, G., Ceccarelli, A., Ciulli, R., Civinini, V., D'Aless, C., Ro, R., Focardi, E., Latino, G., Lizzo, M., Meschini, M., Paoletti, S., Seidita, R., Sguazzoni, G., Viliani, L., Benussi, L., Bianco, S., Piccolo, D., Bozzo, M., Ferro, F., Mulargia, R., Robutti, E., Tosi, S., Benaglia, A., Boldrini, G., Brivio, F., Cetorelli, F., Guio, De, Dinardo, F., Dini, M. E., Gennai, P., Ghezzi, S., Govoni, A., Guzzi, P., Lucchini, L., Malberti, M. T., Malvezzi, M., Massironi, S., Menasce, A., Moroni, D., Paganoni, L., Pedrini, M., Pinolini, D., Ragazzi, B. S., Redaelli, S., Tabarelli de Fatis, Valsecchi, T., Zuolo, D., Buontempo, D., Carnevali, S., Cavallo, F., Iorio, De, Fabozzi, A., Iorio, F., Lista, A. O. M., Meola, L., Paolucci, S., Rossi, P., Sciacca, B., Azzi, C., Bacchetta, P., Bisello, N., Bortignon, D., Bragagnolo, P., Carlin, A., Checchia, R., Dorigo, P., Dosselli, T., Gasparini, U., Gasparini, F., Grosso, U., Hoh, G., Layer, S. Y., Lusiani, L., Margoni, E., Meneguzzo, M., Pazzini, A. T., Ronchese, J., Rossin, P., Simonetto, R., Strong, F., Tosi, G., Yarar, M., Zanetti, H., Zotto, M., Zucchetta, P., Zumerle, A., Aime, G., Braghieri, C., Calzaferri, A., Fiorina, S., Montagna, D., Ratti, P., S. P., Re, Riccardi, V., Salvini, C., Vai, P., Vitulo, I., Asenov, P., Bilei, P., Ciangottini, G. M., Fano, L., Lariccia, P., Magherini, M., Mantovani, G., Mariani, V., Menichelli, M., Moscatelli, F., Piccinelli, A., Presilla, M., Rossi, A., Santocchia, A., Spiga, D., Tedeschi, T., Azzurri, P., Bagliesi, G., Bertacchi, V., Bianchini, L., Boccali, T., Bossini, E., Castaldi, R., Ciocci, M. A., D'Amante, V., Dell'Orso, R., Domenico, Di, Donato, M. R., Giassi, S., Ligabue, A., Manca, F., Orli, G., Matos, Figueiredo, Messineo, D., Palla, A., Parolia, F., Ramirez-Sanchez, S., Rizzi, G., Rol, A., I, G., Roy, Chowdhury, Scribano, S., Shafiei, A., Spagnolo, N., Tenchini, P., Tonelli, R., Turini, G., Venturi, N., Verdini, A., Barria, P. G., Campana, P., Cavallari, M., Del, Re, Marco, Di, Diemoz, E., Longo, M., Meridiani, E., Organtini, P., G. P., Olfi, F., Paramatti, R., Quaranta, C., Rahatlou, S., Rovelli, C., Santanastasio, F., Soffi, L., Tramontano, R., Amapane, N., Arcidiacono, R., Argiro, S., Arneodo, M., Bartosik, N., Bellan, R., Bellora, A., Berenguer, Antequera, Biino, J., Cartiglia, C., Cometti, N., Covarelli, M., Demaria, R., Kiani, N., Legger, B., Mariotti, F., Maselli, C., Migliore, S., Monteil, E., Monteno, E., Obertino, M., Ortona, M. M., Pacher, G., Pastrone, L., Pelliccioni, N., Pinna, Angioni, Ruspa, G. L., Shchelina, M., Siviero, K., Sola, F., Solano, V., Soldi, A., Staiano, D., Tornago, A., Trocino, M., Vagnerini, D., Belforte, A., S. C., Elise, V., Casarsa, M., Cossutti, F., Rold, Da, Della, Ricca, Sorrentino, G., Vazzoler, G., Dogra, F., Huh, S., Kim, C., Kim, B., Kim, D. H., Kim, G. N., Lee, J., Moon, S. W., C. S., Oh, Pak, Y. D., Radburn-Smith, S. I., Sekmen, B. C., Yang, S., Kim, Y. C., Moon, H., Francois, D. H., Park, T. J., Cho, J., Choi, S., Go, S., Hong, Y., Lee, B., Lee, K., Lim, K. S., Park, J., Yoo, S. K., Goh, J., Gurtu, J., Kim, A., Kim, H. S., Almond, Y., Bhyun, J., Choi, J. H., Jeon, J., Kim, S., Kim, J., J. S., Ko, Kwon, S., Lee, H., Oh, S., B. H., Oh, Oh, M., Seo, S. B., Yang, H., Yoon, U. K., Jang, I., Kang, W., Kang, D. Y., Kim, Y., Ko, S., Lee, J. S. H., Merlin, Y., Park, J. A., Roh, I. C., Ryu, Y., Song, M. S., Watson, D., Yang, I. J., Ha, S., Yoo, S., Choi, H. D., Lee, M., Yu, Y., Beyrouthy, I., Maghrbi, T., Dreimanis, Y., Veckalns, K., Ambrozas, V., Carvalho Antunes De Oliveira, Juodagalvis, A., Rinkevicius, A., Tamulaitis, A., Bin, Norjoharuddeen, Wan, Abdullah, Yusli, W. A. T., Zolkapli, M. N., Benitez, Z., J. F., Castaneda, Hern, Ez, A., Leon, Coello, Murillo, Quijada, Sehrawat, J. A., Valencia, Palomo, Ayala, L., Castilla-Valdez, G., De La Cruz-Burelo, Heredia-De La Cruz, Lopez-Fern, I., Ez, R., Mondragon, Herrera, C. A., Perez, Navarro, D. A., Sanchez, Hern, Carrillo, Moreno, Oropeza, Barrera, Vazquez, Valencia, Pedraza, F., Salazar, Ibarguen, H. A., Uribe, Estrada, Mijuskovic, C., Raicevic, J., Krofcheck, N., Butler, D., Ahmad, P. H., Asghar, A., Awais, M. I., Awan, A., Hoorani, M. I. M., Khan, H. R., Shah, W. A., Shoaib, M. A., Waqas, M., Avati, M., Grzanka, V., Malawski, L., Bialkowska, M., Bluj, H., Boimska, M., Gorski, B., Kazana, M., Szleper, M., Zalewski, M., Bunkowski, P., Doroba, K., Kalinowski, K., Konecki, A., Krolikowski, M., Araujo, J., Bargassa, M., Bastos, P., Boletti, D., Faccioli, A., Gallinaro, P., Hollar, M., Leonardo, J., Niknejad, N., Pisano, T., Seixas, M., Toldaiev, J., Varela, O., Afanasiev, J., Budkouski, S., Golutvin, D., Gorbunov, I., Karjavine, I., Korenkov, V., Lanev, V., Malakhov, A., Matveev, A., Palichik, V., Perelygin, V., Savina, V., Seitova, M., Shalaev, D., Shmatov, V., Shulha, S., Smirnov, S., Teryaev, V., Voytishin, O., Yuldashev, N., Zarubin, B. S., Zhizhin, A., Gavrilov, I., Golovtcov, G., Ivanov, V., Kuznetsova, V., Murzin, E., Oreshkin, V., Smirnov, V., Sosnov, I., Sulimov, D., Uvarov, V., Volkov, L., Vorobyev, S., Reev, A., Dermenev, Yu., Gninenko, A., Golubev, S., Karneyeu, N., Kirpichnikov, A., Kirsanov, D., Krasnikov, M., Pashenkov, N., Pivovarov, A., Toropin, G., Epshteyn, A., Gavrilov, V., Lychkovskaya, V., Nikitenko, N., Popov, A., Stepennov, V., Toms, A., Vlasov, M., Zhokin, E., Aushev, A., Chadeeva, T., Oskin, M., Parygin, A., Popova, P., Rusinov, E., Selivanova, V., Reev, D., Azarkin, V., Dremin, M., Kirakosyan, I., Terkulov, M., Belyaev, A., Boos, A., Dubinin, E., Dudko, M., Ershov, L., Klyukhin, A., Kodolova, V., Lokhtin, O., Lukina, I., Obraztsov, O., Petrushanko, S., Savrin, S., Snigirev, V., Blinov, A., Dimova, V., Kardapoltsev, T., Kozyrev, L., Ovtin, A., Radchenko, I., Skovpen, O., Azhgirey, Y., Bayshev, I., Elumakhov, I., Kachanov, D., Konstantinov, V., D. M., Rik, P., Petrov, V., Ryutin, R., Slabospitskii, S., Sobol, A., Troshin, S., Tyurin, N., Uzunian, A., Volkov, A., Babaev, A., Okhotnikov, V., Borshch, V., Ivanchenko, V., Tcherniaev, E., Adzic, P., Dordevic, M., Milenovic, P., Milosevic, J., Aguilar-Benitez, M., Alcaraz, Maestre, Alvarez, Fern, Bachiller, I., Barrio, Luna, Bedoya, M., Cristina, F., Carrillo, Montoya, Cepeda, C. A., Cerrada, M., Colino, M., De La Cruz, Delgado, Peris, Fern, A., Ramos, Ez, Flix, J. P., Fouz, J., M. C., Gonzalez, Lopez, Goy, Lopez, Hern, S., J. M., Ez, Josa, M. I., Leon, Holgado, Moran, J., Navarro, Tobar, Perez, Dengra, Perez-Calero, Yzquierdo, Puerta, Pelayo, Redondo, J., Romero, I., Sanchez, Navas, Urda, Gomez, Willmott, L., Troconiz, De, Reyes-Almanza, J. F., Alvarez, Gonzalez, Cuevas, B., Erice, J., Fern, C., Menendez, Ez, Folgueras, J., Gonzalez, Caballero, Gonzalez, Fern, J. R., Ez, Palencia, Cortezon, Ramon, Alvarez, Rodriguez, Bouza, Soto, Rodriguez, Trapote, A., Trevisani, A., Vico, Villalba, Brochero, Cifuentes, Cabrillo, J. A., Calderon, I. J., Duarte, Campderros, Fern, J., Ez, M., Fern, Madrazo, Ez, Manteca, Ez, P. J., Garcia, Alonso, Gomez, A., Martinez, Rivero, Martinez Ruiz del Arbol, Matorras, P., Matorras, Cuevas, Piedra, Gomez, Prieels, J., Rodrigo, C., Ruiz-Jimeno, T., Scodellaro, A., Vila, L., Vizan, Garcia, Jayan, J. M., M. K., A, Kailasapathy, B., Sonnadara, D. U. J., Wickramarathna, D. D. C., Dharmaratna, W. G. D., Liyanage, K., Perera, N., Wickramage, N., Aarrestad, T. K., Abbaneo, D., Alimena, J., Auffray, E., Auzinger, G., Baechler, J., Baillon, P., Barney, D., Bendavid, J., Bianco, M., Bocci, A., Camporesi, T., Capeans, Garrido, Cerminara, M., Chernyavskaya, G., Chhibra, N., Cipriani, S. S., Cristella, M., D'Enterria, L., Dabrowski, D., David, A., Roeck, De, Defranchis, A., Deile, M. M., Dobson, M., Dunser, M., Dupont, M., Elliott-Peisert, N., Emriskova, A., Fallavollita, N., Fasanella, F., Florent, D., Franzoni, A., Funk, G., Giani, W., Gigi, S., Gill, D., Glege, K., Gouskos, F., Haranko, L., Hegeman, M., Innocente, J., James, V., Janot, T., Kaspar, P., Kieseler, J., Komm, J., Kratochwil, M., Lange, N., Laurila, C., Lecoq, S., Lintuluoto, P., Long, A., Lourenco, K., Maier, C., Malgeri, B., Mallios, L., Mannelli, S., Marini, M., Meijers, A. C., Mersi, F., Meschi, S., Moortgat, E., Mulders, F., Orfanelli, M., Orsini, S., Pantaleo, L., Pape, F., Perez, L., Peruzzi, E., Petrilli, M., Petrucciani, A., Pfeiffer, G., Pierini, A., Piparo, M., Pitt, D., Qu, M., Quast, H., Rabady, T., Racz, D., Reales, Gutierrez, Rieger, G., Rovere, M., Sakulin, M., Salfeld-Nebgen, H., Scarfi, J., Schafer, S., Schwick, C., Selvaggi, C., Sharma, M., Silva, A., Snoeys, P., Sphicas, W., Summers, P., Tatar, S., Tavolaro, K., Treille, V. R., Tropea, D., Tsirou, P., Van, Onsem, Wanczyk, G. P., Wozniak, J., Zeuner, K. A., Caminada, W. D., Ebrahimi, L., Erdmann, A., Horisberger, W., Ingram, R., Kaestli, Q., Kotlinski, H. C., Langenegger, D., Missiroli, U., Noehte, M., Rohe, L., Rosov, T., Backhaus, K., Berger, M., Cal, P., Ri, A., Cosa, De, Dissertori, A., Dittmar, G., Donega, M., Dorfer, M., Eble, C., Gedia, F., Glessgen, K., Gomez, Espinosa, Grab, T. A., Hits, C., Lustermann, D., Lyon, W., A. -M., Manzoni, R. A., Marchese, L., Martin, Perez, Meinhard, C., Nessi-Tedaldi, M. T., Niedziela, F., Pauss, J., Perovic, F., Pigazzini, V., Ratti, S., Reichmann, M. G., Reissel, M., Reitenspiess, C., Ristic, T., Ruini, B., Sanz, Becerra, Stampf, D. A., Steggemann, V., Wallny, J., Zhu, R., Amsler, D. H., Bartschi, C., Botta, P., Brzhechko, C., Canelli, D., Cormier, M. F., Wit, De, Del, Burgo, Heikkila, R., Huwiler, J. K., Jin, M., Jofrehei, W., Kilminster, A., Leontsinis, B., Liechti, S., Macchiolo, S. P., Meiring, A., Mikuni, P., Molinatti, V. M., Neutelings, U., Reimers, I., Robmann, A., Sanchez, Cruz, Schweiger, S., Senger, K., Takahashi, M., Adloff, Y., Kuo, C., Lin, C. M., Roy, W., Sarkar, A., Yu, T., Ceard, S. S., Chao, L., Chen, Y., Chen, K. F., Hou, P. H., W. -S., Y. y., Li, R. -S., Paganis, E., Psallidas, A., Steen, A., H. y., Wu, Yazgan, E., P. r., Yu, Asavapibhop, B., Asawatangtrakuldee, C., Srimanobhas, N., Boran, F., Damarseckin, S., Demiroglu, Z. S., Dolek, F., Dumanoglu, I., Eskut, E., Guler, Y., Gurpinar, Guler, Isik, E., Kara, C., Kayis, Topaksu, Kiminsu, A., Onengut, U., Ozdemir, G., Polatoz, K., Simsek, A., Tali, A. E., Tok, B., Turkcapar, U. G., Zorbakir, S., Isildak, I. S., Karapinar, B., Ocalan, G., Yalvac, K., Akgun, M., Atakisi, B., Gulmez, I. O., Kaya, E., Kaya, M., Ozcelik, O., Tekten, O., Yetkin, S., Cakir, E. A., Cankocak, A., Komurcu, K., Sen, Y., Cerci, S., Hos, S., Kaynak, I., Ozkorucuklu, B., Sunar, Cerci, Zorbilmez, D., Grynyov, C., Levchuk, B., Anthony, L., Bhal, D., Bologna, E., Brooke, S., Bundock, J. J., Clement, A., Cussans, E., Flacher, D., Goldstein, H., Heath, J., Heath, G. P., Kreczko, H. F., Krikler, L., Paramesvaran, B., Seif El Nasr-Storey, Smith, S., Stylianou, V. J., Walkingshaw, Pass, White, K., Bell, R., Belyaev, K. W., Brew, A., Brown, C., Cockerill, R. M., Cooke, D. J. A., Ellis, C., Harder, K. V., Harper, K., Holmberg, S., M. -L., Linacre, J., Manolopoulos, K., Newbold, D. M., Olaiya, E., Petyt, D., Reis, T., Schuh, T., Shepherd-Themistocleous, C. H., Tomalin, I. R., Williams, T., Bainbridge, R., Bloch, P., Bonomally, S., Borg, J., Breeze, S., Buchmuller, O., Cepaitis, V., Chahal, G. S., Colling, D., Dauncey, P., Davies, G., Della, Negra, Fayer, M., Fedi, S., Hall, G., Hassanshahi, G., Iles, M. H., Langford, G., Lyons, J., Magnan, L., Malik, S., Martelli, A., Monk, D. G., Nash, J., Pesaresi, M., Raymond, D. M., Richards, A., Rose, A., Scott, E., Seez, C., Shtipliyski, A., Tapper, A., Uchida, K., Virdee, T., Vojinovic, M., Wardle, N., Webb, S. N., Winterbottom, D., Coldham, K., Cole, J. E., Khan, A., Kyberd, P., Reid, I. D., Teodorescu, L., Zahid, S., Abdullin, S., Brinkerhoff, A., Caraway, B., Dittmann, J., Hatakeyama, K., Kanuganti, A. R., Mcmaster, B., Pastika, N., Saunders, M., Sawant, S., Sutantawibul, C., Wilson, J., Bartek, R., Dominguez, A., Uniyal, R., Vargas, Hern, A. M., Ez, Buccilli, A., Cooper, S. I., Croce, Di, Gleyzer, D., Henderson, S. V., Perez, C., Rumerio, C. U., West, P., Akpinar, C., Albert, A., Arcaro, A., Cosby, D., Demiragli, C., Fontanesi, Z., Gastler, E., May, D., Rohlf, S., Salyer, J., Sperka, K., Spitzbart, D., Suarez, D., Tsatsos, I., Yuan, A., Zou, S., Benelli, D., Burkle, G., Coubez, B., Cutts, X., Hadley, D., Heintz, M., Hogan, U., Kwon, J. M., T. L., Sberg, G., Lau, K. T., Li, D., Lukasik, M., Luo, J., Narain, M., Pervan, N., Sagir, S., Simpson, F., Usai, E., Wong, W. Y., Yan, X., Yu, D., Zhang, W., Bonilla, J., Brainerd, C., Breedon, R., Calderon De La Barca Sanchez, Chertok, M., Conway, M., Cox, J., Erbacher, P. T., Haza, R., Jensen, G., Kukral, F., O. L., Er, R., Mulhearn, M., Pellett, D., Regnery, B., Taylor, D., Yao, Y., Zhang, F., Bachtis, M., Cousins, R., Datta, A., Hamilton, D., Hauser, J., Ignatenko, M., Iqbal, M. A., Lam, T., Nash, W. A., Regnard, S., Saltzberg, D., Stone, B., Valuev, V., Burt, K., Clare, R., Gary, J. W., Gordon, M., Hanson, G., Karapostoli, G., Long, O. R., Manganelli, N., Olmedo, Negrete, Si, M., Wimpenny, W., Zhang, S., Branson, Y., Chang, J. G., Cittolin, P., Cooperstein, S., Deelen, S., Diaz, N., Duarte, D., Gerosa, J., Giannini, R., Guiang, L., Kansal, J., Krutelyov, R., Lee, V., Letts, R., Masciovecchio, J., Mokhtar, M., Pieri, F., Sathia, Narayanan, Sharma, B. V., Tadel, V., Vartak, M., Wurthwein, A., Xiang, F., Yagil, Y., Amin, A., Campagnari, N., Citron, C., Dorsett, M., Dutta, A., Inc, V., Ela, J., Kilpatrick, M., Marsh, B., Mei, H., Oshiro, M., Quinnan, M., Richman, J., Sarica, U., Setti, F., Sheplock, J., Stuart, D., Wang, S., Bornheim, A., Cerri, O., Dutta, I., Lawhorn, J. M., Lu, N., Mao, J., Newman, H. B., Nguyen, T. Q., Spiropulu, M., Vlimant, J. R., Wang, C., Xie, S., Zhang, Z., Zhu, R. Y., Alison, J., Rews, M. B., Bryant, P., Ferguson, T., Harilal, A., Liu, C., Mudholkar, T., Paulini, M., Sanchez, A., Terrill, W., Cumalat, J. P., Ford, W. T., Hassani, A., Macdonald, E., Patel, R., Perloff, A., Savard, C., Stenson, K., Ulmer, K. A., Wagner, S. R., Alex, Er, Bright-Thonney, J., Chen, S., Cheng, X., Cranshaw, Y., Hogan, D. J., Monroy, S., Patterson, J., Quach, J. R., Reichert, D., Reid, J., Ryd, M., Sun, A., Thom, W., Wittich, J., Zou, P., Albrow, R., Alyari, M., Apollinari, M., Apresyan, G., Apyan, A., Banerjee, A., Bauerdick, S., Berry, L. A. T., Berryhill, D., Bhat, J., Burkett, P. C., Butler, K., Canepa, J. N., Cerati, A., Cheung, G. B., Chlebana, H. W. K., Petrillo, Di, Elvira, K. F., Feng, V. D., Freeman, Y., Gecse, J., Gray, Z., Green, L., Grunendahl, D., Gutsche, S., Harris, O., Heller, R. M., Herwig, R., Hirschauer, T. C., Jayatilaka, J., Jindariani, B., Johnson, S., Joshi, M., Klijnsma, U., Klima, T., Kwok, B., Lammel, K. H. M., Lincoln, S., Lipton, D., Liu, R., Madrid, T., Maeshima, C., Mantilla, K., Mason, C., Mcbride, D., Merkel, P., Mrenna, P., Nahn, S., Ngadiuba, S., O'Dell, J., Papadimitriou, V., Pedro, V., Pena, K., Prokofyev, C., Ravera, O., Reinsvold, Hall, Ristori, A., Sexton-Kennedy, L., Smith, E., Soha, N., Spalding, A., Spiegel, W. J., Stoynev, L., Strait, S., Taylor, J., Tkaczyk, L., Tran, S., Uplegger, N. V., Va, L., Ering, E. W., Weber, H. A., Acosta, D., Avery, P., Bourilkov, D., Cadamuro, L., Cherepanov, V., Errico, F., Field, R. D., Guerrero, D., Joshi, B. M., Kim, M., Koenig, E., Konigsberg, J., Korytov, A., K. H., Lo, Matchev, K., Menendez, N., Mitselmakher, G., Muthirakalayil, Madhu, Rawal, A., Rosenzweig, N., Rosenzweig, D., Rotter, S., Shi, J., Sturdy, K., Yigitbasi, J., Zuo, E., Adams, X., Askew, T., Habibullah, A., Hagopian, R., Johnson, V., Khurana, K. F., Kolberg, R., Martinez, T., Prosper, G., Schiber, H., Viazlo, C., Yohay, O., Zhang, R., Baarm, J., Butalla, M. M., Elkafrawy, S., Hohlmann, T., Kumar, Verma, Noonan, R., Rahmani, D., Yumiceva, M., Adams, F., M. R., Becerril, Gonzalez, Cavanaugh, H., Dittmer, R., Evdokimov, S., Gerber, O., Hangal, C. E., Hofman, D. A., Merrit, D. J., Mills, A. H., Oh, C., Roy, G., Rudrabhatla, T., Tonjes, S., Varelas, M. B., Viinikainen, N., Wu, X., Ye, Z., Alhusseini, Z., Dilsiz, M., K. G., Rajula, R. P., Koseyan, O. K., Merlo, J. -P., Mestvirishvili, A., Nachtman, J., Ogul, H., Onel, Y., Penzo, A., Snyder, C., Tiras, E., Amram, O., Blumenfeld, B., Corcodilos, L., Davis, J., Eminizer, M., Gritsan, A. V., Kyriacou, S., Maksimovic, P., Roskes, J., Swartz, M., Vami, T. A., Abreu, A., Anguiano, J., Baldenegro, Barrera, Baringer, C., Bean, P., Bylinkin, A., Flowers, A., Isidori, Z., Khalil, T., King, S., Krintiras, J., Kropivnitskaya, G., Lazarovits, A., Mahieu, Le, Lindsey, C., Marquez, C., Minafra, J., Murray, N., Nickel, M., Rogan, M., Royon, C., Salvatico, C., R. S., Ers, S., Schmitz, E., Smith, C., Tapia, Takaki, Wang, J. D., Warner, Q., Williams, Z., Duric, G., Ivanov, S., Kaadze, A., Kim, K., Maravin, D., Mitchell, Y., Modak, T., Nam, A., Rebassoo, K., Wright, F., Adams, D., Baden, E., Baron, A., Belloni, O., Eno, A., Hadley, S. C., Jabeen, N. J., Kellogg, S., Koeth, R. G., Mignerey, T., Nabili, A. C., Palmer, S., Seidel, C., Skuja, M., Wang, A., Wong, L., Abercrombie, K., Reassi, D., Bi, G., Busza, R., Cali, W., Chen, I. A., D'Alfonso, Y., Eysermans, M., Freer, J., Gomez, Ceballos, Goncharov, G., Harris, M., Hu, P., Klute, M., Kovalskyi, M., Krupa, D., Y. -J., Mironov, C., Paus, C., Rankin, D., Rol, Rol, C., Shi, G., Stephans, Z., Wang, G. S. F., Wyslouch, Z., Chatterjee, B., Evans, R. M., Hiltbr, A., Jain, J., Krohn, Sh., Kubota, M., Mans, Y., Revering, J., Rusack, M., Saradhy, R., Schroeder, R., Strobbe, N., Wadud, N., Bloom, M. A., Bryson, K., Chauhan, M., Claes, S., Fangmeier, D. R., Finco, C., Golf, L., Joo, F., Kravchenko, C., Musich, I., Reed, M., Siado, I., Snow, J. E., Tabb, G. R., Yan, W., Zecchinelli, F., Agarwal, A. G., G. B., Yopadhyay, H., Hay, L., Iashvili, I., Kharchilava, A., Mclean, C., Nguyen, D., Pekkanen, J., Rappoccio, S., Williams, A., Alverson, G., Barberis, E., Haddad, Y., Hortiangtham, A., Li, J., Madigan, G., Marzocchi, B., Morse, D. M., Nguyen, V., Orimoto, T., Parker, A., Skinnari, L., Tishelman-Charny, A., Wamorkar, T., Wang, B., Wisecarver, A., Wood, D., Bueghly, J., Chen, Z., Gilbert, A., Gunter, T., Hahn, K. A., Liu, Y., Odell, N., Schmitt, M. H., Velasco, M., B, R., Bucci, R., Cremonesi, M., Das, A., Dev, N., Goldouzian, R., Hildreth, M., Hurtado, Anampa, Jessop, K., Lannon, C., Lawrence, K., Loukas, J., Lutton, N., Marinelli, D., Mcalister, N., Mccauley, I., Mcgrady, T., Mohrman, C., Moore, K., Musienko, C., Ruchti, Y., Siddireddy, R., Townsend, P., Wayne, A., Wightman, M., Zarucki, A., Zygala, M., Bylsma, L., Cardwell, B., Durkin, B., Francis, L. S., Hill, B., Nunez, Ornelas, Wei, M., Winer, K., Yates, B. L., Addesa, B. R., Bonham, F. M., Das, B., Dezoort, P., Elmer, G., Frankenthal, P., Greenberg, A., Haubrich, B., Higginbotham, N., Kalogeropoulos, S., Kopp, A., Kwan, G., Lange, S., Marlow, D., Mei, D., Ojalvo, K., Olsen, I., Stickl, J., Tully, D., Malik, C., Norberg, S., Bakshi, S., Barnes, A. S., Chawla, V. E., Das, R., Gutay, S., Jones, L., Jung, M., Karmarkar, A. W., Kondratyev, S., Liu, D., Negro, M., Neumeister, G., Paspalaki, N., Piperov, G., Purohit, S., Schulte, A., Stojanovic, J. F., Thieman, M., Xiao, F., Xie, R., Dolen, W., Parashar, J., Baty, N., Carnahan, A., Decaro, T., Dildick, M., Ecklund, S., Freed, K. M., Gardner, S., Geurts, P., Kumar, F. J. M., Li, A., Padley, W., Redjimi, B. P., Shi, R., Stahl, Leiton, Yang, A. G., Zhang, L., Bodek, Y., Barbaro, De, Demina, P., Dulemba, R., Fallon, J. L., Ferbel, C., Galanti, T., Garcia-Bellido, M., Hindrichs, A., Khukhunaishvili, O., Ranken, A., Taus, E., Chiarito, R., Chou, B., J. P. G., Rakota, A., Gershtein, Y., Halkiadakis, E., Hart, A., Heindl, M., Karacheban, O., Laflotte, I., Lath, A., Montalvo, R., Nash, K., Osherson, M., Salur, S., Schnetzer, S., Somalwar, S., Stone, R., Thayil, S. A., Thomas, S., Wang, H., Acharya, H., Delannoy, A. G., Fiorendi, S., Spanier, S., Bouhali, O., Dalchenko, M., Delgado, A., Eusebi, R., Gilmore, J., Huang, T., Kamon, T., Kim, H., Luo, S., Malhotra, S., Mueller, R., Overton, D., Rathjens, D., Safonov, A., Akchurin, N., Damgov, J., Hegde, V., Kunori, S., Lamichhane, K., Lee, S. W., Mengke, T., Muthumuni, S., Peltola, T., Volobouev, I., Wang, Z., Whitbeck, A., Appelt, E., Greene, S., Gurrola, A., Johns, W., Melo, A., Ni, H., Padeken, K., Romeo, F., Sheldon, P., Tuo, S., Velkovska, J., Arenton, M. W., Cox, B., Cummings, G., Hakala, J., Hirosky, R., Joyce, M., Ledovskoy, A., Neu, C., Perez, Lara, Tannenwald, C. E., White, B., Wolfe, S., Poudyal, E., Black, N., Bose, K., Caillol, T., Dasu, C., Bruyn, De, Everaerts, I., Fienga, P., Galloni, F., He, C., Herndon, H., Herve, M., Hussain, A., Lanaro, U., Loeliger, A., Loveless, A., Madhusudanan, Sreekala, Mallampalli, J., Mohammadi, A., Pinna, A., Savin, D., Shang, A., Sharma, V., Smith, V., Teague, W. H., Trembath-Reichert, D., Vetens, S., Cms, Collaboration, Damarseçkin, Serdal, CMS Collaboration, Institut de Recherches sur les lois Fondamentales de l'Univers (IRFU), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Laboratoire Leprince-Ringuet (LLR), Centre National de la Recherche Scientifique (CNRS)-École polytechnique (X)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), Institut Pluridisciplinaire Hubert Curien (IPHC), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA)), Institut de Physique des 2 Infinis de Lyon (IP2I Lyon), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Laboratoire d'Annecy de Physique des Particules (LAPP), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS), CMS, Tumasyan, A, Adam, W, Andrejkovic, JW, Bergauer, T, Chatterjee, S, Damanakis, K, Dragicevic, M, Del Valle, AE, Fruhwirth, R, Jeitler, M, Krammer, N, Lechner, L, Liko, D, Mikulec, I, Paulitsch, P, Pitters, FM, Schieck, J, Schofbeck, R, Schwarz, D, Templ, S, Waltenberger, W, Wulz, CE, Chekhovsky, V, Litomin, A, Makarenko, V, Darwish, MR, De Wolf, EA, Janssen, T, Kello, T, Lelek, A, Sfar, HR, Van Mechelen, P, Van Putte, S, Van Remortel, N, Blekman, F, Bols, ES, D'Hondt, J, Delcourt, M, El Faham, H, Lowette, S, Moortgat, S, Morton, A, Muller, D, Sahasransu, AR, Tavernier, S, Van Doninck, W, Beghin, D, Bilin, B, Clerbaux, B, De Lentdecker, G, Favart, L, Grebenyuk, A, Kalsi, AK, Lee, K, Mahdavikhorrami, M, Makarenko, I, Moureaux, L, Petre, L, Popov, A, Postiau, N, Starling, E, Thomas, L, Vanden Bemden, M, Vander Velde, C, Vanlaer, P, Cornelis, T, Dobur, D, Knolle, J, Lambrecht, L, Mestdach, G, Niedziela, M, Roskas, C, Samalan, A, Skovpen, K, Tytgat, M, Vermassen, B, Wezenbeek, L, Benecke, A, Bethani, A, Bruno, G, Bury, F, Caputo, C, David, P, Delaere, C, Donertas, IS, Giammanco, A, Jaffel, K, Jain, S, Lemaitre, V, Mondal, K, Prisciandaro, J, Taliercio, A, Teklishyn, M, Tran, TT, Vischia, P, Wertz, S, Alves, GA, Hensel, C, Moraes, A, Alda, WL, Pereira, MAG, Ferreira, MB, Malbouisson, HB, Carvalho, W, Chinellato, J, Da Costa, EM, Da Silveira, GG, Damiao, DD, De Souza, SF, Herrera, CM, Amarilo, KM, Mundim, L, Nogima, H, Teles, PR, Santoro, A, Do Amaral, SMS, Sznajder, A, Thiel, M, De Araujo, FTD, Pereira, AV, Bernardes, CA, Calligaris, L, Tomei, TRFP, Gregores, EM, Lemos, DS, Mercadante, PG, Novaes, SF, Padula, SS, Aleksandrov, A, Antchev, G, Hadjiiska, R, Iaydjiev, P, Misheva, M, Rodozov, M, Shopova, M, Sultanov, G, Dimitrov, A, Ivanov, T, Litov, L, Pavlov, B, Petkov, P, Petrov, A, Cheng, T, Javaid, T, Mittal, M, Yuan, L, Ahmad, M, Bauer, G, Dozen, C, Hu, Z, Martins, J, Wang, Y, Yi, K, Chapon, E, Chen, GM, Chen, HS, Chen, M, Iemmi, F, Kapoor, A, Leggat, D, Liao, H, Liu, ZA, Milosevic, V, Monti, F, Sharma, R, Tao, J, Thomas-Wilsker, J, Wang, J, Zhang, H, Zhao, J, Agapitos, A, An, Y, Ban, Y, Chen, C, Levin, A, Li, Q, Lyu, X, Mao, Y, Qian, SJ, Wang, D, Wang, Q, Xiao, J, Lu, M, You, Z, Gao, X, Okawa, H, Zhang, Y, Lin, Z, Xiao, M, Avila, C, Cabrera, A, Florez, C, Fraga, J, Guisao, JM, Ramirez, F, Alvarez, JDR, Gonzalez, CAS, Giljanovic, D, Godinovic, N, Lelas, D, Puljak, I, Antunovic, Z, Kovac, M, Sculac, T, Brigljevic, V, Ferencek, D, Majumder, D, Roguljic, M, Starodumov, A, Susa, T, Attikis, A, Christoforou, K, Erodotou, E, Ioannou, A, Kole, G, Kolosova, M, Konstantinou, S, Mousa, J, Nicolaou, C, Ptochos, F, Razis, PA, Rykaczewski, H, Saka, H, Finger, M, Kveton, A, Ayala, E, Jarrin, EC, Assran, Y, Kamel, AE, Mahmoud, MA, Mohammed, Y, Bhowmik, S, Dewanjee, RK, Ehataht, K, Kadastik, M, Nandan, S, Nielsen, C, Pata, J, Raidal, M, Tani, L, Veelken, C, Eerola, P, Forthomme, L, Kirschenmann, H, Osterberg, K, Voutilainen, M, Bharthuar, S, Brucken, E, Garcia, F, Havukainen, J, Kim, MS, Kinnunen, R, Lampen, T, Lassila-Perini, K, Lehti, S, Linden, T, Lotti, M, Martikainen, L, Myllymaki, M, Ott, J, Siikonen, H, Tuominen, E, Tuominiemi, J, Luukka, P, Petrow, H, Tuuva, T, Amendola, C, Besancon, M, Couderc, F, Dejardin, M, Denegri, D, Faure, JL, Ferri, F, Ganjour, S, Gras, P, de Monchenault, GH, Jarry, P, Lenzi, B, Locci, E, Malcles, J, Rander, J, Rosowsky, A, Sahin, MO, Savoy-Navarro, A, Titov, M, Yu, GB, Ahuja, S, Beaudette, F, Bonanomi, M, Perraguin, AB, Busson, P, Cappati, A, Charlot, C, Davignon, O, Diab, B, Falmagne, G, Ghosh, S, de Cassagnac, RG, Hakimi, A, Kucher, I, Motta, J, Nguyen, M, Ochando, C, Paganini, P, Rembser, J, Salerno, R, Sarkar, U, Sauvan, JB, Sirois, Y, Tarabini, A, Zabi, A, Zghiche, A, Agram, JL, Andrea, J, Apparu, D, Bloch, D, Bourgatte, G, Brom, JM, Chabert, EC, Collard, C, Darej, D, Fontaine, JC, Goerlach, U, Grimault, C, Le Bihan, AC, Nibigira, E, Van Hove, P, Asilar, E, Beauceron, S, Bernet, C, Boudoul, G, Camen, C, Carle, A, Chanon, N, Contardo, D, Depasse, P, El Mamouni, H, Fay, J, Gascon, S, Gouzevitch, M, Ille, B, Laktineh, IB, Lattaud, H, Lesauvage, A, Lethuillier, M, Mirabito, L, Perries, S, Shchablo, K, Sordini, V, Torterotot, L, Touquet, G, Vander Donckt, M, Viret, S, Lomidze, I, Toriashvili, T, Tsamalaidze, Z, Botta, V, Feld, L, Klein, K, Lipinski, M, Meuser, D, Pauls, A, Rowert, N, Schulz, J, Teroerde, M, Dodonova, A, Eliseev, D, Erdmann, M, Fackeldey, P, Fischer, B, Hebbeker, T, Hoepfner, K, Ivone, F, Mastrolorenzo, L, Merschmeyer, M, Meyer, A, Mocellin, G, Mondal, S, Mukherjee, S, Noll, D, Novak, A, Pook, T, Pozdnyakov, A, Rath, Y, Reithler, H, Roemer, J, Schmidt, A, Schuler, SC, Sharma, A, Vigilante, L, Wiedenbeck, S, Zaleski, S, Dziwok, C, Flugge, G, Ahmad, WH, Hlushchenko, O, Kress, T, Nowack, A, Pistone, C, Pooth, O, Roy, D, Sert, H, Stahl, A, Ziemons, T, Zotz, A, Petersen, HA, Martin, MA, Asmuss, P, Baxter, S, Bayatmakou, M, Behnke, O, Martinez, AB, Bhattacharya, S, Bin Anuar, AA, Borras, K, Brunner, D, Campbell, A, Cardini, A, Cheng, C, Colombina, F, Rodriguez, SC, Silva, GC, Danilov, V, De Silva, M, Didukh, L, Eckerlin, G, Eckstein, D, Eren, E, Banos, LIE, Filatov, O, Gallo, E, Gao, J, Geiser, A, Giraldi, A, Grohsjean, A, Guthoff, M, Jafari, A, Jomhari, NZ, Jung, H, Kasem, A, Kasemann, M, Kaveh, H, Kleinwort, C, Krucker, D, Lange, W, Lidrych, J, Lipka, K, Lohmann, W, Makela, T, Mankel, R, Melzer-Pellmann, IA, Morentin, MM, Metwally, J, Meyer, AB, Meyer, M, Mnich, J, Mussgiller, A, Otarid, Y, Adan, DP, Pitzl, D, Raspereza, A, Lopes, BR, Rubenach, J, Saggio, A, Saibel, A, Savitskyi, M, Scham, M, Scheurer, V, Schnake, S, Schutze, P, Schwanenberger, C, Shchedrolosiev, M, Ricardo, RES, Stafford, D, Tonon, N, Van De Klundert, M, Walsh, R, Walter, D, Wen, Y, Wichmann, K, Wiens, L, Wissing, C, Wuchterl, S, Zlebcik, R, Aggleton, R, Albrecht, S, Bein, S, Benato, L, Connor, P, De Leo, K, Eich, M, Feindt, F, Frohlich, A, Garbers, C, Garutti, E, Gunnellini, P, Hajheidari, M, Haller, J, Hinzmann, A, Kasieczka, G, Klanner, R, Kogler, R, Kramer, T, Kutzner, V, Lange, J, Lange, T, Lobanov, A, Malara, A, Nigamova, A, Rodriguez, KJP, Rieger, O, Schleper, P, Schroder, M, Schwandt, J, Sonneveld, J, Stadie, H, Steinbruck, G, Tews, A, Zoi, I, Bechtel, J, Brommer, S, Burkart, M, Butz, E, Caspart, R, Chwalek, T, De Boer, W, Dierlamm, A, Droll, A, El Morabit, K, Faltermann, N, Giffels, M, Gosewisch, JO, Gottmann, A, Hartmann, F, Heidecker, C, Husemann, U, Keicher, P, Koppenhofer, R, Maier, S, Metzler, M, Mitra, S, Muller, T, Neukum, M, Nurnberg, A, Quast, G, Rabbertz, K, Rauser, J, Savoiu, D, Schnepf, M, Seith, D, Shvetsov, I, Simonis, HJ, Ulrich, R, Van Der Linden, J, Von Cube, RF, Wassmer, M, Weber, M, Wieland, S, Wolf, R, Wozniewski, S, Wunsch, S, Anagnostou, G, Daskalakis, G, Geralis, T, Kyriakis, A, Loukas, D, Stakia, A, Diamantopoulou, M, Karasavvas, D, Karathanasis, G, Kontaxakis, P, Koraka, CK, Manousakis-Katsikakis, A, Panagiotou, A, Papavergou, I, Saoulidou, N, Theofilatos, K, Tziaferi, E, Vellidis, K, Vourliotis, E, Bakas, G, Kousouris, K, Papakrivopoulos, I, Tsipolitis, G, Zacharopoulou, A, Adamidis, K, Bestintzanos, I, Evangelou, I, Foudas, C, Gianneios, P, Katsoulis, P, Kokkas, P, Manthos, N, Papadopoulos, I, Strologas, J, Csanad, M, Farkas, K, Gadallah, MMA, Lokos, S, Major, P, Mandal, K, Mehta, A, Pasztor, G, Radl, AJ, Suranyi, O, Veres, GI, Bartok, M, Bencze, G, Hajdu, C, Horvath, D, Sikler, F, Veszpremi, V, Czellar, S, Karancsi, J, Molnar, J, Szillasi, Z, Teyssier, D, Raics, P, Trocsanyi, ZL, Ujvari, B, Csorgo, T, Nemes, F, Novak, T, Choudhury, S, Komaragiri, JR, Kumar, D, Panwar, L, Tiwari, PC, Bahinipati, S, Kar, C, Mal, P, Mishra, T, Bindhu, VKMN, Nayak, A, Saha, P, Sur, N, Swain, SK, Vats, D, Bansal, S, Beri, SB, Bhatnagar, V, Chaudhary, G, Chauhan, S, Dhingra, N, Gupta, R, Kaur, A, Kaur, M, Kaur, S, Kumari, P, Meena, M, Sandeep, K, Singh, JB, Virdi, AK, Ahmed, A, Bhardwaj, A, Choudhary, BC, Gola, M, Keshri, S, Kumar, A, Naimuddin, M, Priyanka, P, Ranjan, K, Shah, A, Bharti, M, Bhattacharya, R, Bhowmik, D, Dutta, S, Gomber, B, Maity, M, Palit, P, Rout, PK, Saha, G, Sahu, B, Sarkar, S, Sharan, M, Singh, B, Thakur, S, Behera, PK, Behera, SC, Kalbhor, P, Muhammad, A, Pradhan, R, Pujahari, PR, Sikdar, AK, Dutta, D, Jha, V, Kumar, V, Mishra, DK, Naskar, K, Netrakanti, PK, Pant, LM, Shukla, P, Aziz, T, Dugad, S, Kumar, M, Banerjee, S, Chudasama, R, Guchait, M, Karmakar, S, Kumar, S, Majumder, G, Mazumdar, K, Alpana, K, Dube, S, Kansal, B, Laha, A, Pandey, S, Rane, A, Rastogi, A, Sharma, S, Bakhshiansohi, H, Khazaie, E, Zeinali, M, Chenarani, S, Etesami, SM, Khakzad, M, Najafabadi, MM, Grunewald, M, Abbrescia, M, Aly, R, Aruta, C, Colaleo, A, Creanza, D, De Filippis, N, De Palma, M, Di Florio, A, Di Pilato, A, Elmetenawee, W, Fiore, L, Gelmi, A, Gul, M, Iaselli, G, Ince, M, Lezki, S, Maggi, G, Maggi, M, Margjeka, I, Mastrapasqua, V, My, S, Nuzzo, S, Pellecchia, A, Pompili, A, Pugliese, G, Ramos, D, Ranieri, A, Selvaggi, G, Silvestris, L, Simone, FM, Venditti, R, Verwilligen, P, Abbiendi, G, Battilana, C, Bonacorsi, D, Borgonovi, L, Brigliadori, L, Campanini, R, Capiluppi, P, Castro, A, Cavallo, FR, Cuffiani, M, Dallavalle, GM, Diotalevi, T, Fabbri, F, Fanfani, A, Giacomelli, P, Giommi, L, Grandi, C, Guiducci, L, Lo Meo, S, Lunerti, L, Marcellini, S, Masetti, G, Navarria, FL, Perrotta, A, Primavera, F, Rossi, AM, Rovelli, T, Siroli, GP, Albergo, S, Costa, S, Di Mattia, A, Potenza, R, Tricomi, A, Tuve, C, Barbagli, G, Cassese, A, Ceccarelli, R, Ciulli, V, Civinini, C, D'Alessandro, R, Focardi, E, Latino, G, Lenzi, P, Lizzo, M, Meschini, M, Paoletti, S, Seidita, R, Sguazzoni, G, Viliani, L, Benussi, L, Bianco, S, Piccolo, D, Bozzo, M, Ferro, F, Mulargia, R, Robutti, E, Tosi, S, Benaglia, A, Boldrini, G, Brivio, F, Cetorelli, F, De Guio, F, Dinardo, ME, Dini, P, Gennai, S, Ghezzi, A, Govoni, P, Guzzi, L, Lucchini, MT, Malberti, M, Malvezzi, S, Massironi, A, Menasce, D, Moroni, L, Paganoni, M, Pedrini, D, Pinolini, BS, Ragazzi, S, Redaelli, N, de Fatis, TT, Valsecchi, D, Zuolo, D, Buontempo, S, Carnevali, F, Cavallo, N, De Iorio, A, Fabozzi, F, Iorio, AOM, Lista, L, Meola, S, Paolucci, P, Rossi, B, Sciacca, C, Azzi, P, Bacchetta, N, Bisello, D, Bortignon, P, Bragagnolo, A, Carlin, R, Checchia, P, Dorigo, T, Dosselli, U, Gasparini, F, Gasparini, U, Grosso, G, Hoh, SY, Layer, L, Lusiani, E, Margoni, M, Meneguzzo, AT, Pazzini, J, Ronchese, P, Rossin, R, Simonetto, F, Strong, G, Tosi, M, Yarar, H, Zanetti, M, Zotto, P, Zucchetta, A, Zumerle, G, Aime, C, Braghieri, A, Calzaferri, S, Fiorina, D, Montagna, P, Ratti, SP, Re, V, Riccardi, C, Salvini, P, Vai, I, Vitulo, P, Asenov, P, Bilei, GM, Ciangottini, D, Fano, L, Lariccia, P, Magherini, M, Mantovani, G, Mariani, V, Menichelli, M, Moscatelli, F, Piccinelli, A, Presilla, M, Rossi, A, Santocchia, A, Spiga, D, Tedeschi, T, Azzurri, P, Bagliesi, G, Bertacchi, V, Bianchini, L, Boccali, T, Bossini, E, Castaldi, R, Ciocci, MA, D'Amante, V, Dell'Orso, R, Di Domenico, MR, Donato, S, Giassi, A, Ligabue, F, Manca, E, Mandorli, G, Figueiredo, DM, Messineo, A, Palla, F, Parolia, S, Ramirez-Sanchez, G, Rizzi, A, Rolandi, G, Chowdhury, SR, Scribano, A, Shafiei, N, Spagnolo, P, Tenchini, R, Tonelli, G, Turini, N, Venturi, A, Verdini, PG, Barria, P, Campana, M, Cavallari, F, Del Re, D, Di Marco, E, Diemoz, M, Longo, E, Meridiani, P, Organtini, G, Pandolfi, F, Paramatti, R, Quaranta, C, Rahatlou, S, Rovelli, C, Santanastasio, F, Soffi, L, Tramontano, R, Amapane, N, Arcidiacono, R, Argiro, S, Arneodo, M, Bartosik, N, Bellan, R, Bellora, A, Antequera, JB, Biino, C, Cartiglia, N, Cometti, S, Costa, M, Covarelli, R, Demaria, N, Kiani, B, Legger, F, Mariotti, C, Maselli, S, Migliore, E, Monteil, E, Monteno, M, Obertino, MM, Ortona, G, Pacher, L, Pastrone, N, Pelliccioni, M, Angioni, GLP, Ruspa, M, Shchelina, K, Siviero, F, Sola, V, Solano, A, Soldi, D, Staiano, A, Tornago, M, Trocino, D, Vagnerini, A, Belforte, S, Candelise, V, Casarsa, M, Cossutti, F, Da Rold, A, Della Ricca, G, Sorrentino, G, Vazzoler, F, Dogra, S, Huh, C, Kim, B, Kim, DH, Kim, GN, Kim, J, Lee, J, Lee, SW, Moon, CS, Oh, YD, Pak, SI, Radburn-Smith, BC, Sekmen, S, Yang, YC, Kim, H, Moon, DH, Francois, B, Kim, TJ, Park, J, Cho, S, Choi, S, Go, Y, Hong, B, Lee, KS, Lim, J, Park, SK, Yoo, J, Goh, J, Gurtu, A, Kim, HS, Kim, Y, Almond, J, Bhyun, JH, Choi, J, Jeon, S, Kim, JS, Ko, S, Kwon, H, Lee, H, Lee, S, Oh, BH, Oh, M, Oh, SB, Seo, H, Yang, UK, Yoon, I, Jang, W, Kang, DY, Kang, Y, Kim, S, Ko, B, Lee, JSH, Lee, Y, Merlin, JA, Park, IC, Roh, Y, Ryu, MS, Song, D, Watson, IJ, Yang, S, Ha, S, Yoo, HD, Choi, M, Yu, I, Beyrouthy, T, Maghrbi, Y, Dreimanis, K, Veckalns, V, Ambrozas, M, De Oliveira, ACA, Juodagalvis, A, Rinkevicius, A, Tamulaitis, G, Bin Norjoharuddeen, N, Abdullah, WATW, Yusli, MN, Zolkapli, Z, Benitez, JF, Hernandez, AC, Coello, ML, Quijada, JAM, Sehrawat, A, Palomo, LV, Ayala, G, Castilla-Valdez, H, De La Cruz-Burelo, E, Heredia-De La Cruz, I, Lopez-Fernandez, R, Herrera, CAM, Navarro, DAP, Hernandez, AS, Moreno, SC, Barrera, CO, Valencia, FV, Pedraza, I, Ibarguen, HAS, Estrada, CU, Mijuskovic, J, Raicevic, N, Krofcheck, D, Butler, PH, Ahmad, A, Asghar, MI, Awais, A, Awan, MIM, Hoorani, HR, Khan, WA, Shah, MA, Shoaib, M, Waqas, M, Avati, V, Grzanka, L, Malawski, M, Bialkowska, H, Bluj, M, Boimska, B, Gorski, M, Kazana, M, Szleper, M, Zalewski, P, Bunkowski, K, Doroba, K, Kalinowski, A, Konecki, M, Krolikowski, J, Araujo, M, Bargassa, P, Bastos, D, Boletti, A, Faccioli, P, Gallinaro, M, Hollar, J, Leonardo, N, Niknejad, T, Pisano, M, Seixas, J, Toldaiev, O, Varela, J, Afanasiev, S, Budkouski, D, Golutvin, I, Gorbunov, I, Karjavine, V, Korenkov, V, Lanev, A, Malakhov, A, Matveev, V, Palichik, V, Perelygin, V, Savina, M, Seitova, D, Shalaev, V, Shmatov, S, Shulha, S, Smirnov, V, Teryaev, O, Voytishin, N, Yuldashev, BS, Zarubin, A, Zhizhin, I, Gavrilov, G, Golovtcov, V, Ivanov, Y, Kim, V, Kuznetsova, E, Murzin, V, Oreshkin, V, Smirnov, I, Sosnov, D, Sulimov, V, Uvarov, L, Volkov, S, Vorobyev, A, Andreev, Y, Dermenev, A, Gninenko, S, Golubev, N, Karneyeu, A, Kirpichnikov, D, Kirsanov, M, Krasnikov, N, Pashenkov, A, Pivovarov, G, Toropin, A, Epshteyn, V, Gavrilov, V, Lychkovskaya, N, Nikitenko, A, Popov, V, Stepennov, A, Toms, M, Vlasov, E, Zhokin, A, Aushev, T, Chadeeva, M, Oskin, A, Parygin, P, Popova, E, Rusinov, V, Selivanova, D, Andreev, V, Azarkin, M, Dremin, I, Kirakosyan, M, Terkulov, A, Belyaev, A, Boos, E, Dubinin, M, Dudko, L, Ershov, A, Klyukhin, V, Kodolova, O, Lokhtin, I, Lukina, O, Obraztsov, S, Petrushanko, S, Savrin, V, Snigirev, A, Blinov, V, Dimova, T, Kardapoltsev, L, Kozyrev, A, Ovtin, I, Radchenko, O, Skovpen, Y, Azhgirey, I, Bayshev, I, Elumakhov, D, Kachanov, V, Konstantinov, D, Mandrik, P, Petrov, V, Ryutin, R, Slabospitskii, S, Sobol, A, Troshin, S, Tyurin, N, Uzunian, A, Volkov, A, Babaev, A, Okhotnikov, V, Borshch, V, Ivanchenko, V, Tcherniaev, E, Adzic, P, Dordevic, M, Milenovic, P, Milosevic, J, Aguilar-Benitez, M, Maestre, JA, Fernandez, AA, Bachiller, I, Luna, MB, Bedoya, CF, Montoya, CAC, Cepeda, M, Cerrada, M, Colino, N, De La Cruz, B, Peris, AD, Ramos, JPF, Flix, J, Fouz, MC, Lopez, OG, Lopez, SG, Hernandez, JM, Josa, MI, Holgado, JL, Moran, D, Tobar, AN, Dengra, CP, Yzquierdo, APC, Pelayo, JP, Redondo, I, Romero, L, Navas, SS, Gomez, LU, Willmott, C, de Troconiz, JF, Reyes-Almanza, R, Gonzalez, BA, Cuevas, J, Erice, C, Menendez, JF, Folgueras, S, Caballero, IG, Fernandez, JRG, Cortezon, EP, Alvarez, CR, Bouza, VR, Rodriguez, AS, Trapote, A, Trevisani, N, Villalba, CV, Cifuentes, JAB, Cabrillo, IJ, Calderon, A, Campderros, JD, Fernandez, M, Madrazo, CF, Manteca, PJF, Alonso, AG, Gomez, G, Rivero, CM, del Arbol, PMR, Matorras, F, Cuevas, PM, Gomez, JP, Prieels, C, Rodrigo, T, Ruiz-Jimeno, A, Scodellaro, L, Vila, I, Garcia, JMV, Jayananda, MK, Kailasapathy, B, Sonnadara, DUJ, Wickramarathna, DDC, Dharmaratna, WGD, Liyanage, K, Perera, N, Wickramage, N, Aarrestad, TK, Abbaneo, D, Alimena, J, Auffray, E, Auzinger, G, Baechler, J, Baillon, P, Barney, D, Bendavid, J, Bianco, M, Bocci, A, Camporesi, T, Garrido, MC, Cerminara, G, Chernyavskaya, N, Chhibra, SS, Cipriani, M, Cristella, L, d'Enterria, D, Dabrowski, A, David, A, De Roeck, A, Defranchis, MM, Deile, M, Dobson, M, Dunser, M, Dupont, N, Elliott-Peisert, A, Emriskova, N, Fallavollita, F, Fasanella, D, Florent, A, Franzoni, G, Funk, W, Giani, S, Gigi, D, Gill, K, Glege, F, Gouskos, L, Haranko, M, Hegeman, J, Innocente, V, James, T, Janot, P, Kaspar, J, Kieseler, J, Komm, M, Kratochwil, N, Lange, C, Laurila, S, Lecoq, P, Lintuluoto, A, Long, K, Lourenco, C, Maier, B, Malgeri, L, Mallios, S, Mannelli, M, Marini, AC, Meijers, F, Mersi, S, Meschi, E, Moortgat, F, Mulders, M, Orfanelli, S, Orsini, L, Pantaleo, F, Pape, L, Perez, E, Peruzzi, M, Petrilli, A, Petrucciani, G, Pfeiffer, A, Pierini, M, Piparo, D, Pitt, M, Qu, H, Quast, T, Rabady, D, Racz, A, Gutierrez, GR, Rieger, M, Rovere, M, Sakulin, H, Salfeld-Nebgen, J, Scarfi, S, Schafer, C, Schwick, C, Selvaggi, M, Silva, P, Snoeys, W, Sphicas, P, Summers, S, Tatar, K, Tavolaro, VR, Treille, D, Tropea, P, Tsirou, A, Van Onsem, GP, Wanczyk, J, Wozniak, KA, Zeuner, WD, Caminada, L, Ebrahimi, A, Erdmann, W, Horisberger, R, Ingram, Q, Kaestli, HC, Kotlinski, D, Langenegger, U, Missiroli, M, Noehte, L, Rohe, T, Androsov, K, Backhaus, M, Berger, P, Calandri, A, De Cosa, A, Dissertori, G, Dittmar, M, Donega, M, Dorfer, C, Eble, F, Gedia, K, Glessgen, F, Espinosa, TAG, Grab, C, Hits, D, Lustermann, W, Lyon, AM, Manzoni, RA, Marchese, L, Perez, CM, Meinhard, MT, Nessi-Tedaldi, F, Niedziela, J, Pauss, F, Perovic, V, Pigazzini, S, Ratti, MG, Reichmann, M, Reissel, C, Reitenspiess, T, Ristic, B, Ruini, D, Becerra, DAS, Stampf, V, Steggemann, J, Wallny, R, Zhu, DH, Amsler, C, Bartschi, P, Botta, C, Brzhechko, D, Canelli, MF, Cormier, K, De Wit, A, Del Burgo, R, Heikkila, JK, Huwiler, M, Jin, W, Jofrehei, A, Kilminster, B, Leontsinis, S, Liechti, SP, Macchiolo, A, Meiring, P, Mikuni, VM, Molinatti, U, Neutelings, I, Reimers, A, Robmann, P, Cruz, SS, Schweiger, K, Senger, M, Takahashi, Y, Adloff, C, Kuo, CM, Lin, W, Roy, A, Sarkar, T, Yu, SS, Ceard, L, Chao, Y, Chen, KF, Chen, PH, Hou, WS, Li, YY, Lu, RS, Paganis, E, Psallidas, A, Steen, A, Wu, HY, Yazgan, E, Yu, PR, Asavapibhop, B, Asawatangtrakuldee, C, Srimanobhas, N, Boran, F, Damarseckin, S, Demiroglu, ZS, Dolek, F, Dumanoglu, I, Eskut, E, Guler, Y, Guler, EG, Isik, C, Kara, O, Topaksu, AK, Kiminsu, U, Onengut, G, Ozdemir, K, Polatoz, A, Simsek, AE, Tali, B, Tok, UG, Turkcapar, S, Zorbakir, IS, Isildak, B, Karapinar, G, Ocalan, K, Yalvac, M, Akgun, B, Atakisi, IO, Gulmez, E, Kaya, M, Kaya, O, Ozcelik, O, Tekten, S, Yetkin, EA, Cakir, A, Cankocak, K, Komurcu, Y, Sen, S, Cerci, S, Hos, I, Kaynak, B, Ozkorucuklu, S, Cerci, DS, Zorbilmez, C, Grynyov, B, Levchuk, L, Anthony, D, Bhal, E, Bologna, S, Brooke, JJ, Bundock, A, Clement, E, Cussans, D, Flacher, H, Goldstein, J, Heath, GP, Heath, HF, Kreczko, L, Krikler, B, Paramesvaran, S, El Nasr-Storey, SS, Smith, VJ, Stylianou, N, Pass, KW, White, R, Bell, KW, Brew, C, Brown, RM, Cockerill, DJA, Cooke, C, Ellis, KV, Harder, K, Harper, S, Holmberg, ML, Linacre, J, Manolopoulos, K, Newbold, DM, Olaiya, E, Petyt, D, Reis, T, Schuh, T, Shepherd-Themistocleous, CH, Tomalin, IR, Williams, T, Bainbridge, R, Bloch, P, Bonomally, S, Borg, J, Breeze, S, Buchmuller, O, Cepaitis, V, Chahal, GS, Colling, D, Dauncey, P, Davies, G, Della Negra, M, Fayer, S, Fedi, G, Hall, G, Hassanshahi, MH, Iles, G, Langford, J, Lyons, L, Magnan, AM, Malik, S, Martelli, A, Monk, DG, Nash, J, Pesaresi, M, Raymond, DM, Richards, A, Rose, A, Scott, E, Seez, C, Shtipliyski, A, Tapper, A, Uchida, K, Virdee, T, Vojinovic, M, Wardle, N, Webb, SN, Winterbottom, D, Coldham, K, Cole, JE, Khan, A, Kyberd, P, Reid, ID, Teodorescu, L, Zahid, S, Abdullin, S, Brinkerhoff, A, Caraway, B, Dittmann, J, Hatakeyama, K, Kanuganti, AR, McMaster, B, Pastika, N, Saunders, M, Sawant, S, Sutantawibul, C, Wilson, J, Bartek, R, Dominguez, A, Uniyal, R, Hernandez, AMV, Buccilli, A, Cooper, SI, Di Croce, D, Gleyzer, SV, Henderson, C, Perez, CU, Rumerio, P, West, C, Akpinar, A, Albert, A, Arcaro, D, Cosby, C, Demiragli, Z, Fontanesi, E, Gastler, D, May, S, Rohlf, J, Salyer, K, Sperka, D, Spitzbart, D, Suarez, I, Tsatsos, A, Yuan, S, Zou, D, Benelli, G, Burkle, B, Coubez, X, Cutts, D, Hadley, M, Heintz, U, Hogan, JM, Kwon, T, Landsberg, G, Lau, KT, Li, D, Lukasik, M, Luo, J, Narain, M, Pervan, N, Sagir, S, Simpson, F, Usai, E, Wong, WY, Yan, X, Yu, D, Zhang, W, Bonilla, J, Brainerd, C, Breedon, R, Sanchez, MCD, Chertok, M, Conway, J, Cox, PT, Erbacher, R, Haza, G, Jensen, F, Kukral, O, Lander, R, Mulhearn, M, Pellett, D, Regnery, B, Taylor, D, Yao, Y, Zhang, F, Bachtis, M, Cousins, R, Datta, A, Hamilton, D, Hauser, J, Ignatenko, M, Iqbal, MA, Lam, T, Nash, WA, Regnard, S, Saltzberg, D, Stone, B, Valuev, V, Burt, K, Chen, Y, Clare, R, Gary, JW, Gordon, M, Hanson, G, Karapostoli, G, Long, OR, Manganelli, N, Negrete, MO, Si, W, Wimpenny, S, Branson, JG, Chang, P, Cittolin, S, Cooperstein, S, Deelen, N, Diaz, D, Duarte, J, Gerosa, R, Giannini, L, Guiang, J, Kansal, R, Krutelyov, V, Lee, R, Letts, J, Masciovecchio, M, Mokhtar, F, Pieri, M, Narayanan, BVS, Sharma, V, Tadel, M, Vartak, A, Wurthwein, F, Xiang, Y, Yagil, A, Amin, N, Campagnari, C, Citron, M, Dorsett, A, Dutta, V, Incandela, J, Kilpatrick, M, Marsh, B, Mei, H, Oshiro, M, Quinnan, M, Richman, J, Sarica, U, Setti, F, Sheplock, J, Stuart, D, Wang, S, Bornheim, A, Cerri, O, Dutta, I, Lawhorn, JM, Lu, N, Mao, J, Newman, HB, Nguyen, TQ, Spiropulu, M, Vlimant, JR, Wang, C, Xie, S, Zhang, Z, Zhu, RY, Alison, J, An, S, Andrews, MB, Bryant, P, Ferguson, T, Harilal, A, Liu, C, Mudholkar, T, Paulini, M, Sanchez, A, Terrill, W, Cumalat, JP, Ford, WT, Hassani, A, MacDonald, E, Patel, R, Perloff, A, Savard, C, Stenson, K, Ulmer, KA, Wagner, SR, Alexander, J, Bright-Thonney, S, Chen, X, Cheng, Y, Cranshaw, DJ, Hogan, S, Monroy, J, Patterson, JR, Quach, D, Reichert, J, Reid, M, Ryd, A, Sun, W, Thom, J, Wittich, P, Zou, R, Albrow, M, Alyari, M, Apollinari, G, Apresyan, A, Apyan, A, Bauerdick, LAT, Berry, D, Berryhill, J, Bhat, PC, Burkett, K, Butler, JN, Canepa, A, Cerati, GB, Cheung, HWK, Chlebana, F, Di Petrillo, KF, Elvira, VD, Feng, Y, Freeman, J, Gecse, Z, Gray, L, Green, D, Grunendahl, S, Gutsche, O, Harris, RM, Heller, R, Herwig, TC, Hirschauer, J, Jayatilaka, B, Jindariani, S, Johnson, M, Joshi, U, Klijnsma, T, Klima, B, Kwok, KHM, Lammel, S, Lincoln, D, Lipton, R, Liu, T, Madrid, C, Maeshima, K, Mantilla, C, Mason, D, McBride, P, Merkel, P, Mrenna, S, Nahn, S, Ngadiuba, J, O'Dell, V, Papadimitriou, V, Pedro, K, Pena, C, Prokofyev, O, Ravera, F, Hall, AR, Ristori, L, Sexton-Kennedy, E, Smith, N, Soha, A, Spalding, WJ, Spiegel, L, Stoynev, S, Strait, J, Taylor, L, Tkaczyk, S, Tran, NV, Uplegger, L, Vaandering, EW, Weber, HA, Acosta, D, Avery, P, Bourilkov, D, Cadamuro, L, Cherepanov, V, Errico, F, Field, RD, Guerrero, D, Joshi, BM, Kim, M, Koenig, E, Konigsberg, J, Korytov, A, Lo, KH, Matchev, K, Menendez, N, Mitselmakher, G, Madhu, AM, Rawal, N, Rosenzweig, D, Rosenzweig, S, Rotter, J, Shi, K, Sturdy, J, Yigitbasi, E, Zuo, X, Adams, T, Askew, A, Habibullah, R, Hagopian, V, Johnson, KF, Khurana, R, Kolberg, T, Martinez, G, Prosper, H, Schiber, C, Viazlo, O, Yohay, R, Zhang, J, Baarmand, MM, Butalla, S, Elkafrawy, T, Hohlmann, M, Verma, RK, Noonan, D, Rahmani, M, Yumiceva, F, Adams, MR, Gonzalez, HB, Cavanaugh, R, Dittmer, S, Evdokimov, O, Gerber, CE, Hangal, DA, Hofman, DJ, Merrit, AH, Mills, C, Oh, G, Roy, T, Rudrabhatla, S, Tonjes, MB, Varelas, N, Viinikainen, J, Wang, X, Wu, Z, Ye, Z, Alhusseini, M, Dilsiz, K, Gandrajula, RP, Koseyan, OK, Merlo, JP, Mestvirishvili, A, Nachtman, J, Ogul, H, Onel, Y, Penzo, A, Snyder, C, Tiras, E, Amram, O, Blumenfeld, B, Corcodilos, L, Davis, J, Eminizer, M, Gritsan, AV, Kyriacou, S, Maksimovic, P, Roskes, J, Swartz, M, Vami, TA, Abreu, A, Anguiano, J, Barrera, CB, Baringer, P, Bean, A, Bylinkin, A, Flowers, Z, Isidori, T, Khalil, S, King, J, Krintiras, G, Kropivnitskaya, A, Lazarovits, M, Le Mahieu, C, Lindsey, C, Marquez, J, Minafra, N, Murray, M, Nickel, M, Rogan, C, Royon, C, Salvatico, R, Sanders, S, Schmitz, E, Smith, C, Takaki, JDT, Warner, Z, Williams, J, Wilson, G, Duric, S, Ivanov, A, Kaadze, K, Kim, D, Maravin, Y, Mitchell, T, Modak, A, Nam, K, Rebassoo, F, Wright, D, Adams, E, Baden, A, Baron, O, Belloni, A, Eno, SC, Hadley, NJ, Jabeen, S, Kellogg, RG, Koeth, T, Mignerey, AC, Nabili, S, Palmer, C, Seidel, M, Skuja, A, Wang, L, Wong, K, Abercrombie, D, Andreassi, G, Bi, R, Busza, W, Cali, IA, D'Alfonso, M, Eysermans, J, Freer, C, Ceballos, GG, Goncharov, M, Harris, P, Hu, M, Klute, M, Kovalskyi, D, Krupa, J, Lee, YJ, Mironov, C, Paus, C, Rankin, D, Roland, C, Roland, G, Shi, Z, Stephans, GSF, Wang, Z, Wyslouch, B, Chatterjee, RM, Evans, A, Hiltbrand, J, Krohn, M, Kubota, Y, Mans, J, Revering, M, Rusack, R, Saradhy, R, Schroeder, N, Strobbe, N, Wadud, MA, Bloom, K, Bryson, M, Claes, DR, Fangmeier, C, Finco, L, Golf, F, Joo, C, Kravchenko, I, Musich, M, Reed, I, Siado, JE, Snow, GR, Tabb, W, Yan, F, Zecchinelli, AG, Agarwal, G, Bandyopadhyay, H, Hay, L, Iashvili, I, Kharchilava, A, McLean, C, Nguyen, D, Pekkanen, J, Rappoccio, S, Williams, A, Alverson, G, Barberis, E, Haddad, Y, Hortiangtham, A, Li, J, Madigan, G, Marzocchi, B, Morse, DM, Nguyen, V, Orimoto, T, Parker, A, Skinnari, L, Tishelman-Charny, A, Wamorkar, T, Wang, B, Wisecarver, A, Wood, D, Bueghly, J, Chen, Z, Gilbert, A, Gunter, T, Hahn, KA, Liu, Y, Odell, N, Schmitt, MH, Velasco, M, Band, R, Bucci, R, Cremonesi, M, Das, A, Dev, N, Goldouzian, R, Hildreth, M, Anampa, KH, Jessop, C, Lannon, K, Lawrence, J, Loukas, N, Lutton, D, Marinelli, N, Mcalister, I, McCauley, T, Mcgrady, C, Mohrman, K, Moore, C, Musienko, Y, Ruchti, R, Siddireddy, P, Townsend, A, Wayne, M, Wightman, A, Zarucki, M, Zygala, L, Bylsma, B, Cardwell, B, Durkin, LS, Francis, B, Hill, C, Ornelas, MN, Wei, K, Winer, BL, Yates, BR, Addesa, FM, Bonham, B, Das, P, Dezoort, G, Elmer, P, Frankenthal, A, Greenberg, B, Haubrich, N, Higginbotham, S, Kalogeropoulos, A, Kopp, G, Kwan, S, Lange, D, Marlow, D, Mei, K, Ojalvo, I, Olsen, J, Stickland, D, Tully, C, Norberg, S, Bakshi, AS, Barnes, VE, Chawla, R, Das, S, Gutay, L, Jones, M, Jung, AW, Karmarkar, S, Kondratyev, D, Liu, M, Negro, G, Neumeister, N, Paspalaki, G, Piperov, S, Purohit, A, Schulte, JF, Stojanovic, M, Thieman, J, Wang, F, Xiao, R, Xie, W, Dolen, J, Parashar, N, Baty, A, Carnahan, T, Decaro, M, Dildick, S, Ecklund, KM, Freed, S, Gardner, P, Geurts, FJM, Li, W, Padley, BP, Redjimi, R, Shi, W, Leiton, AGS, Zhang, L, Bodek, A, de Barbaro, P, Demina, R, Dulemba, JL, Fallon, C, Ferbel, T, Galanti, M, Garcia-Bellido, A, Hindrichs, O, Khukhunaishvili, A, Ranken, E, Taus, R, Chiarito, B, Chou, JP, Gandrakota, A, Gershtein, Y, Halkiadakis, E, Hart, A, Heindl, M, Karacheban, O, Laflotte, I, Lath, A, Montalvo, R, Nash, K, Osherson, M, Salur, S, Schnetzer, S, Somalwar, S, Stone, R, Thayil, SA, Thomas, S, Wang, H, Acharya, H, Delannoy, AG, Fiorendi, S, Spanier, S, Bouhali, O, Dalchenko, M, Delgado, A, Eusebi, R, Gilmore, J, Huang, T, Kamon, T, Luo, S, Malhotra, S, Mueller, R, Overton, D, Rathjens, D, Safonov, A, Akchurin, N, Damgov, J, Hegde, V, Kunori, S, Lamichhane, K, Mengke, T, Muthumuni, S, Peltola, T, Volobouev, I, Whitbeck, A, Appelt, E, Greene, S, Gurrola, A, Johns, W, Melo, A, Ni, H, Padeken, K, Romeo, F, Sheldon, P, Tuo, S, Velkovska, J, Arenton, MW, Cox, B, Cummings, G, Hakala, J, Hirosky, R, Joyce, M, Ledovskoy, A, Li, A, Neu, C, Lara, CEP, Tannenwald, B, White, S, Wolfe, E, Poudyal, N, Black, K, Bose, T, Caillol, C, Dasu, S, De Bruyn, I, Everaerts, P, Fienga, F, Galloni, C, He, H, Herndon, M, Herve, A, Hussain, U, Lanaro, A, Loeliger, A, Loveless, R, Sreekala, JM, Mallampalli, A, Mohammadi, A, Pinna, D, Savin, A, Shang, V, Smith, WH, Teague, D, Trembath-Reichert, S, Vetens, W, Department of Physics, Helsinki Institute of Physics, Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-École polytechnique (X)-Centre National de la Recherche Scientifique (CNRS), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Physics, Elementary Particle Physics, Faculty of Sciences and Bioengineering Sciences, Vriendenkring VUB, Universidad de Cantabria, Tumasyan A., Adam W., Andrejkovic J., Bergauer T., Chatterjee S., Damanakis K., Dragicevic M., Escalante Del Valle A., Frühwirth R., Jeitler M., et al., SCOAP, European Commission, European Research Council, Principado de Asturias, Ministerio de Economía y Competitividad (España), Yerevan Physics Institute, Institut für Hochenergiephysik, Institute for Nuclear Problems, Universiteit Antwerpen, Vrije Universiteit Brussel, Université Libre de Bruxelles, Ghent University, Université Catholique de Louvain, Centro Brasileiro de Pesquisas Fisicas, Universidade do Estado do Rio de Janeiro (UERJ), Universidade Estadual Paulista (UNESP), Bulgarian Academy of Sciences, University of Sofia, Beihang University, Tsinghua University, Institute of High Energy Physics, Peking University, Sun Yat-Sen University, Institute of Modern Physics and Key Laboratory of Nuclear Physics and Ion-beam Application (MOE) — Fudan University, China, Universidad de Los Andes, Universidad de Antioquia, Mechanical Engineering and Naval Architecture, Faculty of Science, Institute Rudjer Boskovic, University of Cyprus, Charles University, Escuela Politecnica Nacional, Universidad San Francisco de Quito, Egyptian Network of High Energy Physics, Fayoum University, National Institute of Chemical Physics and Biophysics, University of Helsinki, Lappeenranta University of Technology, Université Paris-Saclay, Institut Polytechnique de Paris, IPHC UMR 7178, Institut de Physique des 2 Infinis de Lyon (IP2I), Georgian Technical University, I. Physikalisches Institut, III. Physikalisches Institut A, III. Physikalisches Institut B, Deutsches Elektronen-Synchrotron, University of Hamburg, Karlsruher Institut fuer Technologie, NCSR Demokritos, National and Kapodistrian University of Athens, National Technical University of Athens, University of Ioánnina, Eötvös Loránd University, Wigner Research Centre for Physics, Institute of Nuclear Research ATOMKI, University of Debrecen, MATE Institute of Technology, Indian Institute of Science (IISc), HBNI, Panjab University, University of Delhi, Indian Institute of Technology Madras, Bhabha Atomic Research Centre, Tata Institute of Fundamental Research-A, Tata Institute of Fundamental Research-B, Indian Institute of Science Education and Research (IISER), Isfahan University of Technology, Institute for Research in Fundamental Sciences (IPM), University College Dublin, INFN Sezione di Bari, Università di Bari, Politecnico di Bari, INFN Sezione di Bologna, Università di Bologna, INFN Sezione di Catania, Università di Catania, INFN Sezione di Firenze, Università di Firenze, INFN Laboratori Nazionali di Frascati, INFN Sezione di Genova, Università di Genova, INFN Sezione di Milano-Bicocca, Università di Milano-Bicocca, INFN Sezione di Napoli, Università di Napoli ’Federico II’, Università della Basilicata, Università G. Marconi, INFN Sezione di Padova, Università di Padova, INFN Sezione di Pavia, Università di Pavia, INFN Sezione di Perugia, Università di Perugia, INFN Sezione di Pisa, Università di Pisa, Scuola Normale Superiore di Pisa, Università di Siena, INFN Sezione di Roma, Sapienza Università di Roma, INFN Sezione di Torino, Università di Torino, Università del Piemonte Orientale, INFN Sezione di Trieste, Università di Trieste, Kyungpook National University, Institute for Universe and Elementary Particles, Hanyang University, Korea University, Kyung Hee University, Sejong University, Seoul National University, University of Seoul, Yonsei University, Sungkyunkwan University, Kuwait, Riga Technical University, Vilnius University, Universiti Malaya, Universidad de Sonora (UNISON), Centro de Investigacion y de Estudios Avanzados del IPN, Universidad Iberoamericana, Benemerita Universidad Autonoma de Puebla, University of Montenegro, University of Auckland, University of Canterbury, Quaid-I-Azam University, Electronics and Telecommunications, National Centre for Nuclear Research, University of Warsaw, Laboratório de Instrumentação e Física Experimental de Partículas, Joint Institute for Nuclear Research, Petersburg Nuclear Physics Institute, Institute for Nuclear Research, Institute for Theoretical and Experimental Physics named by A.I. Alikhanov of NRC ‘Kurchatov Institute’, Moscow Institute of Physics and Technology, National Research Nuclear University ’Moscow Engineering Physics Institute’ (MEPhI), P.N. Lebedev Physical Institute, Lomonosov Moscow State University, Novosibirsk State University (NSU), Institute for High Energy Physics of National Research Centre ‘Kurchatov Institute’, National Research Tomsk Polytechnic University, Tomsk State University, University of Belgrade: Faculty of Physics and VINCA Institute of Nuclear Sciences, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Universidad Autónoma de Madrid, Instituto Universitario de Ciencias y Tecnologías Espaciales de Asturias (ICTEA), CSIC-Universidad de Cantabria, University of Colombo, University of Ruhuna, European Organization for Nuclear Research, Paul Scherrer Institut, ETH Zurich — Institute for Particle Physics and Astrophysics (IPA), Universität Zürich, National Central University, National Taiwan University (NTU), Science and Art Faculty, Physics Department, Bogazici University, Istanbul Technical University, Istanbul University, Institute for Scintillation Materials of National Academy of Science of Ukraine, Kharkov Institute of Physics and Technology, University of Bristol, Rutherford Appleton Laboratory, Imperial College, Brunel University, Baylor University, Catholic University of America, The University of Alabama, Boston University, Brown University, Davis, University of California, Riverside, San Diego, Santa Barbara — Department of Physics, California Institute of Technology, Carnegie Mellon University, University of Colorado Boulder, Cornell University, Fermi National Accelerator Laboratory, University of Florida, Florida State University, Florida Institute of Technology, University of Illinois at Chicago (UIC), The University of Iowa, Johns Hopkins University, The University of Kansas, Kansas State University, Lawrence Livermore National Laboratory, University of Maryland, Massachusetts Institute of Technology, University of Minnesota, University of Nebraska-Lincoln, State University of New York at Buffalo, Northeastern University, Northwestern University, University of Notre Dame, The Ohio State University, Princeton University, University of Puerto Rico, Purdue University, Purdue University Northwest, Rice University, University of Rochester, The State University of New Jersey, University of Tennessee, Texas A&M University, Texas Tech University, Vanderbilt University, University of Virginia, Wayne State University, University of Wisconsin — Madison, TU Wien, Technology and Maritime Transport, Universidade Estadual de Campinas (UNICAMP), Federal University of Rio Grande do Sul, The University of the State of Amazonas, University of Chinese Academy of Sciences, Universidade Federal de Mato Grosso do Sul (UFMS), Nanjing Normal University Department of Physics, Suez University, British University in Egypt, Cairo University, Université de Haute Alsace, Tbilisi State University, Erzincan Binali Yildirim University, Brandenburg University of Technology, Forschungszentrum Jülich, Assiut University, IIT Bhubaneswar, Institute of Physics, Punjab Agricultural University, Shoolini University, University of Hyderabad, University of Visva-Bharati, Indian Institute of Technology (IIT), Sharif University of Technology, University of Science and Technology of Mazandaran, Energy and Sustainable Economic Development, Centro Siciliano di Fisica Nucleare e di Struttura Della Materia, Consiglio Nazionale delle Ricerche — Istituto Officina dei Materiali, Consejo Nacional de Ciencia y Tecnología, Institute of Nuclear Physics of the Uzbekistan Academy of Sciences, St. Petersburg Polytechnic University, Budker Institute of Nuclear Physics, University of Belgrade, Sri Lanka, Ecole Polytechnique Fédérale Lausanne, Stefan Meyer Institute for Subatomic Physics, IN2P3-CNRS, Şırnak University, Research Center of Experimental Health Science, Konya Technical University, Piri Reis University, Adiyaman University, Ozyegin University, Necmettin Erbakan University, Bozok Universitetesi Rektörlügü, Marmara University, Milli Savunma University, Kafkas University, Istanbul Bilgi University, Hacettepe University, Faculty of Engineering, University of Southampton, IPPP Durham University, Bethel University, Karamanoğlu Mehmetbey University, Ain Shams University, Bingol University, Sinop University, Erciyes University, Texas A&M University at Qatar, Università di Trento, CERN, Andrejkovic, J, Escalante Del Valle, A, Pitters, F, Wulz, C, Darwish, M, De Wolf, E, Rejeb Sfar, H, Bols, E, Sahasransu, A, Kalsi, A, Donertas, I, Tran, T, Alves, G, Alda Junior, W, Alves Gallo Pereira, M, Barroso Ferreira Filho, M, Brandao Malbouisson, H, Da Costa, E, Da Silveira, G, De Jesus Damiao, D, Fonseca De Souza, S, Mora Herrera, C, Mota Amarilo, K, Rebello Teles, P, Silva Do Amaral, S, Torres Da Silva De Araujo, F, Vilela Pereira, A, Bernardes, C, Fernandez Perez Tomei, T, Gregores, E, Lemos, D, Mercadante, P, Novaes, S, Padula, S, Chen, G, Chen, H, Liu, Z, Qian, S, Mejia Guisao, J, Ruiz Alvarez, J, Salazar Gonzalez, C, Razis, P, Carrera Jarrin, E, Ellithi Kamel, A, Mahmoud, M, Dewanjee, R, Faure, J, Hamel de Monchenault, G, Sahin, M, Yu, G, Buchot Perraguin, A, Granier de Cassagnac, R, Sauvan, J, Agram, J, Brom, J, Chabert, E, Fontaine, J, Le Bihan, A, Laktineh, I, Schuler, S, Haj Ahmad, W, Aarup Petersen, H, Aldaya Martin, M, Bermudez Martinez, A, Bin Anuar, A, Consuegra Rodriguez, S, Correia Silva, G, Estevez Banos, L, Jomhari, N, Melzer-Pellmann, I, Mendizabal Morentin, M, Perez Adan, D, Ribeiro Lopes, B, Sosa Ricardo, R, Pena Rodriguez, K, Gosewisch, J, Simonis, H, Von Cube, R, Koraka, C, Gadallah, M, Radl, A, Veres, G, Trocsanyi, Z, Komaragiri, J, Tiwari, P, Muraleedharan Nair Bindhu, V, Swain, S, Beri, S, Singh, J, Virdi, A, Choudhary, B, Rout, P, Behera, P, Behera, S, Pujahari, P, Sikdar, A, Mishra, D, Netrakanti, P, Pant, L, Etesami, S, Mohammadi Najafabadi, M, Simone, F, Cavallo, F, Dallavalle, G, Navarria, F, Siroli, G, Dinardo, M, Lucchini, M, Pinolini, B, Tabarelli de Fatis, T, Iorio, A, Hoh, S, Meneguzzo, A, Aime', C, Ratti, S, Bilei, G, Ciocci, M, Di Domenico, M, Matos Figueiredo, D, Roy Chowdhury, S, Verdini, P, Berenguer Antequera, J, Obertino, M, Pinna Angioni, G, Kim, G, Moon, C, Oh, Y, Pak, S, Radburn-Smith, B, Yang, Y, Moon, D, Kim, T, Park, S, Bhyun, J, Oh, B, Oh, S, Yang, U, Kang, D, Merlin, J, Park, I, Ryu, M, Watson, I, Yoo, H, Carvalho Antunes De Oliveira, A, Norjoharuddeen, N, Wan Abdullah, W, Yusli, M, Benitez, J, Castaneda Hernandez, A, Leon Coello, M, Murillo Quijada, J, Valencia Palomo, L, Mondragon Herrera, C, Perez Navarro, D, Sanchez Hernandez, A, Carrillo Moreno, S, Oropeza Barrera, C, Vazquez Valencia, F, Salazar Ibarguen, H, Uribe Estrada, C, Butler, P, Asghar, M, Awan, M, Hoorani, H, Khan, W, Shah, M, Yuldashev, B, Alcaraz Maestre, J, Alvarez Fernandez, A, Barrio Luna, M, Bedoya, C, Carrillo Montoya, C, Delgado Peris, A, Fernandez Ramos, J, Fouz, M, Gonzalez Lopez, O, Goy Lopez, S, Hernandez, J, Josa, M, Leon Holgado, J, Navarro Tobar, A, Perez Dengra, C, Perez-Calero Yzquierdo, A, Puerta Pelayo, J, Sanchez Navas, S, Urda Gomez, L, de Troconiz, J, Alvarez Gonzalez, B, Fernandez Menendez, J, Gonzalez Caballero, I, Gonzalez Fernandez, J, Palencia Cortezon, E, Ramon Alvarez, C, Rodriguez Bouza, V, Soto Rodriguez, A, Vico Villalba, C, Brochero Cifuentes, J, Cabrillo, I, Duarte Campderros, J, Fernandez Madrazo, C, Fernandez Manteca, P, Garcia Alonso, A, Martinez Rivero, C, Martinez Ruiz del Arbol, P, Matorras Cuevas, P, Piedra Gomez, J, Vizan Garcia, J, Jayananda, M, Sonnadara, D, Wickramarathna, D, Dharmaratna, W, Aarrestad, T, Capeans Garrido, M, Chhibra, S, D'Enterria, D, Defranchis, M, Marini, A, Reales Gutierrez, G, Tavolaro, V, Van Onsem, G, Wozniak, K, Zeuner, W, Kaestli, H, Gomez Espinosa, T, Lyon, A, Manzoni, R, Martin Perez, C, Meinhard, M, Ratti, M, Sanz Becerra, D, Zhu, D, Canelli, M, Heikkila, J, Liechti, S, Mikuni, V, Sanchez Cruz, S, Kuo, C, Yu, S, Chen, K, Chen, P, Hou, W, Li, Y, Lu, R, Wu, H, Yu, P, Demiroglu, Z, Gurpinar Guler, E, Kayis Topaksu, A, Simsek, A, Tok, U, Zorbakir, I, Atakisi, I, Yetkin, E, Sunar Cerci, D, Brooke, J, Heath, G, Heath, H, Seif El Nasr-Storey, S, Smith, V, Walkingshaw Pass, K, Bell, K, Brown, R, Cockerill, D, Ellis, K, Holmberg, M, Newbold, D, Shepherd-Themistocleous, C, Tomalin, I, Chahal, G, Hassanshahi, M, Magnan, A, Monk, D, Raymond, D, Webb, S, Cole, J, Reid, I, Kanuganti, A, Mcmaster, B, Vargas Hernandez, A, Cooper, S, Gleyzer, S, Perez, C, Hogan, J, Lau, K, Wong, W, Calderon De La Barca Sanchez, M, Cox, P, Iqbal, M, Nash, W, Gary, J, Long, O, Olmedo Negrete, M, Branson, J, Sathia Narayanan, B, Lawhorn, J, Newman, H, Nguyen, T, Vlimant, J, Zhu, R, Andrews, M, Cumalat, J, Ford, W, Macdonald, E, Ulmer, K, Wagner, S, Cranshaw, D, Patterson, J, Bauerdick, L, Bhat, P, Butler, J, Cerati, G, Cheung, H, Di Petrillo, K, Elvira, V, Harris, R, Herwig, T, Kwok, K, Mcbride, P, Reinsvold Hall, A, Spalding, W, Tran, N, Vaandering, E, Weber, H, Field, R, Joshi, B, Lo, K, Muthirakalayil Madhu, A, Johnson, K, Baarmand, M, Kumar Verma, R, Adams, M, Becerril Gonzalez, H, Gerber, C, Hangal, D, Hofman, D, Merrit, A, Tonjes, M, Gandrajula, R, Koseyan, O, Merlo, J, Gritsan, A, Vami, T, Baldenegro Barrera, C, Tapia Takaki, J, Eno, S, Hadley, N, Kellogg, R, Mignerey, A, Cali, I, Gomez Ceballos, G, Stephans, G, Chatterjee, R, Wadud, M, Claes, D, Siado, J, Snow, G, Zecchinelli, A, Mclean, C, Morse, D, Hahn, K, Schmitt, M, Hurtado Anampa, K, Mccauley, T, Zygala, B, Durkin, L, Nunez Ornelas, M, Winer, B, Yates, B, Addesa, F, Bakshi, A, Barnes, V, Jung, A, Schulte, J, Ecklund, K, Geurts, F, Padley, B, Stahl Leiton, A, Dulemba, J, Chou, J, Thayil, S, Delannoy, A, Arenton, M, Perez Lara, C, Madhusudanan Sreekala, J, Smith, W, Sağır, Sinan, Belforte, S., Candelise, V., Casarsa, M., Cossutti, F., DA ROLD, A., DELLA RICCA, G., Sorrentino, G., Vazzoler, F., and ET AL (the CMS, Collaboration)
Subjects: 13000 GeV-cms, Temel Bilimler (SCI), parton: distribution function, transverse momentum [jet], PARTICLE PHYSICS, LARGE HADRON COLLIDER, CMS, Physics, Particles & Fields, rapidity dependence, Hadron-Hadron Scattering, Jet Physics, effective field theory, strong interaction: coupling constant, scattering [p p], PROGRAM, jet, production, High energy physics, Experimental particle physics, LHC, p p: scattering, p p: colliding beams, B: decay, tau: hadronic decay, interaction: gauge, interaction: model, transverse momentum: missing-energy, new physics: search for, mass spectrum: transverse, black hole: quantum, vector boson: mass, W': leptonic decay, sensitivity, leptoquark: coupling, CERN LHC Coll, leptoquark: mass: lower limit, anomaly, channel cross section: upper limit, Higgs, Nuclear Experiment, протон-протонные столкновения, parton, distribution function, двойные дифференциальные инклюзивные струи, Physics, QUARK, perturbation theory: higher-order, contact interaction, PHYSICS, NUCLEAR, 2 [higher-order], higher-order, 2, higher-order, 1, track data analysis: jet, Physical Sciences, hadroproduction [jet], colliding beams [p p], distribution function [parton], coupling constant [strong interaction], 1 [higher-order], p p, scattering, strong interaction, coupling constant, 114 Physical sciences, quark, phase space, FİZİK, NÜKLEER, Z0, mass, quantum chromodynamics, strong coupling, TeV, ddc:530, 0206 Quantum Physics, Science & Technology, higher-order [perturbation theory], jet: rapidity, ATLAS, детектор, Большой адронный коллайдер, GeV, jet: transverse momentum, transverse momentum dependence, High Energy Physics - Experiment, High Energy Physics - Experiment (hep-ex), SINGLET, [PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex], jet [track data analysis], 0105 Mathematical Physics, Temel Bilimler, Wilson, higher-order: 2, higher-order: 1, jet, rapidity, Nuclear & Particles Physics, Nükleer ve Yüksek Enerji Fiziği, Natural Sciences (SCI), rapidity [jet], 0202 Atomic, Molecular, Nuclear, Particle and Plasma Physics, Natural Sciences, Particle Physics - Experiment, perturbation theory [quantum chromodynamics], Nuclear and High Energy Physics, data analysis method, jet, transverse momentum, FOS: Physical sciences, Fizik, PARTON DENSITIES, COMPUTATION, differential cross section: measured, PHYSICS, measured [differential cross section], quantum chromodynamics: perturbation theory, hep-ex, High Energy Physics::Phenomenology, 3-LOOP SPLITTING FUNCTIONS, jet: hadroproduction, EVOLUTION, Physics and Astronomy, Fizik Bilimleri, High Energy Physics::Experiment, experimental results
Abstract: A measurement of the inclusive jet production in proton-proton collisions at the LHC at √s = 13 TeV is presented. The double-differential cross sections are measured as a function of the jet transverse momentum pT and the absolute jet rapidity |y|. The anti-kT clustering algorithm is used with distance parameter of 0.4 (0.7) in a phase space region with jet pT from 97 GeV up to 3.1 TeV and |y| < 2.0. Data collected with the CMS detector are used, corresponding to an integrated luminosity of 36.3 fb−1 (33.5 fb−1). The measurement is used in a comprehensive QCD analysis at next-to-next-to-leading order, which results in significant improvement in the accuracy of the parton distributions in the proton. Simultaneously, the value of the strong coupling constant at the Z boson mass is extracted as αS(mZ) = 0.1170±0.0019. For the first time, these data are used in a standard model effective field theory analysis at next-to-leading order, where parton distributions and the QCD parameters are extracted simultaneously with imposed constraints on the Wilson coefficient c1 of 4-quark contact interactions., Individuals have received support from the Marie-Curie programme and the European Research Council and Horizon 2020 Grant, contract Nos. 675440, 724704, 752730, 758316, 765710, 824093, 884104, and COST Action CA16108 (European Union); the Leventis Foundation; the Alfred P. Sloan Foundation; the Alexander von Humboldt Foundation;the Belgian Federal Science Policy Office; the Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture (FRIA-Belgium); the Agentschap voor Innovatie door Wetenschap en Technologie (IWT-Belgium); the F.R.S.-FNRS and FWO (Belgium) under the “Excellence of Science — EOS” — be.h project n. 30820817; the Beijing Municipal Science & Technology Commission, No. Z191100007219010; the Ministry of Education, Youth and Sports (MEYS) of the Czech Republic; the Deutsche Forschungsgemeinschaft (DFG), under Germany’s Excellence Strategy — EXC 2121 “Quantum Universe” — 390833306, and under project number 400140256 - GRK2497; the Lendület (“Momentum”) Programme and the János Bolyai Research Scholarship of the Hungarian Academy of Sciences, the New National Excellence Program ÚNKP, the NKFIA research grants 123842, 123959, 124845, 124850, 125105, 128713, 128786, and 129058 (Hungary); the Council of Science and Industrial Research, India; the Latvian Council of Science; the Ministry of Science and Higher Education and the National Science Center, contracts Opus 2014/15/B/ST2/03998 and 2015/19/B/ST2/02861 (Poland); the Fundação para a Ciência e a Tecnologia, grant CEECIND/01334/2018 (Portugal); the National Priorities Research Program by Qatar National Research Fund; the Ministry of Science and Higher Education, projects no. 14.W03.31.0026 and no. FSWW-2020-0008, and the Russian Foundation for Basic Research, project No.19-42-703014 (Russia); the Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia María de Maeztu, grant MDM-2015-0509 and the Programa Severo Ochoa del Principado de Asturias; the Stavros Niarchos Foundation (Greece); the Rachadapisek Sompot Fund for Postdoctoral Fellowship, Chulalongkorn University and the Chulalongkorn Academic into Its 2nd Century Project Advancement Project (Thailand); the Kavli Foundation; the Nvidia Corporation; the SuperMicro Corporation; the Welch Foundation, contract C-1845; and the Weston Havens Foundation (U.S.A.)., Article funded by SCOAP3.
Published: 2022
Full Text: View/download PDF

3. The Turing model for biological pattern formation

Author: Maini, Philip K., Woolley, Thomas, Bianchi, A., Hillen, T., Lewis, M., and Yi, Y.
Subjects: QH301, QA
Abstract: How spatial patterning arises in biological systems is still an unresolved mystery. Here, we consider the first model for spatial pattern formation, proposed by Alan Turing, which showed that structure could emerge from processes that, in themselves, are non-patterning. He therefore went against the reductionist approach, arguing that biological function arises from the integration of processes, rather than being attributed to a single, unique, process. While still controversial, some 65 years on, his model still inspires mathematical and experimental advances.
Published: 2019

4. Monitoring dust retention variations in different functional zones based on leaf magnetism and the influence of green belt spatial layouts on leaf dust retention.

Author: Tao Z, Li S, Wang B, Xie Y, Wang R, Hu L, Jia J, and Zhang J
Subjects: China, Particulate Matter analysis, Vehicle Emissions analysis, Trees, Dust analysis, Plant Leaves chemistry, Environmental Monitoring methods, Air Pollutants analysis
Abstract: Atmospheric particulate pollution generated by traffic activities poses a threat to human health. Due to their unique structure and function, plant leaves efficiently capture and accumulate atmospheric particulate matter, acting as natural particulate collectors. This study focuses on leaf samples from different functional zones in Jinhua City, Zhejiang Province, employing environmental magnetism methods to explore dust retention differences among zones and the impact of green belt spatial layouts on dust retention. The results indicate that leaf magnetism is an effective method for monitoring traffic-related particulate pollution. The saturation isothermal remanent magnetization per unit area (2D-SIRM) values of leaf samples from traffic zones were significantly higher than those from residential areas; the 2D-SIRM value of tree leaves increases with higher traffic volume, indicating more dust retention, suggesting that traffic activities are a major source of particulate pollution. Leaf height (height above the ground), distance from roads, and orientation significantly influence dust retention, with higher magnetic mineral concentrations found in leaves facing roads, closer to roads, and at a height of 2 m, suggesting that traffic-emitted particulates tend to accumulate in these areas. There are differences in dust retention capacities among tree species; Osmanthus and Loropetalum chinense perform better than Golden Privet and Red Tip Photinia. The research results provide some reference for the design of roadside green vegetation systems in Jinhua City and other cities in subtropical monsoon climate zones., Competing Interests: Declarations. Ethical approval: Not applicable. Consent to participate: All authors consented to participate in the manuscript. Competing interests: The authors declare no competing interests., (© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
Published: 2025
Full Text: View/download PDF

5. Exploring cadmium uptake pathways in the roots of Coptis chinensis Franch.

Author: Niu Y, He S, Xing L, Zhang D, Li Y, Deng C, Jiang Y, Zhang H, Song X, Ding M, Huang W, and Wang W
Abstract: To investigate the cadmium (Cd) uptake mechanism in the roots of Coptis chinensis Franch., we utilized non-invasive micro-test technology (NMT) to analyze Cd 2+ and H + fluxes, alongside ICP-MS to assess Cd content and fluxes under various inhibitors and ion channel blockers. Results revealed that Cd 2+ uptake primarily occurs in the root meristematic zone. Cd 2+ addition significantly inhibited H + influx. The P-type ATPase inhibitor Na 3 VO 4 and the metabolism inhibitor CCCP both reduced Cd 2+ fluxes and Cd content in roots of C. chinensis Ca 2+ channel blocker LaCl 3 exhibited more pronounced inhibition on Cd 2+ flux than K + channel blocker TEA, indicating Cd 2+ uptake mainly via Ca 2+ channels. Therefore, active transport and Ca 2+ channels may play an important role in Cd uptake in C. chinensis roots., Competing Interests: Declarations. Competing interests: The authors declare no competing interests., (© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

6. Circ_DLG1 facilitates cell proliferation and metastasis of esophageal squamous cell carcinoma via upregulating MAP3K9.

Author: Wang H, Wu Y, Yang Y, Pang Y, Hu H, and Gou Y
Abstract: Background: Circ_DLG1 is found to be aberrantly expressed in esophageal squamous cell carcinoma (ESCC) tissues, but its role in the progression of ESCC remains to be elucidated., Methods: The expression of circ_DLG1, miR-338-3p and mitogen-activated protein kinase kinase kinase 9 (MAP3K9) was measured by qRT-PCR. Cell cycle, viability, migration and invasion were investigated using flow cytometry, MTT assay and transwell assay, respectively. The protein levels of MAP3K9, p38, phosphor p38 (p-p38), ERK1/2 (ERKs), phosphor ERKs (p-ERKs) were detected by western blot. Dual-luciferase reporter assay and RIP assay were performed to verify the putative relationship between miR-338-3p and circ_DLG1 or MAP3K9. Animal experiments were performed to ascertain the role of circ_DLG1 in vivo., Results: Circ_DLG1 expression was elevated in ESCC tissues, plasma and cells. Circ_DLG1 knockdown inhibited cell proliferation, migration and invasion. MAP3K9 was highly expressed in ESCC, and its overexpression rescued the effects of circ_DLG1 knockdown on cell proliferation and metastasis. Besides, circ_DLG1 positively regulated MAP3K9 expression by competitively targeting miR-338-3p. Also, miR-338-3p inhibition or MAP3K9 overexpression recovered the inhibiting effect of circ_DLG1 knockdown on the phosphorylated levels of p38 and ERKs. In addition, circ_DLG1 knockdown blocked the tumor growth in vivo by regulating the miR-338-3p/MAP3K9 axis., Conclusion: Circ_DLG1 promoted malignant progression of ESCC by mediating the miR-338-3p/MAP3K9/p38/ERK pathway, indicating that targeted inhibition of the circ_DLG1/miR-338-3p/MAP3K9/p38/ERK axis might be an effective strategy for the treatment of ESCC., Competing Interests: Declarations. Conflict of interest: The authors declare that they have no financial conflict of interest. Ethical approval and consent for publication: All patients included in the presents study provided written informed consent prior to their inclusion. The study was approved by the ethics committee of Gansu Provincial Hospital. Consent for publication: Not applicable., (© 2025. The Author(s) under exclusive licence to The Japan Esophageal Society.)
Published: 2025
Full Text: View/download PDF

7. Advanced diffusion-weighted MRI models for preoperative prediction of lymph node metastasis in resectable gastric cancer.

Author: Li J, Zhang H, Bei T, Wang Y, Ma F, Wang S, Li H, and Qu J
Subjects: Humans, Male, Female, Middle Aged, Prospective Studies, Aged, Predictive Value of Tests, Adult, Stomach Neoplasms diagnostic imaging, Stomach Neoplasms pathology, Stomach Neoplasms surgery, Diffusion Magnetic Resonance Imaging methods, Lymphatic Metastasis diagnostic imaging, Gastrectomy, Adenocarcinoma diagnostic imaging, Adenocarcinoma pathology, Adenocarcinoma surgery
Abstract: Objective: To investigate the potential of six advanced diffusion-weighted imaging (DWI) models for preoperative prediction of lymph node metastasis (LNM) in resectable gastric cancer (GC)., Methods: Between Nov 2022 and Nov 2023, standard MRI scans were prospectively performed in consecutive patients with endoscopic pathology-confirmed gastric adenocarcinoma who were referred for direct radical gastrectomy. Six DWI models, including fractional order calculus (FROC), continuous-time random walk (CTRW), diffusion kurtosis imaging (DKI), intravoxel incoherent motion (IVIM), the mono-exponential model (MEM) and the stretched exponential model (SEM) were computed. Surgical pathologic diagnosis of LNM was the reference standard, and patients were classified into LNM-positive or LNM-negative groups accordingly. The morphological features and quantitative parameters of the DWI models in different LNM categories were analyzed and compared. Multivariable logistic regression was used to screen significant predictors. Receiver-operating characteristic curves and the area under the curve (AUC) were plotted to evaluate the performances, the Delong test was performed to compare the AUCs., Results: In the LNM-positive group, tumor thickness and kurtosis (DKI_K) were significantly higher, while anomalous diffusion coefficient (CTRW_D), diffusivity (DKI_D), diffusion coefficient (FROC_D), pseudodiffusion coefficient (IVIM_D*), perfusion fraction (IVIM_f), and ADC were lower compared to the LNM-negative group. Clinical tumor staging (cT) and CTRW_D were independent predictors. Their combination demonstrated a superior AUC of 0.930, significantly higher than that of individual parameters., Conclusions: Tumor thickness, DKI_K, CTRW_D, DKI_D, FROC_D, IVIM_D*, IVIM_f and ADC were associated with LNM status. The combination of independent predictors of cT and CTRW_D further enhanced the performance., Competing Interests: Declarations. Competing interests: The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

8. MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy - a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis.

Author: Chen H, Tan G, Zhong L, Hu Y, Han W, Huang Y, Liang Q, Szekeres D, Jiang H, Bharadwaj R, Smith SM, Wang HZ, and Liu X
Subjects: Humans, Male, Female, Middle Aged, Retrospective Studies, Adult, Aged, Chemoradiotherapy, Magnetic Resonance Imaging, Brain Neoplasms diagnostic imaging, Brain Neoplasms therapy, Brain Neoplasms pathology, Brain Neoplasms drug therapy, Brain Neoplasms radiotherapy, Immunotherapy methods, Radiation Injuries diagnostic imaging, Radiation Injuries etiology, Radiation Injuries pathology, Necrosis, Disease Progression
Abstract: Purpose: Pseudoprogression is an atypical imaging pattern of response to immunotherapy in patients with brain tumors. MR perfusion studies in this field are limited. The purpose of our study is to compare the perfusion features between pseudoprogression lesions in malignant gliomas and brain metastases treated with immunotherapy (iPsP) and the pseudoprogression after chemo-radiation therapy and radiation necrosis after radiation treatment (ChR-PsP & RN)., Methods: We retrospectively reviewed 25 iPsP lesions in 16 brain tumor patients and 48 ChR-PsP & RN lesions in 35 patients. The cerebral blood volume (CBV) of MR dynamic susceptibility contrast (DSC) perfusion weighted imaging (PWI) was analyzed, and the mean and maximal values of the ratio of CBV (rCBV mean and rCBV max ) of iPsPs and ChR-PsP & RNs were calculated and compared between these two groups using the Mann-Whitney U test. A receiver operating characteristic curve analysis was conducted, and the optimal cutoff of perfusion parameters were determined using the area under the curve, sensitivity, and specificity., Results: The medians of rCBV mean and rCBV max in iPsP group were significantly higher (0.94 and 1.39 respectively) than ChR-PsP & RN group (0.67, p < 0.01 and 1.1, p = 0.01 respectively). The rCBV mean value of 0.69 can differentiate the iPsP from ChR-PsP & RN with the area under the curve of 0.71, sensitivity of 0.72, and specificity of 0.56., Conclusion: These findings may suggest immunotherapy-induced higher perfusion in the iPsP lesions compared to ChR-PsP & RN lesions in primary and metastatic brain tumors., Competing Interests: Declarations. Ethical approval: This retrospective study was approved by the ethics committees of the Yuebei People’s Hospital, and the requirement for informed consent was waived (Date August 1, 2022 /No. KY-2022-042). Consent to participate: The requirement for informed consent was waived. Competing interests: The authors declare no competing interests., (© 2024. The Author(s).)
Published: 2025
Full Text: View/download PDF

9. Spinal cord stimulation induces Neurotrophin-3 to improve diabetic foot disease.

Author: Liu Y, Li X, Xu H, Sun K, Gong HJ, and Luo C
Subjects: Animals, Humans, Rats, Male, Middle Aged, Female, Disease Models, Animal, Aged, Rats, Sprague-Dawley, Wound Healing, Brain-Derived Neurotrophic Factor metabolism, Brain-Derived Neurotrophic Factor blood, Nerve Growth Factor metabolism, Diabetic Foot therapy, Neurotrophin 3 metabolism, Spinal Cord Stimulation methods
Abstract: Low-extremity ischemic disease is a common complication in diabetic patients, leading to reduced quality of life and potential amputation. This study investigated the therapeutic effect of spinal cord stimulation (SCS) on patients with diabetic foot disease and a rat model of diabetic foot injury. SCS was applied to patients with diabetic foot disease, with clinical assessments performed before and after therapy. Blood levels of NGF, BDNF, and NT-3 were determined by ELISA. A rat model of diabetic foot injury was established to validate NT-3's role in SCS therapy. SCS therapy improved the condition of patients with diabetic ischemic foot disease and promoted wound healing in the rat model. NT-3 levels significantly increased after SCS therapy in both patients and rats. Recombinant NT-3 administration improved wound healing and re-vascularization in the rat model, while NT-3 neutralization abrogated SCS's therapeutic effect. SCS improves the condition of patients with diabetic ischemic foot disease by inducing NT-3 production. Both SCS and NT-3 supplementation show therapeutic potential for ameliorating diabetic foot disease., Competing Interests: Declarations. Conflict of interest: The authors of this study promise to be free of any conflicts of interest. Ethical approval and consent to participate: All animal experiments involved in this study have been permitted and approved., (© 2024. The Author(s).)
Published: 2025
Full Text: View/download PDF

10. The research progress on meningeal metastasis in solid tumors.

Author: Yue Y, Ren Y, Lu C, Jiang N, Wang S, Fu J, Kong M, and Zhang G
Abstract: Meningeal metastasis (MM), particularly Leptomeningeal metastases (LM), represents the advanced stage of solid tumors and poses a significant threat to patients' lives. Moreover, it imposes a substantial burden on society. LM represents the ultimate and most fatal stage of solid tumors, inflicting devastating consequences on patients and imposing a substantial burden on society. The incidence of LM continues to rise annually, emphasizing the urgent need for early recognition and treatment initiation in individuals with LM to significantly extend overall patient survival. Despite rapid advancements in current LM detection and treatment methods, the diagnosis of LM remains constrained by several limitations such as low diagnostic efficiency, the therapeutic outcomes remain suboptimal. Furthermore, there is currently no universally recognized industry standard for LM treatment, further underscoring its status as an unresolved challenge in tumor management. Additionally, progress towards elucidating the mechanisms underlying MM has stagnated. Therefore, this review aims to comprehensively summarize recent research advances pertaining to MM in solid tumors by elucidating its underlying mechanisms, exploring diagnostic and prognostic biomarkers while addressing existing research challenges., Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

11. Online Processing of Grammatical Aspect in Subsamples of Preschool Mandarin-acquiring Autistic Children.

Author: Xie QQ and Su Y
Abstract: Grammatical comprehension remains a strength in English-acquiring autistic preschoolers, yet limited studies have examined how autistic children process grammatical constructions in real time, in any language. This study sought to characterize the online processing of grammatical aspect in a diverse sample of Mandarin-acquiring autistic children. Forty-six 3-6-year-old autistic children, further divided into high (N = 23) and low verbal subgroups (N = 23) based on their expressive vocabulary levels, were assessed via Intermodal Preferential Looking (IPL). Children viewed side-by-side renditions of the same event, one of which was ongoing, while the other was completed, paired with familiar verbs with the perfective aspect le or the durative aspect zhe. Both high and low verbal autistic groups demonstrated robust comprehension of le and zhe. Similar to TD children, autistic children in each group showed processing facilities upon the initial presentation of the zhe test audio, but they may be less efficient at le processing. Moreover, the comprehension degree of grammatical aspect correlated negatively with their autism severity scores for the total autistic group; the processing efficiency correlated positively with the production of grammatical aspect for the total and low verbal autistic groups. The findings confirm the strength of processing grammatical aspect in subsamples of preschoolers with autism spanning a wide range of language functioning, suggesting that young autistic group across languages could surmount at least some challenges of aspect acquisition, such as delayed expressive language skills and pragmatic deficits. Additionally, the influencing factors provided insight into the informing intervention strategies that are optimally, developmentally timed., Competing Interests: Declarations. Conflict of interest: The authors declare that they have no conflict of interest. Ethical Approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed Consent: Informed consent was obtained from all individual participants included in the study., (© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

12. A comparative assessment of rheumatoid arthritis burden: trends in China, the US, India, Europe, and globally from 1990 to 2021 and forecasts to 2030 utilizing GBD data.

Author: Yang Y, Ning X, Zhou L, Xie L, Zhang X, Yu L, Shang J, Feng X, Ren J, and Duan X
Abstract: Background: Rheumatoid arthritis (RA) is a pervasive chronic inflammatory condition exerting a substantial impact on global morbidity and mortality. This study provides an in-depth analysis of the epidemiological trends of RA across China, America, India, and Europe as well as at a global level from 1990 to 2021, with forward-looking projections extending to 2030., Methods: Leveraging data from the Global Burden of Disease (GBD) database, a comparative assessment of the age-standardized (AS) incidence rate (ASIR), prevalence rate (ASPR), mortality rate (ASMR), and disability-adjusted life years (DALYs) rate (ASDR) for RA was performed. Trends were evaluated and future burdens forecasted using Joinpoint regression and autoregressive integrated moving average (ARIMA) models., Results: Between 1990 and 2021, a global upsurge in RA incidence was observed, with India experiencing the most rapid growth and America consistently recording the highest ASIR, albeit with a diminishing increment rate. The prevalence escalated across all regions, with America exhibiting the highest ASPR. Mortality rates generally trended downward, with India registering the highest ASMR by 2021, contrasting with the lowest rates in America and Europe. Disability trends, quantified by ASDR, exhibited relative stability, yet a notable increase was observed in India. ARIMA model-based projections anticipate a continued rise in RA incidence and prevalence by 2030, with mortality and disability rates anticipated to exhibit minor oscillations., Conclusion: The escalating burden of RA, particularly in developing nations, underscores an urgent need for enhanced healthcare policies focused on early diagnosis, intervention, and disability mitigation. The projections indicate enduring public health challenges attributed to RA in the forthcoming decade., Competing Interests: Declarations. Conflict of interest: Y. Yang, X. Ning, L. Zhou, L. Xie, X. Zhang, L. Yu, J. Shang, X. Feng, J. Ren, and X. Duan declare that they have no competing interests. All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study., (© 2025. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
Published: 2025
Full Text: View/download PDF

13. N200 and late components reveal text-emoji congruency effect in affective theory of mind.

Author: Zhong Y, Zhong H, Chen Q, Liang X, Xiao F, Xin F, and Chen Q
Abstract: Emojis are thought to be important for online communication, affecting not only our emotional state, but also our ability to infer the sender's emotional state, i.e., the affective theory of mind (aToM). However, it is unclear the role of text-emoji valence congruency in aToM judgements. Participants were presented with positive, negative, or neutral instant messages followed by positive or negative emoji and were required to infer the sender's emotional state as making valence and arousal ratings. Participants rated that senders felt more positive when they displayed positive emojis as opposed to negative emojis, and the senders were more aroused when valence between emoji and sentence was congruent. Event-related potentials were time-locked to emojis and analyzed by robust mass-univariate statistics, finding larger N200 for positive emojis relative to negative emojis in the negative sentence but not in the positive and neutral sentences, possibly reflecting conflict detection. Furthermore, the N400 effect was found between emotional and neutral sentences, but not between congruent and incongruent conditions, which may reflect a rapid bypassing of deeper semantic analysis. Critically, larger later positivity and negativity (600-900 ms) were found for incongruent combinations relative to congruent combinations in emotional sentences, which was more pronounced for positive sentence, reflecting the cognitive efforts needed for reevaluating the emotional meaning of emotional state attribution under incongruent combinations. These results suggest that emoji valence exerts different effects on positive and negative aToM judgments, and affective processing of sentence-emoji combinations precedes semantic processing, highlighting the importance of emojis in aToM., Competing Interests: Declarations. Conflict of interest: All the authors declare that there is no conflict of interest. Ethics approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of Shenzhen University and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Medical Ethics Committee of Shenzhen University. Consent to participate: Informed consent was obtained from all individual participants included in the study. Consent for publication: The authors affirm that human research participants provided informed consent for the publication., (© 2025. The Psychonomic Society, Inc.)
Published: 2025
Full Text: View/download PDF

14. Exploring BIRC family genes as prognostic biomarkers and therapeutic targets in prostate cancer.

Author: Yu XX, Liu Y, Mo ZM, Luo RJ, and Chen WK
Abstract: The potential oncogenic role of Baculoviral inhibitor of apoptosis (IAP) Repeat-Containing (BIRC) genes in prostate cancer (PCa) has yet to be fully investigated. Two genes associated with disease recurrence, BIRC5 and BIRC7, were identified through survival analysis, and prostate cancer patients were categorized into two subtypes, C1 and C2, based on these genes. We performed survival analyses to assess the relationship between subtypes and the prognosis of PCa. Single-cell dataset analysis was used to identify specific cell types with enriched expression of BIRC family genes. Our findings show that BIRC5 and BIRC7 exhibit higher expression in PCa tissues compared to non-cancerous tissues. High expression of BIRC5 and BIRC7 independently correlates with an adverse prognosis in PCa. The analysis of mechanisms reveals that the differentially expressed genes impact signaling pathways associated with cancer and immunity. BIRC5/BIRC7 correlate with several immune cells infiltrating levels including T cells and macrophages. Furthermore, our research indicates that elevated expression of BIRC5 is associated with immune infiltration in PCa. These findings highlight the potential of BIRC5/BIRC7 or C1 subtype as prognostic biomarkers, offering new insights into possible targets for the development of therapeutic biomarkers and immunotherapeutic for PCa., Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

15. Genomic and micro-environmental insights into drug resistance in colorectal cancer liver metastases.

Author: Kuang J, Li J, Zhou S, Li Y, Lin J, Huang W, and Yuan X
Abstract: Background: Colorectal cancer (CRC) is known for its high heterogeneity, with liver metastases significantly impairing survival outcomes. Understanding the tumor microenvironment (TME) and genomic alterations in metastatic sites is crucial for developing personalized therapies that overcome drug resistance and improve prognosis., Methods: We profiled 54 CRC liver metastases, comparing them with 198 other metastatic lesions and normal liver tissues. By analyzing immune cell infiltration, stromal interactions, and key genomic alterations, we constructed an 11-gene prognostic model to predict survival and immunotherapy outcomes., Results: CRC liver metastases with high-risk profiles demonstrated enriched follicular helper T cells, activated dendritic cells, and M2 macrophages in the TME. Frequent mutations in APC, TP53, KRAS, and PIK3CA were identified, alongside altered EGFR signaling. The 11-gene model effectively stratified patients by prognosis and predicted immunotherapy responses, emphasizing the therapeutic potential of targeting resistance mechanisms., Conclusions: This study reveals how genomic and TME-driven factors contribute to drug resistance in CRC liver metastases. Integrating these insights with clinical data could advance precision therapies, addressing the evolving challenge of tumor drug resistance in CRC., Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable. Consent for publicatoion: Not applicable. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

16. Durable Acidic Oxygen Evolution Via Self-Construction of Iridium Oxide/Iridium-Tantalum Oxide Bi-Layer Nanostructure with Dynamic Replenishment of Active Sites.

Author: Guo Q, Li R, Zhang Y, Zhang Q, He Y, Li Z, Liu W, Liu X, and Lu Z
Abstract: Proton exchange membrane (PEM) water electrolysis presents considerable advantages in green hydrogen production. Nevertheless, oxygen evolution reaction (OER) catalysts in PEM water electrolysis currently encounter several pressing challenges, including high noble metal loading, low mass activity, and inadequate durability, which impede their practical application and commercialization. Here we report a self-constructed layered catalyst for acidic OER by directly using an Ir-Ta-based metallic glass as the matrix, featuring a nanoporous IrO 2 surface formed in situ on the amorphous IrTaO x nanostructure during OER. This distinctive architecture significantly enhances the accessibility and utilization of Ir, achieving a high mass activity of 1.06 A mg Ir -1 at a 300 mV overpotential, 13.6 and 31.2 times greater than commercial Ir/C and IrO 2 , respectively. The catalyst also exhibits superb stability under industrial-relevant current densities in acid, indicating its potential for practical uses. Our analyses reveal that the coordinated nature of the surface-active Ir species is effectively modulated through electronic interaction between Ir and Ta, preventing them from rapidly evolving into high valence states and suppressing the lattice oxygen participation. Furthermore, the underlying IrTaO x dynamically replenishes the depletion of surface-active sites through inward crystallization and selective dissolution, thereby ensuring the catalyst's long-term durability., Competing Interests: Declarations. Conflict of Interest: The authors declare no conflict of interest. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

17. Patients with multiple mpMRI region of interests: should we omit targeted biopsies of secondary lesions?

Author: Qin F, Yuan C, Ma J, Li H, Zhang J, Liu Y, and Zhao Z
Abstract: Purpose: To assess the value of secondary lesion-targeted biopsy (SLx) in detecting prostate cancer (PCa) among patients with multifocal disease., Methods: A total of 298 biopsy-naïve patients with 612 lesions (all with Prostate Imaging Reporting and Data System [PI-RADS] v2.1 ≥ 3) underwent cognitive fusion-targeted biopsy (TB) combined with systematic biopsy (SB). Our primary endpoints were to compare the detection rates of PCa and clinically significant PCa (csPCa) across different biopsy strategies (Index lesion-targeted biopsy [ILx] vs. ILx + SLx and ILx + SB vs. ILx + SLx + SB) and to define potential indications for SLx using PI-RADS and PSA density (PSAD). Secondary endpoint was to evaluate the predictive performance of index lesion (IL)- and SL-based multivariate logistic regression (MVA) models for csPCa., Results: The overall detection rates for PCa and csPCa were 71% and 60%, with ILx + SLx + SB as the gold standard. Adding SLx to ILx modestly increased detection rates for PCa (63% vs. 65%, P = 0.016) and csPCa (55% vs. 58%, P = 0.004), but offered no significant advantage over ILx + SB. Stratification by PI-RADS and PSAD revealed that focusing on 80% intermediate- to high-risk lesions detected 39% csPCa while reducing 20% low-risk SLx at the cost of missing 1.6% csPCa. IL-based models outperformed SL-based models in predicting csPCa (Hosmer-Lemeshow P = 0.653 vs. 0.461)., Conclusion: SLx provides limited benefit in csPCa detection when ILx and SB have already been performed. Combining PI-RADS scores and PSAD helps identify patients who could benefit from SLx while avoiding unnecessary procedures in low-risk cases., Clinical Trial Registration: No. 2016 - 1252, January 2017., Competing Interests: Declarations. Competing interests: The authors declare no competing interests., (© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

18. M4S-Net: a motion-enhanced shape-aware semi-supervised network for echocardiography sequence segmentation.

Author: Li M, Tian F, Liang S, Wang Q, Shu X, Guo Y, and Wang Y
Abstract: Sequence segmentation of echocardiograms is of great significance for the diagnosis and treatment of cardiovascular diseases. However, the low quality of ultrasound imaging and the complexity of cardiac motion pose great challenges to it. In addition, the difficulty and cost of labeling echocardiography sequences limit the performance of supervised learning methods. In this paper, we proposed a Motion-enhanced Shape-aware Semi-supervised Sequence Segmentation Network named M4S-Net. First, multi-level shape priors are used to enhance the model's shape representation capabilities, overcoming the low image quality and improving single-frame segmentation. Then, a motion-enhanced optimization module utilizes optical flows to assist segmentation in a geometric sense, which robustly responds to the complex motions and ensures the temporal consistency of sequence segmentation. A hybrid loss function is devised to maximize the effectiveness of each module and further improve the temporal stability of predicted masks. Furthermore, the parameter-sharing strategy allows it to perform sequence segmentation in a semi-supervised manner. Massive experiments on both public and in-house datasets show that M4S-Net outperforms the state-of-the-art methods in both spatial and temporal segmentation performance. A downstream apical rocking recognition task based on M4S-Net also achieves an AUC of 0.944, which significantly exceeds specialized physicians., Competing Interests: Declarations. Competing interests: The authors declare no competing interests., (© 2025. International Federation for Medical and Biological Engineering.)
Published: 2025
Full Text: View/download PDF

19. Irf7 aggravates prostatitis by promoting Hif-1α-mediated glycolysis to facilitate M1 polarization.

Author: Meng T, Zhang Y, Wang H, Wu W, Peng W, Yue J, Huang C, Liu W, Liang C, Yang C, and Chen J
Subjects: Animals, Male, Mice, Disease Models, Animal, Humans, Prostate metabolism, Prostate pathology, Glycolysis genetics, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Prostatitis metabolism, Prostatitis pathology, Prostatitis genetics, Interferon Regulatory Factor-7 metabolism, Interferon Regulatory Factor-7 genetics, Macrophages metabolism, Mice, Inbred C57BL
Abstract: Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common disorder associated with voiding symptoms and pain in the pelvic or perineal area. Macrophages, particularly the pro-inflammatory M1 subtype, are crucial initiating of CP/CPPS. Interferon regulatory factor 7 (Irf7) has been implicated in promoting M1 polarization, contributing to the onset and progression of autoimmunity. However, the role of Irf7 in the etiology and progression of CP/CPPS remains unclear., Method: We established the experimental autoimmune prostatitis (EAP) mouse model by subcutaneous injection of prostate antigen combined with complete Freund's adjuvant. Six weeks after the first immunization, we analyzed the prostates, spleen, and blood to assess the degree of prostate inflammation, Irf7 expression levels, glycolysis, and M1 polarization to evaluate whether Irf7 could exacerbate the development of EAP by enhancing Hif-1α transcription, thereby increasing glycolysis and M1 polarization. Further investigations included sh-Irf7 intervention, Dimethyloxalylglycine (a Hif-1α agonist), and in vitro M1 polarization experiments. We also employed ChIP assays, dual-luciferase reporter assays, and q-PCR to explore if Irf7 could directly interact with the Hif-1α promoter in macrophages., Results: In the EAP mouse and cell models, elevated Irf7 expression was observed in inflamed tissues and cells. Reducing Irf7 expression decreased M1 cell glycolysis by inhibiting the nuclear translocation of Hif-1α, thus mitigating M1 cell polarization. Additionally, Irf7 was identified as a transcription factor that regulates Hif-1α transcription by interacting with its promoter in macrophages, confirmed through ChIP and dual-luciferase assays. Co-culturing macrophage cells with 3T3 fibroblasts with reduced Irf7 levels resulted in decreased fibrosis, and a significant reduction in prostate tissue fibrosis was noted in mice with Irf7 knockdown., Conclusion: Our findings indicate that Irf7 can contribute to the development and progression of CP/CPPS by promoting glycolysis, which can enhance both M1 polarization as well as interstitial fibrosis in the prostate. This process was found to be mediated by the upregulation of Hif-1α transcription, presenting new potential therapeutic targets for managing CP/CPPS., Competing Interests: Declarations. Ethics approval and consent to participate: All animal experiments were approved by the Animal Care and Use Committee of Anhui Medical University (Approval No. LLSC20211051). Consent for publication: All authors have approved submission of the manuscript to this journal. Competing interests: The authors declare that there are no conflict of interests., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

20. Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantation.

Author: Chen J, Fang Y, Tang Z, Dong E, Gao J, Zhu G, Kwangwari P, Feng S, Qu W, Wu X, Mao S, Zhao Q, Wang Y, Yang R, Guan Z, Chu T, Bu Y, Zhou J, Fan J, Fu X, Liu W, Ding Z, and Shi Y
Abstract: Backgrounds and Aims: Hepatocellular carcinoma (HCC) is the most prevalent type of primary liver cancer, characterized by a high rate of recurrence. This study aims to compare the efficacy and safety of repeat hepatectomy (RH) and salvage liver transplantation (sLT) for recurrent hepatocellular carcinoma (rHCC) and explores the predictive value of neutrophil-to-lymphocyte ratio (NLR) and neutrophil extracellular traps (NETs)., Methods: In this study, consecutive patients receiving RH (n = 637) or sLT (n = 53) for rHCC within the University of California San Francisco (UCSF) Criteria were recruited. After propensity score matching (PSM), disease-free survival (DFS) and overall survival (OS) were compared utilizing the Kaplan-Meier method. Additionally, the level of neutrophil infiltration and NETs were analyzed by multiplex immunofluorescence., Results: After PSM, the sLT group demonstrated superior 5-year DFS and OS compared to the RH group (p < 0.001 and p = 0.014). Subgroup analysis demonstrated that NLR > 2.3 was associated with poorer OS (p < 0.001 in the RH group and p = 0.024 in the sLT group) and DFS (p = 0.002 in both groups). Furthermore, we identified that patients in the sLT group are more susceptible to extrahepatic metastasis. In addition, our results revealed that higher infiltration of intratumoral neutrophils was negatively correlated with OS and DFS (p = 0.002 and p = 0.001, respectively), especially in cases with higher NETs level., Conclusions: This study indicates that sLT achieves better long-term outcomes than RH for rHCC. NLR and NETs formation are promising prognostic factors for HCC., Competing Interests: Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: The study protocol was approved by the Research Ethics Committee of Zhongshan Hospital of Fudan University (B2022-157), and written informed consent was obtained from each patient., (© 2025. Asian Pacific Association for the Study of the Liver.)
Published: 2025
Full Text: View/download PDF

21. Geochemical characteristics and environmental implications of heavy metals and fluoride of the hot spring waters in China's Tengchong Geothermal Field.

Author: Xia B, Jiang L, Yuan Y, Tang H, Zhou X, Tian J, He M, Zhang Y, Zhu X, Li J, Zhou D, and Huang Y
Abstract: Tengchong County, Southwestern China, is a renowned volcanic region with abundant geothermal resources. This study systematically investigates the geochemical characteristics of hydrothermal waters in Tengchong, utilizing major and trace elements as well as hydrogen and oxygen isotopes. The primary objectives are to identify the potential sources of the hydrothermal waters and provide a detailed assessment of heavy metal pollution, with a particular focus on fluoride. The results of δD and δ 18 O values indicate that the hydrothermal waters primarily originate from atmospheric precipitation, with some samples (Dagunguo and Huangguajing) showing evidence of high-temperature water-rock interactions. The study reveals significantly high concentrations of F, Hg, and As in the geothermal waters, accompanied by heightened concentrations of other trace elements, including V, Cr, Cu, Zn, Cd, Sb, and Pb. Among these, F and Hg stand out as posing severe contamination risks, particularly at the Rehai and Xiangda sites where the highest water quality index (WQI) values were documented. The fluoride levels, in particular, far surpass safe drinking water thresholds, raising serious public health concerns. The study identifies key mechanisms for fluoride enrichment, including water-rock interactions, cation exchange, and high temperatures. Specifically, the dissolution of fluoride-bearing minerals like fluorite (CaF 2 ), enhanced by elevated temperatures, significantly contributes to fluoride release. Additionally, the exchange of calcium (Ca 2+ ) with sodium (Na + ) promotes fluoride enrichment in the geothermal waters. The study highlights the need for effective monitoring and management of geothermal resources to mitigate the risks associated with trace element contamination., Competing Interests: Declarations. Ethical approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare competing interests., (© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

22. Effect of Blastocyst Morphology and Developmental Rate on Euploidy and Live Birth Rates in PGT-A Cycles: A Retrospective Cohort Study.

Author: Chen X, Fan Y, Ji H, Zhou L, Wu X, Wei Y, Cao S, Zhang J, and Ling X
Abstract: This study was to evaluate the relationship between morphology or developmental rate of blastocysts and ploidy status in preimplantation genetic testing for aneuploidy (PGT-A) cycles, or live birth rates in single euploid frozen-thawed embryo transfer (FET) cycles. We focused on infertile patients who underwent PGT-A procedures, following with single euploid FET cycles in the assisted reproduction center from January 2016 to December 2022. Blastocysts were categorized for biopsy, and euploid embryos would be selected for transfer. Multivariate logistic regression was used to assess the effects of blastocoel expansion degree, inner cell mass (ICM) and trophectoderm (TE) grades and developmental stage (Day 5, 6 and 7) on euploidy and live birth rates. A total of 4172 blastocysts from 941 PGT-A cycles were included. Expansion 4 were associated with lower euploidy rate than expansion 5 (P = 0.011) and 6 (P = 0.001). Better ICM (P < 0.05 for A compared to B grade) increased blastocyst euploidy. Euploidy rate was significantly associated with A grade TE (P < 0.001). However, no relationship existed between blastocyst euploidy and developmental rate. Furthermore, live birth rates had no significant effect on most of morphological parameters in euploidy blastocyst FET cycles, only A grade TE was shown higher live birth rate than C grade (P = 0.024). The rate of euploidy in morphologically poor blastocysts is low in the cohort, but the developmental rate does not associate with euploidy. Moreover, only TE grades take association with live birth rates, when the single euploidy blastocyst was transplanted., Competing Interests: Declarations. Ethics Approval: This study was reviewed and approved by the Ethics Committee of Nanjing Women and Children’s Healthcare Hospital (NJFY-2022KY-049). Consent to Participate (Include Appropriate Statements): Informed consent was obtained from all individual participants included in the study. Conflict of Interest: There were no conflicts of interest or competing interests by any of the authors in this study., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

23. Transarterial embolization of anterior cranial fossa dural arteriovenous fistulas as a first-line approach: A retrospective single-center study.

Author: Zhang G, Pang M, Duan G, Li Z, Chen R, Shang C, Zhang Y, Huang Q, Xu Y, Li Q, and Liu J
Subjects: Humans, Male, Female, Middle Aged, Retrospective Studies, Adult, Aged, Treatment Outcome, Cerebral Angiography, Intracranial Hemorrhages etiology, Embolization, Therapeutic methods, Central Nervous System Vascular Malformations therapy, Central Nervous System Vascular Malformations diagnostic imaging, Cranial Fossa, Anterior surgery, Cranial Fossa, Anterior diagnostic imaging
Abstract: Background: Anterior cranial fossa (ACF) dural arteriovenous fistulas (DAVFs) present unique treatment challenges due to their complex angioarchitecture and high risk of hemorrhage. Recent advancements in endovascular techniques have highlighted the potential of transarterial embolization in managing these fistulas., Objective: The purpose of this study is to evaluate the clinical and angiographic outcomes of transarterial embolization (TAE) as a first-line treatment for ACF DAVFs over a twenty-year period., Methods: From March 200 to September 2021, a total of 54 patients harboring ACF DAVFs underwent TAE as a first-line approach at our institution. The clinical presentation, angiographic features, procedure-related complications, clinical outcomes, and angiographic results were analyzed retrospectively., Results: Among 54 ACF DAVF treated, there were 48 males and 6 females, with a mean age of 52.5 (52.5 ± 13.0) years. Intracranial hemorrhage (51.9%, 28/54) was the most common symptom. A total of 57 embolization attempts were performed. 85.2% (46/54) achieved complete angiographic occlusion immediately post-TAE. Complications occurred in 3.7% (2/54) of patients. 97.6% (41/42) experienced symptom improvement or stabilization during clinical follow-up. Radiological follow-up showed that 85.0% (34/40) maintained complete fistula occlusion. Angiographic recurrence occurred in one (2.5%, 1/40,) patient without any symptoms., Conclusions: TAE for ACF DAVFs demonstrates a high rate of complete occlusion with an acceptable safety profile. Further comparative studies with other treatment approaches are recommended to validate these findings., Competing Interests: Declarations. Ethics approval and consent to participate: This retrospective study involved human participants and was approved by Ethics Committee of Changhai Hospital, Naval Medical University [Y2020-004]. In this retrospective study, the requirement for informed consent was waived. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

24. An updated systematic review and meta-analysis on the efficacy of supine versus prone position for pediatric PCNL.

Author: Fang H, Zhu F, Cui K, Liu X, Wu S, Hua Y, Lin T, He D, Wei G, and Zhang D
Abstract: Background: The incidence of pediatric kidney stones is increasing with recurrence rates ranging from 35 to 50%. Supine percutaneous nephrolithotomy (PCNL) presents a viable alternative to the conventional prone position, offering specific benefits but also posing certain risks., Objective: To update a previously published systematic review and meta-analysis comparing the efficacy of PCNL in the supine versus prone positions in children., Methods: A systematic search of Web of Science, Cochrane Library, PubMed, and Embase was conducted to identify eligible studies. Two authors independently screened the literature and extracted data. The meta-analysis was performed using StataMP 17. The study was prospectively registered in PROSPERO (ID: CRD42024545145). The sensitivity and subgroup analyses explored sources of heterogeneity, and publication bias was assessed with a funnel plot. The study adhered to PRISMA guidelines and the Cochrane Handbook., Results: This study included a total of nine studies, comprising five randomized controlled trials and four case-control studies, with 614 patients in total. Compared with the prone position group, the supine position group demonstrated significant advantages in terms of operative time (WMD = - 15.43, 95% CI: - 22.18 to - 8.69, P = 0.0001), hospital stay (WMD = - 0.77, 95% CI: - 1.12 to - 0.42, P = 0.0001), overall complication rate (OR = 0.46, 95% CI: 0.42-0.99, P = 0.046), and hemoglobin decrease (WMD = - 0.22, 95% CI: - 0.40 to - 0.05, P = 0.013). However, no significant differences were observed between the two groups in stone clearance rate, high-grade complication rate, or radiation exposure time. Subgroup analysis revealed that in studies published after 2024, cases of small stones (< 2 cm), and older children (> 9 years), the supine position group had fewer low-grade complications. Additionally, in the supine PCNL group with ultrasound or endoscopy-assisted puncture, radiation exposure time was significantly reduced., Conclusion: This study shows that supine position PCNL in children is superior to the prone position in terms of operative time, hospital stay, complication rate, and hemoglobin decrease, with no significant difference in stone clearance, high-grade complications, or radiation exposure. The subgroup analysis found that supine position resulted in fewer low-grade complications in studies published after 2024, small stones, and older children. It also significantly reduced radiation exposure with ultrasound or endoscopy-assisted puncture, suggesting that supine position is a safer and more effective option., Competing Interests: Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval and consent to participate: Not applicable. Consent for publication: Not applicable., (© 2025. The Author(s), under exclusive licence to Springer Nature B.V.)
Published: 2025
Full Text: View/download PDF

25. Laparoscopic perineal hernia repair after abdominoperineal resection.

Author: Yuan X, Lin Zhu Y, Zhao XF, and Chen J
Subjects: Humans, Male, Female, Aged, Middle Aged, Retrospective Studies, Aged, 80 and over, Incisional Hernia surgery, Incisional Hernia etiology, Postoperative Complications etiology, Operative Time, Laparoscopy adverse effects, Laparoscopy methods, Perineum surgery, Herniorrhaphy methods, Herniorrhaphy adverse effects, Surgical Mesh, Proctectomy adverse effects, Proctectomy methods
Abstract: Purpose: Perineal hernia(PH) is a complication after abdominoperineal resection(APR), which is a special kind of incisional hernia, lacking consensus about treatment. This study is aimed at the effect of laparoscopic repair with mesh., Methods: A retrospective study was conducted from Januarary 1st 2015 to December 31st 2023 for the patients undergoing laparoscopic perineal hernia repair after abdominoperineal resection(APR). The data of characteristics, surgery details and follow-up were collected and analysed to evaluate the effect and complications., Results: 41 cases were included altogether and all patients received laparoscopy approach, 14 males and 27 females, median age was 70 years(range 45-80years), the mean BMI was 25.04 ± 3.38 kg/m 2 . Operations were completed under laparoscopy in 22 cases, combined with open surgery in 19 cases. 40 cases were treated with synthetic mesh and 1 case with biological mesh. The median operative time was 145 min(range 55-270 min), and the post operative hospital day was 13 days(range 4-47 days). The median follow-up time was 30 months(range 6-103months). There were 2 cases of wound infection and 1 case of intestinal obstruction after operation during in hospital days. 1 cases of recurrence and 2 cases of abnormal sensation in the operation area were observed during the follow-up period. The total incidence of complications was 14.6%., Conclusion: Laparoscopic perineal hernia repair with mesh shows low rates of complications, which is a safe and effective method to perineal hernia after APR. For large defects, hybrid technique helps to close the defect and eliminate dead spaces. The appropriate kind and adequate mesh overlap are critical. Short-term follow up shows positive outcomes in this retrospective study and the controlled trial and long-term follow-up is needed in the future., Competing Interests: Declarations. Ethical approval: Approval from the Institutional Review Board was not required for this study. Human and animal rights: This article does not contain any studies with human participants or animals performed by any of the authors. Informed consent: For this retrospective review, formal consent is not required but all patients were informed of their participation. Conflict of interest: The authors declare that they have no conflict of interest., (© 2025. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

26. The clinical effects and skin histological changes induced by a novel insulated radiofrequency microneedle: a pilot study.

Author: Wang M, Li Y, Lai X, Shi C, and Yan Y
Subjects: Pilot Projects, Humans, Animals, Swine, Female, Adult, Swine, Miniature, Radiofrequency Therapy methods, Radiofrequency Therapy instrumentation, Cosmetic Techniques instrumentation, Face, Male, Erythema etiology, Erythema pathology, Skin Aging radiation effects, Purpura pathology, Needles, Skin pathology, Skin radiation effects
Abstract: Radiofrequency microneedle (RFMN) could mechanically penetrates the epidermis and emits radiofrequency energy to the target skin layer. This innovative system offers the capability to deliver precisely controlled radiofrequency energy at varying depths within the skin in a single insertion. We hypothesized that the new RFMN could improve both pore size and skin laxity simultaneously by single insertion and multiple discharges, thus reducing the number of treatment passes and improving the treatment efficiency. Therefore, we carried out this pilot study to confirm the clinical effects and corresponding histological changes. In clinical part, 3 subjects received a single RFMN treatment. Subjects' faces were randomly divided into superficial base-energy and deep high-energy side or superficial high-energy and deep base-energy side. Facial characteristics were documented using standardized photographic techniques at various points in the study. In animal experiment, the abdomen of Bama miniature pig was divided into 4 treatment zones: the blank control group; superficial base-energy and deep high-energy group; superficial high-energy and deep base-energy group; no energy control group. Skin samples were collected immediately and 1 month post-treatment for histological analysis to observe the corresponding histological changes. Immediately after treatment, we found that the severity of erythema and petechiae may be related to the parameter settings. 1 month after treatment, improvement in skin laxity and facial pore size on both sides of the face was observed. The treatment resulted in a more significant improvement in relaxation on the superficial base-energy and deep high-energy side, but the pore improvement appeared to be more pronounced on the superficial high-energy and deep base-energy side. A trend of decreasing intensity in vascular dilatation was observed across the treatment groups, with the superficial high-energy and deep base-energy group exhibiting the most pronounced dilation. Histological observations immediately after treatment revealed that 2 seperated injury zones, which was caused by the same needle discharged electric twice, and one charge in the deep and one in the shallow. Immediate post-treatment dilation of blood vessels in all treatment groups was observed. A trend of decreasing intensity in vascular dilatation was observed across the treatment groups, with the superficial high-energy and deep base-energy group exhibiting the most pronounced dilation. 1 month post-treatment, histological analysis revealed an increase in dermal thickness, elastin, collagen fiber thickness and density, perivascular inflammatory cell infiltration across all treatment groups. Overall, our study demonstrated that variations in energy delivered at different depths by a new RFMN could induce distinct histological changes and corresponding clinical efficacy. This finding holds promise for optimizing the clinical application of RFMN. By tailoring the depth and energy settings in one insertion, specific concerns such as enlarged pores or facial laxity can be addressed more efficiently., Competing Interests: Declarations. Ethical approval: All experimental procedures were approved by The Ethics Committee of the Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College [2023(220)]. Informed consent: All patients provided informed consent. Conflict of interest: The authors declare that they have no conflicts of interest to disclose., (© 2025. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

27. Comprehensive analysis of basement membrane-related genes showed that NELL2 is a new therapeutic target for colorectal cancer.

Author: Wang W, Dai Z, Ge C, Zhou X, Zhan Y, and Chen C
Abstract: Background: The basement membrane (BM), an omnipresent extracellular matrix, plays a pivotal role as a physiological element in the process of tumor metastasis. However, given the heterogeneity of colorectal cancer (CRC), prognosis is challengingly predictive. Therefore, we aim to construct a prognostic model using BM-associated genes to assess patient prognosis and clinical drug treatment effects., Method: The Non-negative Matrix Factorization (NMF) algorithm leverages the characteristics or categories of matrix rows and columns to achieve BMAG molecular classification and further develop a model for predicting patient prognosis. ssGSEA quantified the relatively abundance of 13 immune functionalities and 16 immune cell typologies. To predict the efficacy of immunotherapy, a comprehensive investigation was conducted on the correlations between riskScores and key factors such as TME, immune checkpoints, and MMR-related genes. The CCK8 method, plate cloning method and Cell Apoptosis Assessment were used to evaluate the ability of NELL2 to affect the proliferation., Result: We developed a powerful riskScore to predict colorectal cancer prognosis and effectively differentiate the tumor microenvironment. In clinical practice, this riskScore can also be utilized to further assess patient prognosis, thereby facilitating personalized treatment strategies. In addition, downregulation of NELL2 expression inhibits CRC cell proliferation., Conclusion: In summary, we constructed a novel riskScore using BMAG for predicting prognosis in patients with CRC and explored the efficacy of this riskScore in predicting patient response to clinical drug therapy. Most importantly, we have identified the oncogenic role of NELL2 in CRC. By inhibiting NELL2, we can further suppress the initiation and progression of CRC., Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

28. Immuno-oncological Challenges and Chemoresistance in Veterinary Medicine: Probiotics as a New Strategic Tool.

Author: Nisar MF, Yan T, Cai Y, and Wan C
Abstract: Cancer has the highest death rates due to increased immuno-oncological (IO) challenges and chemoresistance caused by gut dysbiosis, whereas administration of probiotics may reverse these responses against anticancer therapies. Recently, immunotherapeutics have extensively been focused for significant advancements in pharmacological drug discovery and clinical outcomes. Mammals have intestinal epithelial cells, mucosal immune cells, and indigenous gut microbiota which may reshape immunotherapeutics efficacy. These include use of T-cell immune checkpoint inhibitors (ICPI), genetically engineered T-cells, tumor vaccines, monoclonal antibodies (mAbs), and anti-B- and T-cell antibodies. Immunotherapeutics for cancer treatment became popular in both veterinary and human health care systems due to their strong inhibitory actions against PD-1 and CTLA-4 to check tumorigenesis. IO issues in animals also need special attention, where caninized mAbs targeting CD-20 and CD-52 have been clinically used in treating canine B-cell and T-cell lymphomas, respectively. Probiotics appeared as strong immunotherapeutics that might be shaping the epigenetics of the organisms specifically in animal breeding practices for desired features, but limited literature regarding the immunomodulatory effects in humans and animals is available. In addition, considering the important role of probiotics in humans and veterinary medicine, a new perspective on the probiotic-mediated modulation of ncRNAs (miRNAs, lncRNAs, circRNAs) is also highlighted and would be a new therapeutic tool. This review provides insight into the cellular processes and pharmacological activities for treating veterinary infectious diseases and covers small drug molecules as ncRNA-modulators in veterinary medicine., Competing Interests: Declarations. Ethics approval and consent to participate: “Not applicable” Consent for publication: All the authors listed have consent for publication. Competing interests: The authors declare no competing interests., (© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

29. Impacts of construction land expansion on cultivated land fragmentation in China, 2000-2020.

Author: Zheng L, Wang J, Zeng Y, Gu T, and Chen W
Subjects: China, Cities, Urbanization, Agriculture, Conservation of Natural Resources, Environmental Monitoring
Abstract: The construction land expansion (CLE) in China, based on the occupation of cultivated land, has resulted in a notable alteration of the landscape of cultivated land, leading to an increase in cultivated land fragmentation (CLF) in China. However, previous studies have devoted minimal attention to CLF due to CLE, thereby constraining the coordination of CLE and cultivated land conservation. Accordingly, the study examined the impact mechanism of CLE on CLF utilizing land use/cover datasets and the geographically weighted regression model from 2000 to 2020 in China. The findings indicate that a considerable amount of cultivated land was converted into construction land. The extent of CLF increased from 0.352 in 2000 to 0.383 in 2020, with the majority of this expansion occurring in the urban-rural fringe. CLE, in conjunction with the expansion of construction land in terms of both area and shape, has evolved from a phenomenon confined to individual cities to one that is characterized by regional expansion. The impact of CLE on CLF was found to be spatially heterogeneous over the study period, with an overall weakening trend. In highly urbanized areas, CLE typically promoted CLF, in contrast to low urbanized areas. The area growth and form complexity of the construction land caused by CLE promoted CLF over most regions. Different levels of land urbanization were identified as the primary contributor to the above results. The study findings support decision-making on food production improvement and construction land control., Competing Interests: Declarations. Ethics approval: All our research complies with ethical guidelines, including compliance with the legal requirements of the research country. Consent to participate: The authors of this paper have participated in the entire process of this article, including conceptualization, paper ideas, methods, writing, and review. Consent to publication: The participant has consented to the submission of the case report to the journal. Conflict of interest: The authors declare no competing interests., (© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
Published: 2025
Full Text: View/download PDF

30. Short-term effectiveness and safety of photobiomodulation on low-to-moderate myopia.

Author: Ren J, Xu JN, Liu YZ, Gu XL, and Wang Y
Subjects: Humans, Male, Female, Child, Prospective Studies, Treatment Outcome, Adolescent, Refraction, Ocular radiation effects, Refraction, Ocular physiology, Tomography, Optical Coherence, Lasers, Semiconductor therapeutic use, Myopia radiotherapy, Myopia physiopathology, Low-Level Light Therapy methods, Visual Acuity radiation effects
Abstract: To find and assess the effectiveness and safety of short-term Photobiomodulation (PBM) treatment in children with low-to-moderate myopia. Children with low-to-moderate myopia were recruited and divided into PBM or control groups based on whether they received PBM treatment. The PBM group underwent a three-month treatment with a 650 nm low-energy semiconductor laser, while the control group did not receive any therapeutic intervention. At the end of the trial, the changes in spherical equivalent refractive (SER) and axial length (AL) before and after treatment were compared between the PBM group and the control group to evaluate the effectiveness of PBM in preventing myopia. The best corrected visual acuity (BCVA), nerve fiber layer thickness (RNFLT), ganglion cell layer thickness (GCLT), central point retinal thickness (CPRT), 3-mm subfield central retinal thickness (3 mm-CRT), superficial retinal vascular density (SCP), and central choroid thickness (CCT) were self-compared to assess the safety of PBM. A total of 57 subjects were prospectively followed from October 2020 to September 2021, comprising 28 participants (56 eyes) in the PBM group and 29 participants (58 eyes) in the control group. After three months of treatment, the AL decreased by 0.07 ± 0.11 mm, and the SER decreased by -0.12 ± 0.39 D in the PBM group. However, both SER and AL increased in the control group. Furthermore, there were statistically significant differences between the PBM and control groups (p < 0.01). The BCVA, RNFLT, GCLT, CPRT, and 3 mm-CRT remained almost unchanged in the PBM group; The SCP decreased from 0.37 ± 0.03 to 0.35 ± 0.02 in the PBM group with a statistically significant difference before and after treatment (p = 0.045). The CCT increased from 255 ± 41 µm to 274 ± 29 µm in the PBM group without any significant difference before and after treatment. The administration of PBM significantly suppresses the elevation of AL and SER following a three-month duration. No significant adverse effects were observed on visual function and retinal morphology.Trial Registration: This study is registered at https://clinicaltrials.gov/ (registration number: NCT04604405)., Competing Interests: Declarations: Presentation at a meeting: N/A. Ethical approval: Ethical approval was acquired from the human ethics committee of the Chongqing Aier Eye Hospital. Conflicting interest: The authors claim no competing interests., (© 2025. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

31. Value of Post-NAC CT-based Node-RADS score for Predicting residual lymph node metastasis and survival outcome of locally advanced gastric cancer.

Author: Sun Y, Xiao H, Wen L, Xiang W, Luo X, Yang X, Chen L, Yang Y, Zhang Y, Yu S, and Yu X
Abstract: Objectives: The Node Reporting and Data System (Node-RADS) provides structured and effective evaluation for lymph nodes in malignancies. This study aims to investigate its value in predicting residual lymph node metastasis (LNM) and survival outcome of locally advanced gastric cancer (LAGC)., Materials and Methods: This retrospective study included 118 patients with LAGC underwent neoadjuvant chemotherapy (NAC) and gastrectomy from April 2015 to June 2020. The diagnostic performance of the post-NAC CT-based Node-RADS score for regional LNM, both at the patient level and at the perigastric/extragastric subgroup level, was estimated using area under receiver operating characteristic curve (AUC) and Youden's index. Kaplan-Meier curve was employed for prognostic analyses between high/low Node-RADS score group. A predictive Node-RADS (NR) model for LNM was developed using logistic regression analyses and a prognostic NR model for overall survival (OS) was developed using Cox regression analyses., Results: In the prediction of LNM, the Node-RADS score exhibited an AUC of 0.843 (95%CI: 0.765-0.921) at patient level, 0.838 (95%CI: 0.757-0.918) in perigastric subgroup and 0.813 (95%CI: 0.724-0.901) in extragastric subgroup, surpassing LN short-axis criteria (AUC:0.664 [95%CI: 0.584-0.743], p < 0.001). The AUC of the NR predictive model for LNM increased to 0.870 (95%CI: 0.795-0.945), with 88.7% sensitivity and 78.9% specificity. The Node-RADS score was significantly correlated with post-NAC pathological status, and served as an independent indicator for OS (all p < 0.05).The NR prognostic model exhibited a Harrell's consistency index (C-index) of 0.724 (95%CI: 0.663-0.785), with no significant difference from the pathological prognostic model (0.739 [95%CI: 0.677-0.801], p = 0.695)., Conclusion: The post-NAC Node-RADS score provides accurate prediction of regional LNM and shows promising prognostic value for LAGC patients. Post-NAC Node-RADS related predictive models show potential in early identification of high-risk LAGC patients with residual lymph nodes or poor prognosis after NAC., Competing Interests: Declarations. Competing interests: The authors declare no competing interests., (© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

32. Association of the various physical activity patterns with low bone mineral density in Americans aged 20-60.

Author: Wang Y, Long L, Liu L, Fan P, Zheng X, Li X, Wang YT, Xu BS, and Tao YA
Subjects: Humans, Adult, Male, Middle Aged, Female, United States, Young Adult, Osteoporosis epidemiology, Exercise physiology, Bone Density physiology, Nutrition Surveys
Abstract: Through analyzing the data of the NHANES 2007-2020 cycle, this study concluded that high-intensity exercise 1-2 sessions a week can help maintain bone mass, and there is no significant difference from regular exercise more than 3 times a week., Purpose: This study aims to explore the relationship between the various physical activity(PA) patterns and the risk of low bone mineral density(BMD) in Americans of working age., Method: A total of 6482 participants aged 20-60 were selected from the National Health and Nutrition Survey (NHANES) conducted from 2007 to 2020. The PA data of the participants were obtained through individual interviews, and the participants were divided into four groups (inactive, insufficiently active, less frequent but sufficiently active(1-2 sessions a week and PA ≥ 150 min), and regularly active). Weighted logistic regression was used to analyze the correlation between PA patterns and the risk of low BMD. Subgroup analyses were applied to display the correlation between PA patterns and low BMD in different subgroups., Result: After adjusting for confounding factors, the multiple logistic regression model showed that compared with inactive individuals, sufficiently active and regularly active individuals had a 35% (OR, 0.65; 95% CI, 0.46-0.92) and 24% (OR, 0.76; 95% CI, 0.62-0.93) lower risk of low BMD, respectively. Compared with regularly active adults, inactive adults had a 32% (OR, 1.32; 95% CI, 1.07-1.62) increased risk of low BMD, while sufficiently active individuals (OR, 0.85; 95% CI, 0.59-1.23) showed no significant difference compared with regularly active adults., Conclusion: Compared with inactive adults, less frequent but sufficiently active adults have a lower risk of low BMD and showed benefits similar to those in regularly active groups. The sufficiently active pattern may become a new trend in modern working-age adults' PA patterns., Competing Interests: Declarations. Ethics approval and consent to participate: The National Center has approved the survey plan and study procedure for Health Statistics’ Ethics Review Board, and the participants/patients have given their written informed consent. We conducted a study exempt from institutional review since it involves secondary data analysis from the National Health and Nutrition Examination Survey. Consent for publication: All authors consent for the publication of the manuscript and figures. Conflicts of interest: None., (© 2025. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.)
Published: 2025
Full Text: View/download PDF

33. Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review.

Author: Yang J, Luo Y, Yao Z, Wang Z, and Jiang K
Abstract: Lung cancer is one of the deadliest malignancies worldwide, with distant metastasis being a major cause of death. However, the specific mechanisms of lung cancer metastasis remain unclear. NcRNAs, a widely present type of non-coding RNAs in the body, constitute about 98% of the human genome, lacking protein-coding capacity but involved in various cellular processes such as proliferation, apoptosis, invasion, and migration. Studies have shown that ncRNAs play a crucial role in the metastasis of lung cancer, although research in this area is limited. This review summarizes the biological origins and functions of ncRNAs, their specific roles and mechanisms in lung cancer metastasis, and discusses their potential for early screening and therapeutic applications in lung cancer. Furthermore, it outlines the challenges in translating basic advancements of ncRNAs in lung cancer metastasis into clinical practice., Competing Interests: Declarations. Ethics approval and consent to participate: No ethics approval was required for this review that did not involve patients or patient data. Consent for publication: All authors consent to publication. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

34. CPT1A mediates succinylation of LDHA at K318 site promoteing metabolic reprogramming in NK/T-cell lymphoma nasal type.

Author: Tian H, Ge Y, Yu J, Chen X, Wang H, Cai X, Shan Z, Zuo L, and Liu Y
Subjects: Humans, Cell Line, Tumor, Glycolysis, Succinic Acid metabolism, Metabolic Reprogramming, L-Lactate Dehydrogenase, Carnitine O-Palmitoyltransferase metabolism, Carnitine O-Palmitoyltransferase genetics, Cell Proliferation genetics, Apoptosis, Lymphoma, Extranodal NK-T-Cell metabolism, Lymphoma, Extranodal NK-T-Cell genetics, Lymphoma, Extranodal NK-T-Cell pathology
Abstract: Carnitine palmitoyltransferase 1A (CPT1A), a succinylating enzyme, is highly expressed in various malignant tumors and promotes tumor progression. Succinylation is a posttranslational modification that has been reported in various diseases, but its role in NK/T-Cell lymphoma nasal type (ENKTL-NT) remains underexplored. In this study, bioinformatics analysis showed that glycolytic is a major metabolic pathway in ENKTL-NT as the expression of many glycolytic related kinases are increased. CPT1A probably mediates glycolytic process, as indicated by GO-enrichment analysis. Studies showed that CPT1A was upregulated in ENKTL-NT tissues, and that high CPT1A expression was associated with poor prognosis of ENKTL-NT. CPT1A promoted the proliferation, colony formation, invasion and glycolytic process of ENKTL-NT cells and suppresses apoptosis. Mechanistically, CPT1A promotes succinylation of LDHA at lysine 318 (K318), which increase the protein stability and the final protein level of LDHA. Both knockdown and mutation (K318R) of LDHA abolished the cancer-promoting effects of CPT1A in ENKTL-NT. In all, this study reveals the mechanism underlying the cancer-promoting effects of CPT1A via inducing LDHA succinylation and metabolic reprogramming in ENKTL-NT. These findings might provide potential targets for the diagnosis or therapy of ENKTL-NT., Competing Interests: Declarations. Ethical approval: The clinical and animal study has been approved by the Ethics Committee of Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine(2024110). Conflict of interest: The authors declare no competing interests. Consent for publication: Informed consent was obtained from the patient for publication of the pathological images., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

35. miR-1264 Exacerbates Proliferation, Migration and Invasion of Endometrial Cancer Cells by Targeting MSH2.

Author: Han W, Yong X, Wang B, Zhang Q, Zhang Y, Shao M, and Wang C
Abstract: Accumulating studies have revealed that microRNAs serve significant regulatory for endometrial carcinoma (EC) tumorigenesis and progression. The specific objective of this investigation is to seek the potential function of miR-1264 in EC and clarified the underlying mechanism. Determination of miR-1264 and MSH2 expression in EC tissues or cell lines was performed by RT-qPCR and/or western blot assay. The malignant behaviors of EC cells were verified by CCK-8 assay, EdU staining, wound healing assay and Transwell assay, respectively. Besides, the interaction between miR-1264 and MSH2 was verified by dual-luciferase reporter assay and RNA immunoprecipitation assay. MiR-1264 exhibited high levels in EC tissues and has been found to be correlated with a poor prognosis in EC patients. Functionally, silencing miR-1264 resulted in inhibiting the aggressiveness behaviors of HEC-1 A and KLE cells, while forced miR-1264 expression executed opposite effects. Mechanistically, miR-1264 directly targeted and suppressed MSH2 expression. Functional rescue experiments further validated that overexpression of MSH2 diminished malignant behaviors of EC cells and greatly reversed the promoting effects of miR-1264 on the malignant behaviors of EC cells. MiR-1264 acted as an oncogene in EC, promoting aggressiveness behaviors of EC cells by inhibiting MSH2. This study provided novel insights into anti-cancer treatment and a theoretical basis for potential therapeutic targets of EC., Competing Interests: Declarations. Ethics Approval: This study was approved by the Ethics Committee of People’s Hospital of Xinjiang Uygur Autonomous Region on September 2022 (No. YBK2022090224). Competing Interests: These authors declared no competing interests in this work., (© 2025. The Author(s), under exclusive licence to Society for Reproductive Investigation.)
Published: 2025
Full Text: View/download PDF

36. Exploring the molecular mechanism of Tripterygium Wilfordii Hook F in treating systemic lupus erythematosus via network pharmacology and molecular docking.

Author: Hong Y, Wang D, Qian H, Jiang X, Wang Y, Liang X, Gao S, and Hua C
Abstract: Background: Tripterygium wilfordii Hook F (TwHF) is a prominent Chinese herbal formula. It exhibits significant clinical efficacy in treating systemic lupus erythematosus (SLE), though its mechanisms remain unclear. Our study employs network pharmacology and molecular docking to explore active compounds of TwHF and their associated targets for SLE treatment., Methods: Primary active compounds of TwHF and their targets were sourced from the TCMSP, SwissTargetPrediction, and UniProt databases. SLE-relevant target proteins were identified from the OMIM and GeneCards databases. Enrichment analyses were conducted to reveal results of common TwHF-SLE targets. STRING and Cytoscape software were used to systematically analyze and construct protein-protein interaction (PPI) networks, compound-target-pathway, and target-organ networks. Molecular docking was utilized to confirm the binding of key targets to the top active compounds., Results: A total of 14 active compounds and 300 overlapping targets between TwHF and SLE were identified. PPI network analysis revealed 29 core targets. Several pathways were found to contribute to the potential therapeutic effects of TwHF in SLE, including PI3K-Akt signaling pathway, Th17 cell differentiation, chemokine signaling, and T cell receptor signaling. Disease Ontology (DO) analysis highlighted the involvement of TwHF in genes associated with myocardial infarction (MI), atherosclerosis (AS), breast carcinoma, and ischemia. Molecular docking results demonstrated strong binding affinities, with 37 signal molecule-receptor interactions in SLE and 97 interactions in SLE-related MI and AS showing binding energies lower than -7 kJ/mol., Conclusions: This research effectively anticipates the potent constituents, probable targets, and pathways implicated in treating SLE with TwHF, specifically addressing complications such as MI and AS. Comprehending the precise molecular mechanism targeting SLE of TwHF and its efficacious bioactive components furnishes a theoretical groundwork for enhancing its clinical utilization. Key Points •SLE is characterized by aberrant immune activation and persistent inflammation. •TwHF exerts immunomodulatory and anti-inflammatory effects. •TwHF exhibits prospects in the treatment of SLE with unknown molecular mechanisms. •Network pharmacology and molecular docking reveal promise in the mechanism of TwHF., Competing Interests: Declarations. Competing interests: The authors declared no competing interests., (© 2025. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).)
Published: 2025
Full Text: View/download PDF

37. Development and validation of a surgical robot system for orbital decompression surgery.

Author: Lin Y, Peng S, Jiao S, Wang Y, Li Y, and Zhou H
Abstract: Purpose: Orbital decompression surgery, which expands the volume of the orbit by removing sections of the orbital walls with a drill and saw, is an important treatment option for thyroid-associated ophthalmopathy. However, it is often limited by physical factors such as a narrow operating space and instability of the manual holding of surgical instruments, which constrains doctors from accurately executing surgical planning., Methods: To overcome these limitations, we designed a surgical robot comprising position adjustment, remote center of motion, and end-effector with a rapid surgical instrument assembly mechanisms. Additionally, to guide surgical robots in precisely performing preoperative surgical planning, we constructed a surgical navigation system comprising preoperative surgical planning and intraoperative optical navigation subsystems. An internally complementary orbital surgical robot system in which the navigation system, optical tracker, and surgical robot and its motion control system serve as the decision-making, perception, and execution layers of the system, respectively, was developed., Results: The results of precision measurement experiments revealed that the absolute and repeated pose accuracies of the surgical robot satisfied the design requirements. As verified by animal experiments, the precision of osteotomy and bone drilling operation of orbital surgical robot system can meet the clinical technical indicators., Conclusion: The developed orbital surgical robotic system for orbital decompression surgery could perform routine operations such as drilling and sawing on the orbital bone with assistance and supervision from surgeons. The feasibility and reliability of the orbital surgical robot system were comprehensively verified through accuracy measurements and animal experiments., Competing Interests: Declarations. Conflict of interest: All authors declare that there is no conflict of interest. Ethics approval: All procedures performed in studies involving animals were in accordance with the ethical standards of the Chinese Regulations for the Administration of Affairs Concerning Experimental Animals. The study was approved by the Ethics Committee of Jiagan Biotechnology Co., Ltd. under Application No. JGLL-20220114., (© 2025. CARS.)
Published: 2025
Full Text: View/download PDF

38. Improving sustainable land use level with the aim of enhancing urban ecosystem service value: a case study of Xi'an in China.

Author: Yang Y, Qin Y, and Yuan Z
Subjects: China, Cities, Environmental Monitoring methods, Urbanization, Conservation of Natural Resources methods, Ecosystem, Sustainable Development
Abstract: The supply capacity of urban ecosystem services is the foundation for achieving the Sustainable Development Goals (SDGs). However, due to the difficulty in reaching a consensus on the multiple attributes of land ecosystems, the coercion issue between land use change, the enhancement of ecosystem service value (ESV), and urban development is exposed. The objectives of the study are to improve land structure with the goal of enhancing ESV, based on the evaluation of the relationship between land use change and urban ESV. In response to the SDGs, an evaluation index system for sustainable land use (SLU) was constructed by comparing subgoals. Factor analysis was used to evaluate the SLU level. The impact of SLU level changes on ESV was explored by grouping regression. The logarithmic mean Divisia index was used to describe the contributions of various factors to ESV changes. The results indicated that ESV increased by 17.71%, but SLU comprehensive evaluation score decreased from 0.324 to -0.522. The changes in SLU level had varying effects on ESV. The main factors driving changes in ESV were ESV coefficient and total green space area, with average contributions of 198.32% and -98.32%, respectively. The study points out that differences in factors driving ESV changes provide potential opportunities for urban development. Improving SLU level is an important way to promote the realization of SDGs and improve urban ESV., Competing Interests: Declarations. Ethics approval: All authors have read, understood, and have complied as applicable with the statement on “Ethical responsibilities of Authors” as found in the Instructions for Authors and are aware that with minor exceptions, no changes can be made to authorship once the paper is submitted. Consent to participate: Not applicable as the study did not include human subjects. Consent for publication: The author approves this submission. Conflict of interest: The authors declare no competing interests., (© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
Published: 2025
Full Text: View/download PDF

39. Prognostic Impact of Sarcopenia and Surgical Timing in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy: TIMES Study.

Author: Huang G, Zhu J, He B, Zhou X, Wang Y, Wu L, Zhang W, Huang W, Hu B, Zheng Z, Wan G, Li N, Leng X, Han Y, Peng L, Tang X, and Wang Q
Abstract: Background: Optimal timing for surgery after neoadjuvant chemoradiotherapy (NCRT) remains controversial, necessitating reliable preoperative indicators. This study examines how sarcopenia and surgical timing affect prognosis in patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC)., Patients and Methods: This retrospective study analyzed patients with LA-ESCC who underwent NCRT and surgery at three institutions in China from 2014 to 2023. The skeletal muscle area at the third lumbar vertebra was measured to calculate the skeletal muscle index (SMI). Prognostic analysis was performed using Cox proportional hazards models and propensity score matching (PSM), with survival curves generated using the Kaplan-Meier method and statistical significance set at p<0.05., Results: A total of 415 patients were analyzed, with a median follow-up of 39.1 months. The 5-year overall survival (OS) and progression-free survival (PFS) rates were 59.3% and 53.1%, respectively. Malnutrition and time to surgery (TTS) were independent prognostic factors for both OS and PFS (p < 0.05). Patients with long TTS showed better OS [hazard ratio (HR) = 0.62, p = 0.01] and PFS (HR = 0.68, p = 0.02) compared with those with short TTS. Among patients with sarcopenia, long TTS significantly improved OS (HR = 0.56; p = 0.01) and PFS (HR = 0.62; p = 0.02), while no survival benefit was observed for TTS in patients who were nonsarcopenic (p > 0.05)., Conclusions: Sarcopenia does not independently impact OS or PFS. Patients with sarcopenia benefit from a longer surgical time interval after NCRT. In addition, preoperative evaluation of muscle quality may aid in optimizing surgical timing to improve outcomes., Competing Interests: Disclosure: The authors declare that they have no conflicts of interest. Ethical Approval: The TIMES study was approved by the Ethics Committee for Medical Research and NEW Medical Technology of Sichuan Cancer Hospital (SCCHEC-02-2023-134) and performed in accordance with the principles of the Declaration of Helsinki., (© 2025. Society of Surgical Oncology.)
Published: 2025
Full Text: View/download PDF

40. Microbial production systems and optimization strategies of antimicrobial peptides: a review.

Author: Lou M, Ji S, Wu R, Zhu Y, Wu J, and Zhang J
Subjects: Bacteria metabolism, Bacteria genetics, Bacteria drug effects, Gene Editing, Anti-Bacterial Agents biosynthesis, Anti-Bacterial Agents pharmacology, Artificial Intelligence, Humans, Industrial Microbiology, Antimicrobial Peptides pharmacology
Abstract: Antibiotic resistance has become a public safety issue of the twenty-first century, posing a growing threat and drawing increased attention. Compared to traditional antibiotics, antimicrobial peptides (AMPs), as naturally produced small peptides, can target multiple pathways within pathogens and render them less prone to developing resistance. This makes them promising alternatives to antibiotics. However, traditional chemical synthesis methods face challenges, such as high costs, low yields, and poor stability, limiting the large-scale industrial production of AMPs. Despite extensive research to improve AMP production efficiency, issues such as low yields and complex extraction processes continue to pose significant barriers to commercial application. Therefore, there is an urgent need for new biosynthesis strategies and optimization methods to enhance AMP production efficiency and quality. This review summarizes the sources, classification, mechanisms of action and recent advances in the microbial synthesis of AMPs. It also explores innovative production methods, including recombinant microbial expression systems, fusion tags, codon optimization, tandem multimer expression, and hybrid peptide expression. Furthermore, we review the applications of gene editing technologies and artificial intelligence in AMP production, providing new perspectives and strategies for efficient, large-scale AMP production., Competing Interests: Declarations. Conflict of interest: The authors declare no competing interests., (© 2025. The Author(s), under exclusive licence to Springer Nature B.V.)
Published: 2025
Full Text: View/download PDF

41. KLF5 promotes esophageal squamous cell carcinoma radioresistance by targeting the Keap1-Nrf2 pathway.

Author: Wang Y, Yang YY, Kamili A, Aishanjiang D, and Liu Y
Abstract: Objective: Esophageal squamous cell carcinoma (ESCC) has high morbidity and mortality in developing countries. The purpose of this article is to study the mechanism of KLF5's effect on ESCC radiosensitivity., Methods: WGCNA gene expression profiling identified core genes associated with ESCC radiosensitivity. KLF5 expression was detected by RT-qPCR. The effects of overexpression or downregulation of KLF5 on anti-irradiated cells' proliferation, migration, invasion, and apoptotic activity were studied through colony formation assay, Transwell assay, and flow cytometry. Western blot can detect the activity of Nrf2 signaling pathway in cells and tissues. The enrichment of KLF5 at the Keap1 promoter was analyzed by ChIP-base, and the binding of KLF5 to Keap1 was analyzed by ChIP and dual-luciferase. They then injected ESCC cells into mice and used radiation to monitor tumor progression., Results: KLF5 is a core gene in ESCC and is significantly associated with radiosensitivity. KLF5 expression is upregulated in drug-resistant ESCC cells. Overexpression of KLF5 significantly increased cell viability and attenuated cellular responses to radiation. KLF5 knockdown reduces radioresistance. After KLF5 overexpression, the Nrf2 signaling pathway was significantly up-regulated, and after KLF5 was up-regulated, the Keap1 signaling pathway was down-regulated. KLF5 inhibits the transcriptional activity of Keap1. Upregulation of Keap1 inhibits the effect of KLF5 overexpression on radioresistance of ESCC cells. KLF5/Keap1 regulates the effects of ESCC on in vivo radiotherapy., Conclusion: KLF5 promotes ESCC radioresistance by inhibiting Keap1 transcription and activating the Nrf2 pathway., Competing Interests: Declarations. Ethics approval and consent to participate: All procedures were ratified by the Ethics Committee of Tumor Hospital Affiliated to Xinjiang Medical University and conducted as per the Declaration of Helsinki. Signed informed consent was received from each eligible participant. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

42. Comment on: "KangDuo surgical robot versus da Vinci robotic system in urologic surgery: a systematic review and meta‑analysis".

Author: Liu Y, Chen H, and Yang N
Abstract: Competing Interests: Declarations. Conflict of interest: All participating authors declare that they have no conflicts of interest.
Published: 2025
Full Text: View/download PDF

43. Highly Thermally Conductive and Flame-Retardant Waterborne Polyurethane Composites with 3D BNNS Bridging Structures via Magnetic Field Assistance.

Author: Jiang H, Xie Y, He M, Li J, Wu F, Guo H, Guo Y, Xie D, Mei Y, and Gu J
Abstract: The microstructure design for thermal conduction pathways in polymeric electrical encapsulation materials is essential to meet the stringent requirements for efficient thermal management and thermal runaway safety in modern electronic devices. Hence, a composite with three-dimensional network (Ho/U-BNNS/WPU) is developed by simultaneously incorporating magnetically modified boron nitride nanosheets (M@BNNS) and non-magnetic organo-grafted BNNS (U-BNNS) into waterborne polyurethane (WPU) to synchronous molding under a horizontal magnetic field. The results indicate that the continuous in-plane pathways formed by M@BNNS aligned along the magnetic field direction, combined with the bridging structure established by U-BNNS, enable Ho/U-BNNS/WPU to exhibit exceptional in-plane (λ // ) and through-plane thermal conductivities (λ ⊥ ). In particular, with the addition of 30 wt% M@BNNS and 5 wt% U-BNNS, the λ // and λ ⊥ of composites reach 11.47 and 2.88 W m -1 K -1 , respectively, which representing a 194.2% improvement in λ ⊥ compared to the composites with a single orientation of M@BNNS. Meanwhile, Ho/U-BNNS/WPU exhibits distinguished thermal management capabilities as thermal interface materials for LED and chips. The composites also demonstrate excellent flame retardancy, with a peak heat release and total heat release reduced by 58.9% and 36.9%, respectively, compared to WPU. Thus, this work offers new insights into the thermally conductive structural design and efficient flame-retardant systems of polymer composites, presenting broad application potential in electronic packaging fields., Competing Interests: Declarations. Conflict of Interest: The authors declare no interest conflict. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Prof. Junwei Gu is an associate editor of Nano-Micro Letters and was not involved in the editorial review or the decision to publish this article., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

44. Hyperconnectivity and Connectome Gradient Dysfunction of Cerebello-Thalamo-Cortical Circuitry in Alzheimer's Disease Spectrum Disorders.

Author: Yao C, Shan Y, Cui B, Chen Z, Bi S, Wang T, Yan S, and Lu J
Subjects: Humans, Female, Male, Aged, Aged, 80 and over, Retrospective Studies, Cerebral Cortex diagnostic imaging, Cerebral Cortex physiopathology, Middle Aged, Neuropsychological Tests, Alzheimer Disease diagnostic imaging, Alzheimer Disease physiopathology, Connectome, Cerebellum diagnostic imaging, Cerebellum physiopathology, Magnetic Resonance Imaging methods, Thalamus diagnostic imaging, Thalamus physiopathology, Cognitive Dysfunction physiopathology, Cognitive Dysfunction diagnostic imaging, Neural Pathways physiopathology, Neural Pathways diagnostic imaging
Abstract: Cerebellar functional connectivity changes have been reported in Alzheimer's disease (AD), but a comprehensive framework integrating these findings is lacking. This retrospective study investigates the cerebello-thalamo-cortical (CTC) circuit in AD, using functional gradient analysis to elucidate deficits and potential biomarkers. We analyzed data from 246 participants enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI-3; NCT02854033), including 58 with AD, 103 with mild cognitive impairment (MCI), and 85 cognitively normal (CN) controls, matched for age and sex. All individuals underwent comprehensive neuropsychological assessments (MMSE, MoCA, ADAS-Cog) and MRI scans. We extracted mean time series for 270 brain regions (an extended Power atlas) and computed pairwise functional connectivity, focusing on CTC circuitry. Thalamic and cerebellar connectivity gradients were derived using voxel-wise correlation matrices and the BrainSpace toolbox, defining thalamic and cerebellar masks from the Melbourne subcortical atlas and AAL atlas, respectively. ANCOVA with post hoc analyses, controlling for age and sex, was conducted to assess abnormal CTC connectivity across AD, MCI, and CN groups. LASSO regression identified edges within the CTC circuitry that significantly differed between AD and CN, MCI and CN, AD and MCI, as well as was used to construct Logistic classification model. Pearson correlations were performed to examine relationships between mean CTC connectivity, individual edges, and cognitive scores (MMSE, MoCA, ADAS-Cog). To explore the hierarchical organization of the thalamus and cerebellum, global gradient distributions were compared across groups using two-sample Kolmogorov-Smirnov tests. Additionally, ANCOVA was applied to compare subfield- and functional-level gradients of the thalamus and cerebellum among AD, MCI, and CN. False discovery rate (FDR) corrections were used, setting the statistical significance threshold was set at P < 0.05. AD and MCI individuals exhibited increased CTC connectivity compared to CN (all P < 0.05). Average CTC connectivity did not correlate with cognitive scores (P > 0.05), but specific CTC edges were correlated. LASSO regression identified 20 discriminative edges, achieving high accuracy in AD-CN classification (AUC = 0.92 training, AUC = 0.80 test). Thalamic and cerebellar gradient distributions differed significantly across groups (all P < 0.05), with specific regions showing distinct gradient scores. Five cerebellar functional networks exhibited decreased gradient scores. Significant CTC hyperconnectivity in AD and MCI compared with CN suggests early thalamic and cerebellar dysregulation. Classification analyses effectively distinguished AD vs. CN but were moderate for MCI vs. CN and limited for MCI vs. AD. Gradient analyses revealed global- and subfield-level disruptions in AD, emphasizing the role of thalamic and cerebellar interactions in cognitive decline and offering potential diagnostic markers and therapeutic targets., Competing Interests: Declarations. Ethics Approval and Consent to Participate: Our research data were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) multicenter public dataset. Approval was granted by the Ethics Committee of each participating ADNI site. Informed consent was obtained from all individual participants included in the dataset. Our study was performed in line with the principles of the Declaration of Helsinki and approved by the Ethics Committee of Xuanwu Hospital Capital Medical University. Human Ethics and Consent to Participate: Not applicable. Competing Interests: The authors declare no competing interests., (© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

45. Light Management in 2D Perovskite Toward High-Performance Optoelectronic Applications.

Author: Dong K, Jiang T, Chen G, Cui H, Wang S, Zhou S, Wang C, Yang Y, Yao F, Tao C, Ke W, and Fang G
Abstract: Two-dimensional Dion-Jacobson (DJ) perovskite has garnered significant attention due to its superior responsivity and operation stability. However, efforts are predominantly focused on discovering new organic spacer to synthesize novel perovskites, while material-form-associated light management, which is crucial for enhancing the photodetector's efficiency, is largely overlooked. Herein, we introduced surface light management strategy into DJ-type perovskite system by synthesizing surface-patterned BDAPbBr 4 (BPB, BDA = NH 3 (CH 2 ) 4 NH 3 ) microplates (MPs) using template-assisted space-confined method, which was further elucidated by theoretical optical simulation. By leveraging surface-patterned MPs to enhance light absorption, the BPB-based photodetectors (PDs) achieved remarkable photoresponse in ultraviolet region, marked by a high on/off ratio (~ 5000), superior responsivity (2.24 A W -1 ), along with large detectivity (~ 10 13 Jones) and low detection limit (68.7 nW cm -2 ). Additionally, the PDs showcased superior light communication and imaging capabilities even under weak-light illumination. Notably, the anisotropic nature of the surface-patterned MPs conferred excellent polarization sensitivity to the PD. These results represented the first demonstration of BPB perovskite in weak-light communication and imaging, as well as in polarized light detection. Our findings offer valuable insights into enhancing photodetector performance and optoelectronic applications through surface light management strategies., Competing Interests: Declarations. Conflict of Interest: The authors declare no conflict of interest. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2025. The Author(s).)
Published: 2025
Full Text: View/download PDF

46. A high temperature responsive UDP-glucosyltransferase gene OsUGT72F1 enhances heat tolerance in rice and Arabidopsis.

Author: Ma Y, Zhao S, Ma X, Dong G, Liu C, Ding Y, and Hou B
Subjects: Glucosyltransferases genetics, Glucosyltransferases metabolism, Hot Temperature, Heat-Shock Response genetics, Transcription Factors genetics, Transcription Factors metabolism, Oryza genetics, Oryza enzymology, Arabidopsis genetics, Gene Expression Regulation, Plant, Plant Proteins genetics, Plant Proteins metabolism, Thermotolerance genetics, Reactive Oxygen Species metabolism, Plants, Genetically Modified
Abstract: Key Message: OsUGT72F1 enhances heat tolerance in plants by improving ROS scavenging and modifying multiple metabolic pathways, under the regulation of transcription factors OsHSFA3 and OsHSFA4a. High temperature is one of the most critical environmental constraints affecting plant growth and development, ultimately leading to yield losses in crops such as rice (Oryza sativa L.). UDP (uridine diphosphate)-dependent glycosyltransferases (UGTs) are believed to play crucial roles in coping with environmental stresses. However, the functions for the vast majority of UGTs under high temperature stress remain largely unknown. In this study, we isolated and characterized a high temperature responsive UDP-glycosyltransferase gene OsUGT72F1 in rice. Our findings demonstrated that overexpression of OsUGT72F1 enhanced heat-stress tolerance, while the mutant plants displayed a sensitive phenotype under the same stress conditions. Ectopic expression of OsUGT72F1 in Arabidopsis thaliana also conferred improved heat tolerance to the plants. Further investigation revealed that OsUGT72F1 reduced the generation of reactive oxygen species (ROS) and boosted the activity of antioxidant enzymes, thereby alleviating oxidative damage under heat-stress conditions. Moreover, transcriptomic analysis indicated that the action of OsUGT72F1 leads to the upregulation of multiple metabolic pathways including phenylpropanoid biosynthesis, zeatin biosynthesis, and flavonoid biosynthesis. In addition, the upstream regulatory mechanism of the OsUGT72F1 gene has been identified. We found that the transcription factors OsHSFA3 and OsHSFA4a can bind to the OsUGT72F1 promoter and enhance its transcription level. Together, this study revealed that the glycosyltransferase gene OsUGT72F1 plays a vital role in the adaptive adjustment of high temperature stress in plants, revealing a new heat tolerance pathway and providing a promising gene candidate for the breeding of heat-resistant crop varieties., Competing Interests: Declarations. Conflict of interest: All authors declare that they have no conflict of interest., (© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

47. HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion.

Author: Tang S, Shi F, Xiao Y, Cai H, Ma P, Zhou Y, Wu Z, Chen S, and Guo W
Subjects: Humans, Male, Female, Middle Aged, Retrospective Studies, Aged, Adult, Neoplasm Invasiveness, Carcinoma, Hepatocellular drug therapy, Liver Neoplasms drug therapy, Liver Neoplasms pathology, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Monoclonal, Humanized administration & dosage, Phenylurea Compounds therapeutic use, Phenylurea Compounds administration & dosage, Phenylurea Compounds adverse effects, Quinolines therapeutic use, Quinolines administration & dosage, Portal Vein pathology, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Infusions, Intra-Arterial
Abstract: Background/objective: The treatment strategy for hepatocellular carcinoma (HCC) with Vp4 (main trunk) portal vein tumor thrombosis (PVTT) remains controversial due to the dismal prognosis. We aimed to investigate the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and tislelizumab in these patients., Methods: This multicenter retrospective study included treatment-naive HCC patients with Vp4 PVTT from 2017 to 2022. They were treated with HAIC plus lenvatinib and tislelizumab (HLP group) or HAIC alone (HAIC group). Overall survival (OS), progression-free survival (PFS), objective response rate (ORR), and adverse events (AEs) were assessed. Propensity score matching (PSM) was performed to reduce bias., Results: In this study, 155 HCC patients with Vp4 PVTT were included, with 38 in the HLP group and 117 in the HAIC group, with 35 per group matched by PSM. The HLP group showed longer median OS (23.2 vs. 6.9 months; HR 0.333, p < 0.001) and PFS (6.6 vs. 2.4 months; HR 0.403, p = 0.002) than the HAIC group. Higher ORR for tumor (77.1% vs. 42.9%, p = 0.003) and PVTT (51.4% vs. 22.9%, p = 0.025) was observed in the HLP group. More patients underwent hepatectomy post-conversion therapy (15.8% vs. 0.9%). Grade 3/4 AEs were higher in the HLP group (47.4% vs. 35.0%), but there was no significant difference, and no grade 5 AEs occurred in either group., Conclusions: HAIC combined with lenvatinib and tislelizumab may be a promising treatment in patients with HCC and Vp4 PVTT because of the improved prognosis and acceptable safety profile., Competing Interests: Declarations. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose. Ethical approval: The study was approved by the Ethics Committee of the present study center. Written informed consent for the treatment was obtained from all patients., (© 2024. Asian Pacific Association for the Study of the Liver.)
Published: 2025
Full Text: View/download PDF

48. The altered resting-state functional connectivity of thalamic subregions in patients with globus pharyngeus.

Author: Hu Y, Zhao J, Jin Y, Du Y, Zhao Q, Xu S, Li L, and Zhou Y
Subjects: Humans, Female, Male, Adult, Brain Mapping methods, Middle Aged, Cerebellum physiopathology, Cerebellum diagnostic imaging, Magnetic Resonance Imaging methods, Thalamus physiopathology, Thalamus diagnostic imaging, Neural Pathways physiopathology, Neural Pathways diagnostic imaging, Rest
Abstract: Globus Pharyngeus (GP) is a somatic symptom that accompanies mood distress. Although the etiology of GP remains unclear, its specific symptom of a false lump sensation in the throat without physical obstruction raises the possibility of alterations in brain networks responsible for somatosensory and emotion processing in patients with GP. To address this possibility, we investigated resting-state functional connectivity (rsFC) in 31 patients with GP and 24 healthy individuals using resting-state functional magnetic resonance imaging. Considering its significance in somatosensory and emotional functions, we focused on rsFC in the subregions of the thalamus. We found significantly decreased rsFC between the right caudal temporal thalamus (rcTtha) and the midcingulate cortex (MCC) as well as significantly decreased rsFC between the right rostral temporal thalamus (rrTtha) and the left cerebellum in the patients with GP. Additionally, within the patient group, the abnormalities in rsFC between the rcTtha and the MCC were correlated with the severity of somatization symptoms but not with depression and anxiety. These findings suggest alterations in the rsFC of thalamic subregions in patients with GP, shedding light on the pathogenesis of GP and potentially leading to improved diagnosis and treatment approaches for the condition., Competing Interests: Declaration. Ethics approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was reviewed and given ethical clearance by the Institutional Review Board of Beijing Friendship Hospital (approval number: 2018-P2-091-01). Consent to participate: Before participation, all participants provided written informed consent. Consent to publish: Patients signed informed consent regarding publishing their data and photographs. Competing interests: The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Published: 2025
Full Text: View/download PDF

49. Global, regional, and national epidemiology of hepatoblastoma in children from 1990 to 2021: a trend analysis.

Author: Guo C, Liu Z, Zhang X, Zhao S, Fan H, Wang H, Li Y, Wang T, Dai L, Huang J, Chen X, and Zhang T
Subjects: Humans, Infant, Child, Preschool, Child, Incidence, Male, Infant, Newborn, Female, Disability-Adjusted Life Years, Hepatoblastoma epidemiology, Liver Neoplasms epidemiology, Global Health statistics & numerical data, Global Burden of Disease trends
Abstract: Background and Purpose: Hepatoblastoma is the most common primary liver cancer in children, yet comprehensive understanding of its epidemiology is limited globally. We aimed to estimate the global trend of hepatoblastoma in children from 1990 to 2021., Methods: We collected data on hepatoblastoma in children aged 0 to 10 years from 1990 to 2021, derived from Global Burden of Disease (GBD) 2021. Three disease burden indicators, including incidence, mortality, and disability-adjusted life-years (DALYs), were studied. The corresponding average annual percentage changes (AAPCs) were used to explore the temporal trends of hepatoblastoma., Results: In 2021, hepatoblastoma accounted for 4048 incident cases, 2416 deaths, and 213,478 DALYs globally. Incidence, mortality, and DALYs of hepatoblastoma decreased significantly from 1990 to 2021, with AAPCs of -2.12, -2.53, and -2.53. The highest incidence of hepatoblastoma was observed among those aged < 28 days in 2021 (2.57 per 100,000 individuals). Only high-income region showed an upward trend in incidence from 1990 to 2021, with an AAPC of 0.57. The Western Pacific region had the fastest decrease in the incidence, mortality, and DALY rate of hepatoblastoma. Human development level (HDI) was positively associated with the AAPC in incidence from 1990 to 2021, while HDI was negatively associated with the incidence, mortality, and DALY rate of hepatoblastoma in 2021., Conclusion: Global efforts over the past 3 decades have substantially decreased the disease burden of hepatoblastoma in children. However, increases in the incidence of hepatoblastoma in high-income region merit attention. The highest disease burden of hepatoblastoma was observed in the neonatal period. Improved understanding of hepatoblastoma epidemiology may facilitate prevention and management., Competing Interests: Declarations. Conflict of interest: All authors declare no potential conflicts of interest., (© 2024. Asian Pacific Association for the Study of the Liver.)
Published: 2025
Full Text: View/download PDF

50. Practical prognostic tools to predict the risk of postoperative delirium in older patients undergoing cardiac surgery: visual and dynamic nomograms.

Author: Bah CS, Mbambara B, Xie X, Li J, Iddi AK, Chen C, Jiang H, Feng Y, Zhong Y, Zhang X, Xia H, Yan L, Si Y, Zhang J, and Zou J
Subjects: Humans, Female, Male, Aged, Retrospective Studies, Prognosis, Risk Factors, Risk Assessment methods, China epidemiology, Aged, 80 and over, Middle Aged, Logistic Models, Incidence, Nomograms, Cardiac Surgical Procedures adverse effects, Postoperative Complications diagnosis, Postoperative Complications epidemiology, Delirium diagnosis, Delirium epidemiology, ROC Curve
Abstract: Purpose: Postoperative Delirium (POD) has an incidence of up to 65% in older patients undergoing cardiac surgery. We aimed to develop two dynamic nomograms to predict the risk of POD in older patients undergoing cardiac surgery., Methods: This was a single-center retrospective cohort study, which included 531 older patients who underwent cardiac surgery from July 2021 to June 2022 at Nanjing First Hospital, China. Univariable and multivariable logistic regression were used to identify the significant predictors used when constructing the models. We evaluated the performances and accuracy, validated, and estimated the clinical utility and net benefit of the models using the receiver operating characteristic (ROC), the 10-fold cross-validation, and decision curve analysis (DCA)., Results: A total of 30% of the patients developed POD, the significant predictors in the preoperative model were ASA ( p < 0.001 OR = 3.220), cerebrovascular disease (p < 0.001 OR = 2.326), Alb (p < 0.037 OR = 0.946), and URE (p < 0.001 OR = 1.137), while for the postoperative model they were ASA (p = 0.044, OR = 1.737), preoperative MMSE score (p = 0.005, OR = 0.782), URE (p = 0.017 OR = 1.092), CPB duration (p < 0.001 OR = 1.010) and APACHE II (p < 0.001, OR = 1.353). The preoperative and postoperative models achieved satisfactory predictive performances, with AUC values of 0.731 and 0.799, respectively. The web calculators can be accessed at https://xxh152.shinyapps.io/Pre-POD/ and https://xxh152.shinyapps.io/Post-POD/ ., Conclusion: We established two nomogram models based on the preoperative and postoperative time points to predict POD risk and guide the flexible implementation of possible interventions at different time points., Competing Interests: Declarations. Ethical approval: This study complied with the principles of the Declaration of Helsinki and postoperative ethical requirements. The ethical approval for the study was obtained from the Nanjing First Hospital Ethics Committee (document number: KY20220621-05-KS-01). Consent to participate: Due to the study’s retrospective nature, no written informed consent was required. This study was not concerned with patients’ confidential information. Consent to publish: Due to the study’s retrospective nature, no consent for publication was required. This study was not concerned with patients’ confidential information. Competing interests: The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
Published: 2025
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

2,992 results on '"Yi Y."'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources